<SEC-DOCUMENT>0001193125-19-265496.txt : 20191010
<SEC-HEADER>0001193125-19-265496.hdr.sgml : 20191010
<ACCEPTANCE-DATETIME>20191010065045
ACCESSION NUMBER:		0001193125-19-265496
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20191010
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20191010
DATE AS OF CHANGE:		20191010

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDNAX, INC.
		CENTRAL INDEX KEY:			0000893949
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				263667538
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12111
		FILM NUMBER:		191145304

	BUSINESS ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323
		BUSINESS PHONE:		9543840175

	MAIL ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PEDIATRIX MEDICAL GROUP INC
		DATE OF NAME CHANGE:	19950801
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d811805d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:md="http://www.mednax.com/20191010" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2019-10-10_to_2019-10-10">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2019-10-10_to_2019-10-10">0000893949</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="md-20191010.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2019-10-10_to_2019-10-10"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000893949</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2019-10-10</xbrli:startDate> <xbrli:endDate>2019-10-10</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="font-size:10pt;width:8.5in;margin:0 auto"> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <p style="margin-bottom:0px;margin-top:4pt"></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">UNITED STATES</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">SECURITIES AND EXCHANGE COMMISSION</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Washington, D.C. 20549</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0px;margin-top:12pt">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2019-10-10_to_2019-10-10">8-K</ix:nonNumeric> </span></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:12pt">CURRENT REPORT</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Pursuant to Section&#160;13 or 15(d)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">of the Securities Exchange Act of 1934</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:12pt">Date of Report (date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2019-10-10_to_2019-10-10" format="ixt:datemonthdayyearen">October&#160;10, 2019</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:24pt;margin-bottom:0px;margin-top:12pt"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2019-10-10_to_2019-10-10">MEDNAX, INC.</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">(Exact Name of Registrant as Specified in Its Charter)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2019-10-10_to_2019-10-10" format="ixt-sec:stateprovnameen">Florida</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2019-10-10_to_2019-10-10">001-12111</ix:nonNumeric> </span></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2019-10-10_to_2019-10-10">26-3667538</ix:nonNumeric> </span></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(State or Other Jurisdiction</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">of Incorporation)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Commission</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">File Number)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(IRS Employer</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Identification No.)</p></td></tr></table> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2019-10-10_to_2019-10-10">1301 Concord Terrace</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2019-10-10_to_2019-10-10">Sunrise</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2019-10-10_to_2019-10-10" format="ixt-sec:stateprovnameen">Florida</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2019-10-10_to_2019-10-10">33323</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Address of principal executive office) (zip code)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt">Registrant&#8217;s telephone number, including area code <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2019-10-10_to_2019-10-10">(954)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2019-10-10_to_2019-10-10">384-0175</ix:nonNumeric> </span></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt">N/A</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Former name or former address, if changed since last report.)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2019-10-10_to_2019-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2019-10-10_to_2019-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12) </span></td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2019-10-10_to_2019-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"> <span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b)) </span></td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2019-10-10_to_2019-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"> <span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c)) </span></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Securities registered pursuant to Section&#160;12(b) of the Act:</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Title of each class</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Trading</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Symbol(s)</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Name of each exchange</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">on which registered</p></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2019-10-10_to_2019-10-10">Common Stock, par value $.01 per share</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2019-10-10_to_2019-10-10">MD</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2019-10-10_to_2019-10-10" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></p></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (&#167;<span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="font-family:Times New Roman;margin-left:0%;text-align:left;text-indent:0%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Emerging growth company&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2019-10-10_to_2019-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal">&#9744;</span></p> <p style="margin-bottom:0px;margin-top:10pt"></p> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <div></div> <p style="margin-top:0"></p></div>

<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto">
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;1.01 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Entry into a Material Definitive Agreement.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">On October&#160;10, 2019, MEDNAX, Inc., a Florida corporation (the &#8220;Company&#8221;), through MEDNAX Services, Inc., a Florida corporation and wholly-owned subsidiary of the Company (&#8220;MEDNAX Services&#8221;), entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with FH MD Buyer, Inc., a Delaware corporation (&#8220;Buyer&#8221;) and affiliate of Frazier Healthcare Partners, pursuant to which Buyer and its parent company will acquire all of the outstanding capital stock (the &#8220;Transaction&#8221;) of MedData Holding Co., a Delaware corporation (&#8220;MedData Holding&#8221;), and MedDirect Holding Co., a Delaware corporation (&#8220;MedDirect Holding&#8221; and together with MedData Holdings, the &#8220;Purchased Companies&#8221;). The Purchased Companies constitute the Company&#8217;s management services service line, which operates as MedData. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">In November 2018, the Company announced the initiation of a process to divest MedData to allow the Company to focus on its core physician services business. In connection with the divestment, the Company classified MedData as discontinued operations beginning in the first quarter of 2019. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Pursuant to the terms and conditions of the Purchase Agreement, at the closing of the Transaction, MEDNAX Services will receive a cash payment of $250&#160;million, subject certain net working capital and similar adjustments, as well as contingent economic consideration in an indirect holding company of Buyer, the value of which is contingent on both short and long-term performance of MedData. The maximum amount payable in respect of such economic consideration is $50&#160;million. In addition, the Company anticipates certain cash tax benefits from the Transaction in the coming quarters. The Company expects to use net proceeds from the Transaction for debt repayment, share repurchases and strategic acquisitions. The Transaction is subject to customary closing conditions and is expected to close during the fourth quarter of 2019. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">The Purchase Agreement contains customary representations, warranties, covenants, including restrictive covenants, and limited indemnifications provisions, including with respect certain ongoing litigation. The Company has agreed to provide certain transition services to MedData after the closing of the Transaction. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">In connection with the Transaction, MEDNAX Services and <span style="white-space:nowrap">Med-Data,</span> Incorporated, a wholly-owned subsidiary of MedData Holding, have entered into a long-term Master Services Agreement pursuant to which, effective as of the closing of the Transaction, MedData has agreed to continue to provide certain revenue cycle support services to MEDNAX Services and its subsidiaries and MEDNAX Services has agreed to provide certain minimum volume levels to MedData. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">The foregoing description of the Purchase Agreement is not complete and is qualified in its entirety by the full text of the Purchase Agreement, a copy of which is attached hereto as Exhibit&#160;2.1 and the terms of which are incorporated herein by reference. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Certain statements and information in this Current Report on Form <span style="white-space:nowrap">8-K</span> may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section&#160;21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to the Company&#8217;s objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as &#8220;believe,&#8221; &#8220;hope,&#8221; &#8220;may,&#8221; &#8220;anticipate,&#8221; &#8220;should,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;positioned,&#8221; &#8220;strategy&#8221; and similar expressions, and are based on assumptions and assessments made by the Company&#8217;s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this Current Report on Form <span style="white-space:nowrap">8-K</span> are made as of the date hereof, and the Company undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future </p> <div></div> <p style="margin-top:0"></p>
 </div>



<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in the Company&#8217;s most recent Annual Report on Form <span style="white-space:nowrap">10-K</span> and its Quarterly Reports on Form <span style="white-space:nowrap">10-Q,</span> including the sections entitled &#8220;Risk Factors&#8221;, as well the Company&#8217;s current reports on Form <span style="white-space:nowrap">8-K,</span> filed with the Securities and Exchange Commission, and include the effects of economic conditions on the Company&#8217;s business; the effects of the Affordable Care Act and potential changes thereto or a repeal thereof; the Company&#8217;s relationships with government-sponsored or funded healthcare programs, including Medicare and Medicaid, and with managed care organizations and commercial health insurance payors; the Company&#8217;s ability to consummate the Transaction; the performance of MedData subsequent to the closing of the Transaction; the timing and contribution of future acquisitions; the effects of share repurchases; and the effects of the Company&#8217;s shared services and operational initiatives. </p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;7.01 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Regulation FD Disclosure.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">On October&#160;10, 2019, the Company issued a press release disclosing the entrance into the Transaction. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein. The information contained in this Item 7.01, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; with the Securities and Exchange Commission nor incorporated by reference in any registration statement or other document filed by the Company under the Securities Act except as shall be expressly set forth by specific reference in such filing. </p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;9.01 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Financial Statements and Exhibit.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">(d) <span style="font-style:Italic">Exhibits</span></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;text-decoration:underline;font-size:10pt;margin-bottom:0px;margin-top:24pt">Exhibit Index </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td></td>
<td></td>
<td></td>
<td style="width:4%;"></td>
<td style="width:92%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td colspan="2" style="white-space:nowrap;vertical-align:bottom;text-align:CENTER;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Exhibit </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt;border-bottom:1pt solid #000000;display:inline-block">Number </p> </td>
<td style="white-space:nowrap;vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;display:inline-block;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:CENTER;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt;border-bottom:1pt solid #000000;display:inline-block">Description of Exhibit </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;&#160;&#160;&#160;2.1* </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d811805dex21.htm">Securities Purchase Agreement, dated October&#160;10, 2019, by and between MEDNAX Services, Inc. and FH MD Buyer, Inc. </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;&#160;99.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d811805dex991.htm">Press Release of MEDNAX, Inc. dated October&#160;10, 2019. </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">104 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Cover Page Interactive Data File (embedded within the Inline XBRL document) </p> </td> </tr> </table> <p style="margin-bottom:0px;margin-top:12pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:2%;vertical-align:top;white-space:nowrap;">* </td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Portions of this exhibit have been omitted pursuant to Item 601(b)(2) of Regulation <span style="white-space:nowrap">S-K</span> because they are both (i)&#160;not material and (ii)&#160;would likely cause competitive harm to the registrant if publicly disclosed. The schedules and similar attachments to this exhibit have been omitted pursuant to Item 601(a)(5) of Regulation <span style="white-space:nowrap">S-K.</span> The Company undertakes to promptly provide an unredacted copy of the exhibit or a copy of the omitted schedules and similar attachments on a supplemental basis to the Commission or its staff, if requested.</td> </tr> </table> <div></div> <p style="margin-top:0"></p>
 </div>



<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">SIGNATURES </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:0px;margin-right:auto">
<tr>
<td style="width:46%;"></td>
<td style="width:1%;"></td>
<td style="width:4%;"></td>
<td></td>
<td style="width:2%;"></td>
<td style="width:1%;"></td>
<td style="width:45%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:center;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:center;">&#160;</td>
<td style="vertical-align:center;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:center;">&#160;</td>
<td colspan="3" style="vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">MEDNAX, INC. </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Date: October&#160;10, 2019 </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">By: </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;margin-bottom:1pt;font-size:10pt;margin-top:0pt;border-bottom:1px solid #000000">/s/ Stephen D. Farber </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:center;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:center;">&#160;</td>
<td style="vertical-align:center;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:center;">&#160;</td>
<td style="vertical-align:center;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:center;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Stephen D. Farber </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Chief Financial Officer </p> </td> </tr> </table> <div></div> <p style="margin-top:0"></p>
 </div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d811805dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF
PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SECURITIES
PURCHASE AGREEMENT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BY AND BETWEEN </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FH MD BUYER, INC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AND </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">MEDNAX SERVICES, INC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">October&nbsp;10, 2019 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE I THE TRANSACTION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic Transaction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated Closing Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Payment Determination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preparation of Closing Statement; Cooperation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment of the Closing Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Withholding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE II CLOSING CONDITIONS AND DELIVERABLES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conditions to the Obligations of the Buyer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conditions to the Obligations of the Seller</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE III REPRESENTATIONS AND WARRANTIES REGARDING THE BUYER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Status</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Power and Authority</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enforceability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Violations; Consents and Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Brokers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due Diligence</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment Representation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post-Closing Solvency</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IV REPRESENTATIONS AND WARRANTIES REGARDING THE SELLER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Status</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Power and Authority; Ownership</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enforceability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Violations; Consents and Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Brokers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE V REPRESENTATIONS AND WARRANTIES REGARDING THE COMPANIES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Status</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capitalization; Subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Violation; Consents and Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Undisclosed Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Absence of Certain Developments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Environmental Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title to Properties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-i- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compliance with Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Labor and Employment Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Affiliated Transactions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Privacy and Security</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Health Care Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.21</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Brokers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Customers and Suppliers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.23</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment Company Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VI <FONT STYLE="white-space:nowrap">PRE-CLOSING</FONT> COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Further Assurances; Closing Conditions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notices and Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regulatory Filings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conduct of the Business</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Access to Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exclusivity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidentiality Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing Cooperation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VII POST-CLOSING COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Further Assurances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director and Officer Liability and Indemnification</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Access to Books and Records</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intercompany Obligations and Arrangements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Release</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Litigation Support</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller Restrictive Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">A&amp;M Project</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VIII NO SURVIVAL; LIMITED INDEMNIFICATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Survival of Representations; Survival of Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IX TERMINATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE X GENERAL PROVISIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entire Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment; Waiver</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-ii- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Binding Effect; Assignment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Counterparts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interpretation; Disclosure Schedule</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governing Law; Interpretation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forum Selection and Consent to Jurisdiction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Specific Performance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Arm&#146;s Length Negotiations; Drafting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acknowledgement by the Buyer; Disclaimers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidentiality; Publicity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Made Available</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Electronic Delivery</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representation of the Companies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Recourse</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WAIVER OF JURY TRIAL</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Financing Sources</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.21</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Strict Construction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Captions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>EXHIBITS </U></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="77%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit&nbsp;A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Definitions</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit&nbsp;B</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Illustrative Closing Statement Methodology</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit C</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Transition Services Agreement</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>DISCLOSURE SCHEDULES </U></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.04</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No Violation; Consents and Approvals &#150; Seller</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.05</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No Brokers &#150; Seller</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.01</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Corporate Status</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.02</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Capitalization</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.03</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No Violations; Consents and Approvals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.04</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Financial Statements</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.05</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Undisclosed Liabilities</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.06</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Absence of Certain Developments</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.07</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Litigation</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.08(a)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Environmental Matters</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.09(a)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Personal Property</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.09(b)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Leased Real Property</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Compliance with Laws</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.12(a)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Labor and Employment Matters</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.12(b)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Contingent Workers</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.12(c)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Labor and Employment Matters</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.12(f)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Employment Loss</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.12(g)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Contractual Employment</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.12(h)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Restricted Employees</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.12(i)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Labor Exceptions</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.13(a)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Employee Benefit Plans</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iii- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="84%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Tax Matters</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Insurance</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.16</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Affiliated Transactions</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.17(a)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Material Contracts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.17(b)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Material Contracts &#150; Exception</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.18</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Intellectual Property</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.21</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No Brokers &#150; Companies</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.22(a)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Top Customers</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.22(b)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Top Suppliers</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.02</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Notices and Consents</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.04</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Conduct of Business</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;7.04(b)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Excluded Affiliate Agreements</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;7.04(c)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Parent-Level Agreements</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;7.04(d)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Shared Agreements</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>OTHER SCHEDULES </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule 1.04(d)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Allocation Statement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Schedule 8.02</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Indemnification Matters</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iv- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SECURITIES PURCHASE AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This SECURITIES PURCHASE AGREEMENT (this &#147;<U>Agreement</U>&#148;) is entered into as of October&nbsp;10, 2019, by and between FH MD
Buyer, Inc., a Delaware corporation (the &#147;<U>Buyer</U>&#148;), and MEDNAX Services, Inc., a Florida corporation (the &#147;<U>Seller</U>&#148;). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them on
<U>Exhibit A</U> attached hereto. The Buyer and the Seller are referred to collectively herein as the &#147;<U>Parties</U>&#148; and each individually as a &#147;<U>Party</U>.&#148; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>RECITALS </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,
the Seller owns 100% of the issued and outstanding Equity Securities (the &#147;<U>Outstanding Securities</U>&#148;) of MedData Holding Co., a Delaware corporation (&#147;<U>MedData Holding</U>&#148;), and MedDirect Holding Co., a Delaware
corporation (&#147;<U>MedDirect Holding</U>&#148; and together with MedData Holding, the &#147;<U>Companies</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the
Seller desires to sell to the Buyer all of its right, title, and interest in and to the Purchased Securities, and the Buyer desires to purchase from the Seller all of the Seller&#146;s right, title, and interest in and to the Purchased Securities,
in each case, upon the terms and subject to the conditions set forth in this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, as a further inducement and as a
condition to the Seller entering into this Agreement, the Sponsors have entered into one or more limited guarantees, dated as of the date hereof, in favor of the Seller guaranteeing certain payment obligations of the Buyer arising under
<U>Section</U><U></U><U>&nbsp;9.02</U> of this Agreement on the terms specified therein; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, as a further inducement and as a
condition to the Buyer and the Seller entering into this Agreement, on the date hereof, FH MD Holdings, LLC (&#147;<U>Holdings</U>&#148;) and the Seller have entered into that certain Contribution and Exchange Agreement, pursuant to which, among
other things, on the terms and subject to the conditions set forth therein, the Seller shall, at the Closing, contribute to Holdings the Contributed Shares, and in exchange therefor, Holdings shall issue to the Seller certain equity interests of
Holdings as described therein (such transactions, the &#147;<U>Exchange Transactions</U>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, as a further inducement and
as a condition to the Buyer entering into this Agreement, on the date hereof, Mednax, Inc. has entered into a guarantee and restrictive covenant (the &#147;<U>Parent Guarantee and Restrictive Covenant Agreement</U>&#148;), pursuant to which, among
other things, Mednax, Inc. has guaranteed the obligations of the Seller hereunder and agreed to certain other covenants and agreements as set forth therein; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the respective governing bodies of the Buyer and the Seller have approved this Agreement and the transactions contemplated hereby, in
each case, upon the terms and subject to the conditions set forth herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual covenants, representations, and warranties herein made, and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE
TRANSACTION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.01&nbsp;&nbsp;&nbsp;&nbsp;<U>Basic Transaction</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the terms and subject to the conditions set forth in this Agreement, at the Closing, the Buyer shall purchase, acquire, and accept from the Seller, and
the Seller shall sell, transfer, assign, convey, and deliver to the Buyer all right, title, and interest in and to all of the Purchased Securities, free and clear of any and all Liens. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.02&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase Price</U>.<U> </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the adjustments set forth in this <U>ARTICLE I</U>, the aggregate consideration for the Purchased Securities will be an amount of cash equal to
(a)<U></U>&nbsp;the Purchase Price, plus (b)<U></U>&nbsp;the Cash Amount, minus (c)<U></U>&nbsp;the Debt Amount, minus (d)<U></U>&nbsp;the Transaction Expenses Amount, minus (e)<U></U>&nbsp;the amount by which Working Capital is less than the
Working Capital Target, if any, plus (f)<U></U>&nbsp;the amount by which Working Capital is greater than the Working Capital Target, if any (the &#147;<U>Closing Payment</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing Payment</U>. At the Closing, the Buyer shall: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Pay the Seller the Estimated Closing Payment; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Pay, on behalf of the Seller, the Companies, and their respective Subsidiaries, the Transaction Expenses Amount
(other than any portion thereof that is payable following the Closing). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Payments</U>. All payments to the
Seller pursuant to this <U>Section&nbsp;1.02</U> shall be made by wire transfer of immediately available funds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.03&nbsp;&nbsp;&nbsp;&nbsp;<U>Estimated Closing Payment</U>. Not less than three (3)&nbsp;Business Days prior to the Closing Date, the Seller
shall deliver to the Buyer a written statement (the &#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Statement</U>&#148;) that shall set forth the Seller&#146;s good faith estimate of (a)&nbsp;the Cash Amount, (b)&nbsp;the Debt Amount,
(c)&nbsp;the Transaction Expenses Amount, (d)&nbsp;Working Capital (the &#147;<U>Estimated Working Capital</U>&#148;) and based on the Estimated Working Capital, the Working Capital Surplus, if any, or the Working Capital Deficit, if any, and
(e)&nbsp;based on the foregoing clauses (a)-(d), the Closing Payment (the &#147;<U>Estimated Closing Payment</U>&#148;). The <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Statement and the calculations contained therein will be prepared in
good faith by the Seller from the Books and Records of the Companies and their respective Subsidiaries in accordance with the Accounting Principles and the definitions contained herein. The Seller shall reasonably cooperate with the Buyer in its
review of the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Statement and shall consider in good faith any comments the Buyer may have thereon. The Seller shall redeliver an updated <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Statement
one (1)&nbsp;Business Day prior to the Closing Date, and all Closing Date payments to be made under <U>Section</U><U></U><U>&nbsp;1.02(a)</U> shall be calculated using such updated <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.04&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing Payment Determination</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing Statement</U>. As promptly as possible, but in any event within ninety (90)&nbsp;days after the Closing
Date, the Buyer shall prepare and deliver to the Seller an unaudited consolidated balance sheet of the Companies and their respective Subsidiaries as of the Effective Time together with a statement setting forth the Buyer&#146;s good faith
calculation of (i)&nbsp;the Working Capital and the Working Capital Surplus or Working Capital Deficit, if any, (ii)&nbsp;the Cash Amount, (iii)&nbsp;the outstanding amount of all Debt, (iv)&nbsp;the Transaction Expenses Amount, and (v)&nbsp;based
on the amounts set forth in clauses (i)-(iv), the Closing Payment (the &#147;<U>Closing Statement</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Objections</U>. After delivery of the Closing Statement by the Buyer, the Seller and its Representatives shall
be permitted to make written inquiries of the Buyer and its Representatives regarding questions, concerns, or disagreements with the Closing Statement arising in the course of their review thereof. If the Seller has any objections to the Closing
Statement, then the Seller will deliver to the Buyer a written statement (an &#147;<U>Objection Statement</U>&#148;) setting forth each particularized disputed or objected item (the &#147;<U>Objection Disputes</U>&#148;) to the Closing Statement
including the basis for such dispute or objection and the Seller&#146;s proposed resolution of each such Objection Dispute. Any component of Buyer&#146;s Closing Statement that is not the subject of an Objection Dispute set forth in the Objection
Statement shall be final and binding on the Parties and will be the basis for the adjustments described in <U>Section&nbsp;1.06</U>. If an Objection Statement is not delivered to the Buyer within forty-five (45)&nbsp;days after receipt of the
Closing Statement by the Seller, then the Closing Statement as originally received by the Seller shall be final, binding, and <FONT STYLE="white-space:nowrap">non-appealable</FONT> by the Parties. If an Objection Statement is timely delivered within
such forty-five (45)&nbsp;day period, then the Buyer and the Seller shall negotiate in good faith to resolve any Objection Disputes within thirty (30)&nbsp;days after the delivery of the Objection Statement (as such thirty (30)&nbsp;day period may
be extended pursuant to the mutual written agreement of the Seller and the Buyer, the &#147;<U>Negotiation Period</U>&#148;) (and all such discussions and communications related thereto that occur during such period shall be governed by Rule 408 of
the Federal Rules of Evidence and any applicable similar state Law unless otherwise specified in a writing by the Seller and the Buyer). If, during the Negotiation Period, the Seller and the Buyer are able to resolve any Objection Disputes in
written statement jointly executed by the Buyer and the Seller, then such agreed upon amounts shall become final, binding, <FONT STYLE="white-space:nowrap">non-appealable,</FONT> and conclusive on the Parties and not subject to further appeal or
collateral attack. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Independent Auditor</U>. If the Buyer and Seller do not reach a final resolution of each
Objection Dispute within the Negotiation Period, then Seller and the Buyer shall retain and submit each unresolved Objection Dispute to (A)&nbsp;Plante Moran, and (B)&nbsp;if Plante Moran is not available or is not independent at such time, an
independent accounting firm mutually agreed upon by the Buyer and the Seller (the &#147;<U>Independent Auditor</U>&#148;) to resolve such Objection Disputes. Each of the Buyer and the Seller agrees to execute a customary joint engagement letter with
respect to Independent Auditor, in a form and substance reasonably acceptable to such parties. The Independent Auditor shall be instructed to promptly resolve any unresolved Objection Disputes and, in any event, to make its determination in respect
of such Objection Disputes in writing within thirty (30)&nbsp;days following its retention. Except as expressly set forth herein, neither the Buyer nor </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Seller shall have or conduct any communication, either written or oral, with the Independent Auditor without the other Party either being present (or having waived or declined its right to be
present) or receiving a concurrent copy of any written communication. The Buyer and the Seller may furnish a single written statement of their position with respect all of the Objection Disputes (the &#147;<U>Initial Submissions</U>&#148;) to the
Independent Auditor within twenty (20)&nbsp;days following the Independent Auditor&#146;s retention. The Initial Submissions shall be strictly limited to the Objection Disputes that remain in dispute and that have not been resolved in writing by the
Buyer and the Seller prior to submission of the dispute to the Independent Auditor, and with regard to any Objection Dispute, Buyer shall not be entitled to submit to the Independent Auditor a value for such disputed item that is more favorable to
Buyer than that value set forth on the Closing Statement and the Seller shall not be entitled to submit to the Independent Auditor a value for any such Objection Dispute that is more favorable to the Seller than the value set forth in the Objection
Statement. The Independent Auditor shall forward a copy of each applicable party&#146;s Initial Submission to Buyer and Seller, as applicable. Within ten (10)&nbsp;Business Days after the expiration of such initial twenty (20)&nbsp;day period, the
Buyer and the Seller may deliver to the Independent Auditor a single written response to the other Party&#146;s Initial Submission (the &#147;<U>Written Responses</U>&#148;), which Written Responses the Independent Auditor shall forward to the Buyer
and the Seller, as applicable.&nbsp;The Buyer and the Seller, and their respective Representatives, shall reasonably cooperate with the Independent Auditor during its engagement and respond on a timely basis with information or access to documents
or personnel reasonably requested by the Independent Auditor, all with the intent to fairly and in good faith resolve all Objection Disputes as promptly as reasonably practicable. The Parties shall be entitled to have a judgment entered on the final
written report provided by the Independent Auditor in any court of competent jurisdiction. In resolving any particular Objection Dispute, the Independent Auditor (1)&nbsp;may not assign a value to any particular item greater than the greatest value
for such item claimed by either the Buyer or the Seller, or less than the lowest value for such item claimed by the Buyer or the Seller in their respective Initial Submissions, (2)&nbsp;shall be bound by the principles set forth in this Agreement,
(3)&nbsp;shall act as an expert and not as an arbitrator, and (4)&nbsp;shall limit its review to matters specifically set forth in the Initial Submissions and Written Responses. For the avoidance of doubt, in no event shall the Independent Auditor
be entitled to make any adjustment to the Net Working Capital Target. The Independent Auditor shall conduct its determination activities in a manner wherein all materials submitted to it are held in confidence and shall not be disclosed to third
parties. The Independent Auditor&#146;s determination of such Objection Disputes shall be final and binding upon the Parties, absent Fraud or manifest error. The fees and expenses of the Independent Auditor shall initially be borne and paid fifty
percent (50%) by the Buyer, on the one hand, and fifty&nbsp;percent&nbsp;(50%) by the Seller, on the other hand; <U>provided</U>, that such fees and expenses shall ultimately be borne by the Buyer, on the one hand, and the Seller, on the other hand,
based upon the percentage which the aggregate portion of the contested amount as set forth in each Party&#146;s Initial Submissions not awarded to each Party bears to the aggregate amount actually contested by such Party. The Independent Auditor
shall include a calculation of the portion of their fees and expenses to be paid by each of the Seller and the Buyer in its final written determination delivered pursuant to this <U>Section&nbsp;1.04(c)</U>. The final Closing Statement, however
determined pursuant to this <U>Section&nbsp;1.04</U>, will produce the Working Capital Surplus or Working Capital Deficit, if any, and the Cash Amount, the Debt Amount, and the Transaction Expenses Amount, in each case, to be used to determine the
final Closing Payment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Seller and Buyer hereby agree (i)&nbsp;that the consideration
paid by Buyer for the purchase of Equity Securities of MedData Holding is seventy percent (70%) of the aggregate Purchase Price, and that the consideration paid by Buyer for the purchase of Equity Securities of MedDirect Holding is thirty percent
(30%) of the aggregate Purchase Price, (ii)&nbsp;that the consideration paid for the purchase of the Equity Securities of MedData Holding shall be allocated among the assets of MedData Holding and its Subsidiaries in accordance with the methodology
set forth on <U>Schedule 1.04(d)</U> (the &#147;<U>Allocation Statement</U>&#148;), and (iii)&nbsp;to take consistent positions with respect to the Purchase Price allocation in the foregoing clause (i)&nbsp;and the Allocation Statement for all U.S.
federal, state and local income Tax purposes except as otherwise required by applicable Law </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.05&nbsp;&nbsp;&nbsp;&nbsp;<U>Preparation of
Closing Statement; Cooperation</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Preparation of Closing Statement</U>. The Closing Statement (including
the calculation of the Closing Payment and each of the components thereof) shall be prepared and calculated in accordance with the Accounting Principles and definitions contained in this Agreement, except that the Closing Statement (including the
calculations of Working Capital and the Cash Amount) shall: (i)&nbsp;not include any purchase accounting or other adjustment arising out of the consummation of the transactions contemplated by this Agreement; and (ii)&nbsp;be based on facts and
circumstances as they exist prior to the Closing and shall exclude the effect of any act, decision or event occurring on or after the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Cooperation</U>. Following the Closing, the Buyer shall, and shall cause the Companies and their respective
Subsidiaries, and their respective officers, employees, consultants, accountants, and agents to, reasonably cooperate with the Seller and its Representatives in connection with its review of the Closing Statement and the preparation of the Objection
Statement and upon prior written notice or request by the Seller, to provide (without undue interruption to the operations of any of the Companies, and during normal business operations)&nbsp;(i) copies of such information as may be reasonably
requested by the Seller that were actually used to prepare the Closing Statement or otherwise reasonably related thereto (<U>provided</U>, that in no event shall any of the Buyer, the Companies or their Subsidiaries be required to create any new
documentation solely for purposes of complying with this <U>Section&nbsp;1.05(b)</U>) solely for purposes of reviewing the Closing Statement and (ii)&nbsp;reasonable access to the accounting and controlling personnel responsible for the preparation
of the Closing Statement, in each case, in connection therewith or in connection with resolving any Objection Disputes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.06&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment of the Closing Payment</U>. Upon the final determination of the Closing Statement pursuant to
<U>Section&nbsp;1.04:</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;If the Closing Payment (as finally determined in accordance with
<U>Section&nbsp;1.04</U>) exceeds the Estimated Closing Payment (such excess, the &#147;<U>Positive Adjustment Amount</U>&#148;), then promptly (but in any event within five (5)&nbsp;Business Days after the final determination of the Closing
Statement pursuant to <U>Section&nbsp;1.04</U>), the Buyer will pay, or cause to be paid, the Positive Adjustment Amount to the Seller. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;If the Estimated Closing Payment (as finally determined in
accordance with <U>Section 1.04</U>) exceeds the Closing Payment (such excess, the &#147;<U>Negative Adjustment Amount</U>&#148;), then promptly (but in any event within five (5) Business Days after the final determination of the Closing Statement
pursuant to <U>Section 1.04</U>), the Seller will pay the Negative Adjustment Amount to the Buyer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;All
payments required pursuant to this <U>Section&nbsp;1.06</U> will be deemed to be adjustments for Tax purposes to the Purchase Price to the extent permitted by applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.07&nbsp;&nbsp;&nbsp;&nbsp;<U>Withholding</U>. <U>T</U>he Buyer, the Companies and each of their respective Subsidiaries (each, individually,
a &#147;<U>Withholding Party</U>&#148;) will deduct and withhold from any amount payable or otherwise deliverable pursuant to this Agreement any such amounts as are required to be deducted or withheld therefrom under the Code, or under any provision
of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Tax Law, taking into account any applicable exemption under such Law. To the extent such amounts are so deducted or withheld and duly and timely paid to the appropriate Taxing
Authority, such amounts will be treated for all purposes under this Agreement as having been paid to the Person to whom such amounts would otherwise have been paid. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CLOSING
CONDITIONS AND DELIVERABLES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.01&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing</U>. The closing of the transactions contemplated by this
Agreement (the &#147;<U>Closing</U>&#148;) shall take place electronically by the mutual exchange of facsimile or portable document format (.pdf) signatures on (a)&nbsp;the second (2<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP>) Business
Day following satisfaction or waiver (in writing by the Person with the authority to provide such waiver) of all of the closing conditions set forth in <U>Sections 2.02</U> and <U>2.03</U> (other than those to be satisfied at the Closing, but
subject to the satisfaction or waiver of those conditions at such time), or (b)&nbsp;such other date as is mutually agreed in writing by the Buyer and the Seller; <U>provided</U>, <U>however</U>, that in no event shall the Closing occur earlier than
November&nbsp;25, 2019 without the prior written consent of the Buyer. The date on which the Closing actually occurs is referred to herein as the &#147;<U>Closing Date</U>.&#148; All transactions contemplated herein to occur on and as of the Closing
Date shall be deemed to have occurred simultaneously and to be effective as of 12:01 a.m. Eastern Time on the Closing Date (the &#147;<U>Effective Time</U>&#148;); <U>provided</U>, that the Closing Payment shall be calculated as if the transactions
contemplated by this Agreement had not occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.02&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to the Obligations of the Buyer</U>. The
obligations of the Buyer to consummate the transactions contemplated by this Agreement are subject to the satisfaction of the following conditions as of the Closing Date, any or all of which may be waived in whole or in part by the Buyer: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;(i) the representations and warranties of the Seller (other than Fundamental Representations) set forth in
<U>ARTICLE IV</U> and <U>ARTICLE V</U>, or in any certificate delivered hereunder, shall be true and correct in all respects as of the date hereof and as of the Closing Date, as if made on the Closing Date, without regard to any
&#147;material,&#148; &#147;materiality,&#148; &#147;in all material respects,&#148; &#147;Material Adverse Effect&#148; or other similar qualifications, in each case, except for (a) those representations and warranties that are made expressly as of
a particular date, which need only be true and correct in all respects as of such date, and (b) those instances in which </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the failure of the representations and warranties to be true and correct have not, and would not reasonably be expected to have individually or in the aggregate, a Material Adverse Effect and
(ii)&nbsp;the Fundamental Representations shall be true and correct in all respects at and as of the date hereof and as of the time of the Closing, as if made on the Closing Date (other than those representations and warranties that are made
expressly as of a specified date, which representations and warranties shall be true and correct in all respects as of such date); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;the Seller shall have performed in all material respects all of its obligations required to be performed under this
Agreement at or prior to the Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;no Governmental Authority shall have enacted, promulgated, issued,
entered, or enforced any injunction, judgment, order, or ruling enjoining, materially delaying, restraining, or prohibiting the transactions contemplated by this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;the substantially concurrent consummation of the Exchange Transactions in accordance with the terms of the
Contribution and Exchange Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;since the date of this Agreement, there shall not have occurred or be
continuing any change, event, circumstance or development that has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;the Seller shall have delivered to the Buyer a certificate from the Seller stating that the Seller is not a
&#147;foreign person&#148; for purposes of Section&nbsp;1445 of the Code; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;the Seller shall have delivered to
the Buyer a copy of the certificate of good standing of each of the Companies and their respective material Subsidiaries from the Secretary of State of their respective State of organization dated within ten (10)&nbsp;Business Days of the Closing
Date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;the Seller shall have delivered to the Buyer a certificate of the Secretary of the Seller certifying
that attached thereto are true and correct copies of the resolutions or written consent duly adopted by the governing body of the Seller authorizing the execution, delivery, and performance of this Agreement and the Related Agreements to which the
Seller is a party, and the consummation of all transactions contemplated hereby and thereby; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;the Seller shall
have delivered to the Buyer a certificate from an officer of the Seller certifying that the conditions set forth in <U>Sections 2.02(a)</U>, <U>2.02(b)</U> and <U>2.02(e)</U> has been and is satisfied; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;the Seller shall have delivered to the Buyer no later than three (3)&nbsp;Business Days prior to the Closing Date
evidence satisfactory to the Buyer that (x)&nbsp;each of the Companies and their respective Subsidiaries have been, or concurrently with the Closing will be, released from their guarantee and any other obligations under the Existing Credit Facility
and (y)&nbsp;the Liens, if any, granted by the Companies or their respective Subsidiaries in connection with the Existing Credit Facility, including any Liens with respect to the Outstanding Securities, are, or concurrently with the Closing will be,
forever terminated, discharged and of no further force or effect, as applicable, in each case in accordance with the terms of the Existing Credit Facility and the documents executed in connection therewith; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;the Seller shall have delivered to the Buyer duly executed and
delivered agreements effecting the termination of each Affiliate Arrangement (other than those Affiliate Arrangements expressly set forth on <U>Section&nbsp;7.04(b) of the Disclosure Schedules</U> and other than this Agreement and the Related
Agreements), in each case, in form and substance reasonably acceptable to Buyer; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;the Seller shall have
delivered to the Buyer resignations or documents evidencing the removal, effective as of the Closing, of the officers and directors of each of the Companies identified in writing by the Buyer not less than five (5)&nbsp;Business Days prior to the
Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;the Seller shall have delivered to the Buyer counterparts of each Related Agreement to which Seller
or any of the Companies is a party duly executed by the Seller or Company or applicable Affiliate party thereto; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;the Seller shall have delivered to the Buyer such other documents or instruments as Buyer reasonably requests and
are reasonably necessary to effect the transactions contemplated by this Agreement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;the Seller shall have
delivered to the Buyer a copy of a USB or disc containing a true, correct, and complete copy of the electronic data room created in connection with the transactions contemplated by this Agreement at least two (2)&nbsp;Business Days prior to the
Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.03&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to the Obligations of the Seller</U>. The obligation of the Seller to consummate the
transactions contemplated by this Agreement is subject to the satisfaction of the following conditions as of the Closing Date, any or all of which may be waived in whole or in part by the Seller: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;the representations and warranties of the Buyer set forth in <U>ARTICLE III</U> shall be true and correct in all
material respects as of the date hereof and as of the Closing Date, as of if made on the Closing Date (except for representations and warranties qualified by materiality, which shall be true and correct in all respects), except for (a)&nbsp;those
representations and warranties that address matters only as of a particular date, which need only be true and correct in all material respects as of such date, and (b)&nbsp;those instances in which the failure of the representations and warranties
to be true and correct would not in the aggregate have a material adverse effect on the ability of the Buyer to consummate the transactions contemplated by this Agreement and perform all of its obligations hereunder; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall have performed in all material respects all of its material obligations required to be performed
under this Agreement at or prior to the Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;no Governmental Authority shall have enacted, promulgated,
issued, entered, or enforced any injunction, judgment, order, or ruling enjoining, materially delaying, restraining, or prohibiting the transactions contemplated by this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;the substantially concurrent consummation of the Exchange Transactions in accordance with the terms of the
Contribution and Exchange Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-12- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;copies of the resolutions duly adopted by the governing body of
the Buyer authorizing the execution, delivery, and performance of this Agreement and the Related Agreements to which the Buyer is a party, and the consummation of all transactions contemplated hereby and thereby; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall have delivered to the Seller a copy of the certificate of good standing of the Buyer from the
Secretary of State of Delaware dated within ten (10) Business Days of the Closing Date. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES REGARDING THE BUYER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Buyer represents and warrants to the Seller as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.01&nbsp;&nbsp;&nbsp;&nbsp;<U>Status</U>. The Buyer is a corporation duly organized, validly existing and in good standing under the Laws of
the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.02&nbsp;&nbsp;&nbsp;&nbsp;<U>Power and Authority</U>. The Buyer has all requisite corporate power and authority
to execute and deliver this Agreement and the Related Agreements to which it is a party, to perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. All corporate acts or proceedings
required to be taken by the Buyer to authorize the execution and delivery of this Agreement and the Related Agreements to which it is a party and the performance of the Buyer&#146;s obligations hereunder and thereunder have been properly taken. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.03&nbsp;&nbsp;&nbsp;&nbsp;<U>Enforceability</U>. This Agreement and the Related Agreements have been duly authorized, executed, and
delivered by the Buyer and, assuming the due and valid authorization, execution, and delivery of this Agreement and the Related Agreements by the Seller, this Agreement and the Related Agreement constitute legal, valid, and binding obligations of
the Buyer, enforceable against it in accordance with its terms, except as the same may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, or similar Laws affecting or relating to creditors&#146; rights generally and general
equitable principles (the &#147;<U>Bankruptcy and Equity Exceptions</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.04&nbsp;&nbsp;&nbsp;&nbsp;<U>No Violations; Consents
and Approvals</U>. The execution and delivery of this Agreement and the Related Agreements to which it is a party by the Buyer, and the consummation by it of the transactions contemplated hereby and thereby will not (a)&nbsp;violate any provision of
the Organizational Documents of the Buyer, (b)&nbsp;violate any material Law applicable to, binding upon, or enforceable against the Buyer, (c)&nbsp;result in any material breach of, or constitute a material default (or an event which would, with
the passage of time or the giving of notice or both, constitute a material default) under, or give rise to a right of payment under or the right to terminate, amend, modify, abandon, or accelerate, any Contract to which the Buyer is a party or
bound, (d)&nbsp;result in the creation or imposition of any Lien upon any of the material property or material assets of the Buyer, or (e)&nbsp;require the consent or approval of any Governmental Authority or any other Person. Buyer does not meet
the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">size-of-person</FONT></FONT> test under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, 15 U.S.C. section 18a, as amended, and the applicable rules as set forth in 16
C.F.R. Part 801. <U></U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-13- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.05&nbsp;&nbsp;&nbsp;&nbsp;<U>No Brokers</U>. The Buyer has not incurred any obligation for
any finder&#146;s or broker&#146;s or agent&#146;s fees or commissions or similar compensation in connection with the transactions contemplated by this Agreement and the Related Agreements to which it is a party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.06&nbsp;&nbsp;&nbsp;&nbsp;<U>Financing</U>. The Buyer has delivered to the Seller a true, complete and correct copy of (i)&nbsp;one or more
executed commitment letters from the Sponsors dated as of the date of this Agreement (including all exhibits, schedules and annexes thereto, collectively, the &#147;<U>Equity Commitment Letter</U>&#148;, and the commitments under the Equity
Commitment Letter, the &#147;<U>Equity Financing Commitments</U>&#148;), pursuant to which the Sponsors have committed and agreed to provide equity financing in the amount set forth therein for the purposes set forth therein (the &#147;<U>Equity
Financing</U>&#148;), (ii) an executed debt commitment letter, dated as of the date of this Agreement (including all exhibits, schedules and annexes thereto, and as amended from time to time after the date hereof solely as permitted by
<U>Section</U><U></U><U>&nbsp;6.08</U>, the &#147;<U>Debt Commitment Letter</U>&#148; and, together with the Equity Commitment Letter, the &#147;<U>Commitment Letters</U>&#148;, and the commitments under the Debt Commitment Letter, the &#147;<U>Debt
Financing Commitments</U>&#148; and, together with the Equity Financing Commitments, the &#147;<U>Financing Commitments</U>&#148;), from the Debt Financing Sources, pursuant to which the Debt Financing Sources have committed, subject to the terms
and conditions set forth therein, to provide to the Buyer debt financing in the amounts set forth therein (the &#147;<U>Debt Financing</U>&#148;; <U>provided</U>, that for purposes of this Agreement, the Debt Financing shall also include, after the
date hereof, to the extent Alternative Financing from any other Person is obtained in accordance with this Agreement, such Alternative Financing, the Debt Financing, together with the Equity Financing, is collectively referred to as the
&#147;<U>Financing</U>&#148;). As of the date hereof, (i)&nbsp;the Financing Commitments have not been amended, modified, restated, replaced, terminated, waived or withdrawn, (ii)&nbsp;other than amendments or modifications solely to add lenders,
lead arrangers, bookrunners and similar entities who have not executed the Debt Financing Commitment as of the date hereof, no such amendment, modification, restatement, replacement, termination, waiver or withdrawal of the Financing Commitments is
contemplated and (iii)&nbsp;the Financing Commitments are in full force and effect and constitute the legal, valid and binding obligations of the Buyer and, to the Knowledge of the Buyer, the other parties thereto, in each case, subject to
applicable bankruptcy, insolvency, reorganization, moratorium or other Laws affecting generally the enforcement of creditors&#146; rights and subject to general principles of equity. As of the date hereof, the Financing to be funded on the Closing
Date is subject to no conditions precedent other than those set forth in the Financing Commitments. As of the date hereof, the Buyer is not aware of any fact or occurrence that would result in any additional conditions or contingencies to the
availability of the Financing to be funded on the Closing Date. As of the date hereof, no event has occurred which, with or without notice, lapse of time or both, would reasonably be expected to constitute a default or breach by the Buyer under the
Financing Commitments and, as of the date hereof, assuming the conditions set forth in <U>Section</U><U></U><U>&nbsp;2.02</U> have been satisfied, the Buyer has no reason to believe that it will be unable to satisfy the conditions to the funding of
the Financing contemplated on the Closing Date or that the Financing will not be made available to the Buyer on the Closing Date. As of the date hereof, none of the Sponsors nor the Debt Financing Sources have notified the Buyer of its intention to
terminate or withdraw the Financing Commitments, as applicable, or the commitments thereunder. The Buyer has paid (or caused to be paid) in full any and all commitment or other fees and expenses required by the terms of the Financing Commitments to
be paid on or prior to the date hereof and has otherwise satisfied all of the other conditions required to be satisfied pursuant to the terms of the Financing Commitments, if any, prior to the date of this Agreement. For the avoidance of doubt,
Buyer acknowledges that its ability to obtain any financing (including without limitation, the Financing) it is not a condition to its obligation to consummate the Closing and the other transactions under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-14- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.07&nbsp;&nbsp;&nbsp;&nbsp;<U>Due Diligence</U>. The Buyer has completed such
investigations of the Companies and their respective Subsidiaries as it deems necessary and appropriate and has received all of the information that it has requested from the Companies and their respective Subsidiaries in connection with the
execution and delivery of this Agreement and the Related Agreements to which it is a party and the consummation of the transactions contemplated hereby and thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.08&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment Representation</U>. The Buyer is acquiring the Purchased Securities for its own account with the
present intention of holding the Purchased Securities for investment purposes and not with a view to or for sale in connection with any public distribution of such securities in violation of any federal or state securities Laws. The Buyer is an
&#147;accredited investor&#148; as defined in Regulation D promulgated by the Securities and Exchange Commission under the Securities Act. The Buyer acknowledges and agrees that the representations and warranties made by the Seller in this Agreement
(as qualified by the Disclosure Schedule) supersede, replace, and nullify in every respect the data set forth in any other document, material, or statement, whether written or oral, made available to the Buyer or any of its Representatives with
respect to transactions contemplated by this Agreement and the Buyer shall be deemed to have not relied on any data contained in such data for any purpose whatsoever, including as a promise, projection, guaranty, representation, warranty, or
covenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.09&nbsp;&nbsp;&nbsp;&nbsp;<U>Post-Closing Solvency</U>. Assuming that (i)&nbsp;the representations and warranties of the
Sellers set forth in this Agreement and certificate delivered hereunder by the Seller or the Companies are true and correct as of the Closing, (ii)&nbsp;the Sellers and the Companies shall have complied with each of their respective covenants,
obligations and other agreements under this Agreement, immediately after giving effect to the transactions contemplated hereby, the Buyer and its Subsidiaries (including the Companies and their Subsidiaries), taken as a collective group on a
consolidated basis, will not (i)&nbsp;be insolvent because the &#147;fair market value&#148; of its assets is less than the value of &#147;all of its liabilities, including contingent and other liabilities,&#148; as such quoted terms are generally
determined in accordance with applicable federal Laws governing determinations of insolvency of debtors, (ii)&nbsp;have unreasonably small capital with which to engage in its business or (iii)&nbsp;have incurred debts beyond its ability to pay as
they become due in the Ordinary Course of Business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.10&nbsp;&nbsp;&nbsp;&nbsp;<U>Litigation</U>. There are no Proceedings pending or,
to the Knowledge of the Buyer, expressly threatened in writing against the Buyer or its Affiliates, at Law or in equity, or before or by any Governmental Authority which reasonably would be expected to affect the legality, validity, or
enforceability of this Agreement or the consummation of the transactions contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-15- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES REGARDING THE SELLER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth in the Disclosure Schedule, the Seller represents and warrants to the Buyer as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.01&nbsp;&nbsp;&nbsp;&nbsp;<U>Status</U>. The Seller is a corporation duly organized, validly existing and in good standing under the Laws of
the State of Florida. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.02&nbsp;&nbsp;&nbsp;&nbsp;<U>Power and Authority; Ownership</U>. The Seller has all requisite corporate power and
authority to execute and deliver this Agreement and the Related Agreements to which it is a party, to perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. All corporate acts or
proceedings required to be taken by the Seller to authorize the execution and delivery of this Agreement and the Related Agreements to which it is a party and the performance of the Seller&#146;s obligations hereunder and thereunder have been
properly taken. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.03&nbsp;&nbsp;&nbsp;&nbsp;<U>Enforceability</U>. This Agreement and the Related Agreements have been duly authorized,
executed, and delivered by the Seller. Assuming the due and valid authorization, execution, and delivery of this Agreement and the Related Agreements by the Buyer, this Agreement and the Related Agreements constitute legal, valid, and binding
obligations of the Seller, enforceable against the Seller in accordance with its terms, except as enforceability may be limited by the Bankruptcy and Equity Exceptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.04&nbsp;&nbsp;&nbsp;&nbsp;<U>No Violations; Consents and Approvals</U>. Except as set forth on <U>Section</U><U></U><U>&nbsp;4.04 of the
Disclosure Schedule</U>, the execution and delivery of this Agreement and the Related Agreements to which it is a party by the Seller, and the consummation by the Seller of the transactions contemplated hereby and thereby will not (a)&nbsp;violate
any provision of the Organizational Documents of the Seller, (b)&nbsp;violate any material Law applicable to, binding upon, or enforceable against the Seller, (c)&nbsp;result in any material breach of, or constitute a material default (or an event
which would, with the passage of time or the giving of notice or both, constitute a material default) under, or give rise to a right of payment under or the right to terminate, amend, modify, abandon, or accelerate, any Contract to which the Seller
is a party or bound, (d)&nbsp;result in the creation or imposition of any Lien upon any of the Outstanding Securities owned by the Seller or any asset or property of the Companies, or (e)&nbsp;require the consent or approval of any Governmental
Authority or any other Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.05&nbsp;&nbsp;&nbsp;&nbsp;<U>No Brokers</U>. Except as set forth <U>Section</U><U></U><U>&nbsp;4.05 of
the Disclosure Schedule</U>, the Seller has not incurred any obligation for any finder&#146;s or broker&#146;s or agent&#146;s fees or commissions or similar compensation in connection with the transactions contemplated by this Agreement and the
Related Agreements to which it is a party for which the Seller or the Companies or any of their respective Subsidiaries may be liable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.06&nbsp;&nbsp;&nbsp;&nbsp;<U>Litigation</U>. There is no Proceeding pending or, to the Knowledge of the Seller, threatened that are
reasonably likely to prohibit or restrain the ability of the Seller to enter into this Agreement, the Related Agreements or consummate the transactions contemplated hereby or thereby. As of the date of this Agreement, there is no Proceeding pending
or, to the Knowledge of such Seller, threatened against the Seller or any of its Affiliates and there is no outstanding Order against the Seller or any of its Affiliates, in each case, that, individually or in the aggregate, would be reasonably
expected to have the effect of preventing, delaying, making illegal or otherwise materially interfering with any of the transactions contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-16- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES REGARDING THE COMPANIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth in the Disclosure Schedule, the Seller hereby represents and warrants to the Buyer as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.01&nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate Status</U>. Each of the Companies and their respective Subsidiaries are duly organized, validly
existing, and in good standing under the Laws of the jurisdictions set forth on <U>Section</U><U></U><U>&nbsp;5.01 of the Disclosure Schedule</U>. Each of the Companies and their respective Subsidiaries has the requisite corporate or limited
liability company power and authority, as applicable, to conduct its business as it is now being conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.02&nbsp;&nbsp;&nbsp;&nbsp;<U>Capitalization; Subsidiaries</U>. <U>Section</U><U></U><U>&nbsp;5.02 of the Disclosure Schedule</U> sets forth
(a)&nbsp;the number of issued and outstanding Equity Securities of each of the Companies and their respective Subsidiaries, and (b)&nbsp;the record and beneficial owner of all such Equity Securities as of the date hereof. All of the Outstanding
Securities are validly issued, fully paid, and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> The Outstanding Securities constitute the only outstanding Equity Securities of the Companies. Except as set forth on
<U>Section</U><U></U><U>&nbsp;5.02 of the Disclosure Schedule</U>, there are no outstanding rights, options, warrants, convertible securities, subscription rights, conversion rights, exchange rights, or other agreements that require the Companies or
their respective Subsidiaries to issue or sell any Equity Securities or to redeem or otherwise acquire any of its outstanding Equity Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.03&nbsp;&nbsp;&nbsp;&nbsp;<U>No Violation; Consents and Approvals</U>. Except as set forth on <U>Section</U><U></U><U>&nbsp;5.03 of the
Disclosure Schedule</U>, the execution and delivery of this Agreement and the Related Agreements and the consummation of the transactions contemplated hereby and thereby will not (a)&nbsp;violate any provision of the Organizational Documents of the
Companies or their respective Subsidiaries, (b)&nbsp;violate any material Law applicable to, binding upon or enforceable against the Companies or their respective Subsidiaries, (c)&nbsp;result in any material breach of, or constitute a material
default (or an event which would, with the passage of time or the giving of notice or both, constitute a material default) under, or give rise to a right of payment under or the right to terminate, amend, modify, abandon or accelerate, any Material
Contract or Permit held by the Companies or their respective Subsidiaries, or otherwise relating to or used in the operation of the Business, (d)&nbsp;result in the creation or imposition of any Lien upon any of the material property or material
assets of the Companies or their respective Subsidiaries, or (e)&nbsp;require the consent or approval of any Governmental Authority or any other Person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.04&nbsp;&nbsp;&nbsp;&nbsp;<U>Financial Statements</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Seller has made available to the Buyer copies of the: (a) audited balance sheets of the Companies and their
respective Subsidiaries, on a consolidated basis, as of December&nbsp;31, 2017 and December 31, 2018, and the related statements of operations, parent company equity, and cash flows for the years ended December 31, 2017 and December&nbsp;31, 2018
(collectively, the &#147;<U>Audited Financial Statements</U>&#148;), and (b)&nbsp;unaudited balance sheets of the Companies and their respective Subsidiaries, on a consolidated basis, as of August<U></U>&nbsp;31, 2019 (the &#147;<U>Latest Balance
Sheet Date</U>&#148;) and the related statements of operations for the eight (8)<U></U>&nbsp;month period ended on the Latest Balance Sheet Date (the &#147;<U>Interim Financial Statements</U>,&#148; and together
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-17- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with the Audited Financial Statements, the &#147;<U>Financial Statements</U>&#148;). The Financial Statements fairly present, in accordance with the past practices of the Companies and their
respective Subsidiaries, in all material respects the financial position of the Companies at each of the balance sheet dates and the results of operations for each of the periods covered thereby. Except as otherwise set forth on <U>Section&nbsp;5.04
of the Disclosure Schedule</U>, the Financial Statements have been prepared from the Books and Records in accordance with GAAP as consistently applied by the Companies and their respective Subsidiaries, except that the Interim Financial Statements
do not reflect customary <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments and do not contain footnote disclosures and other presentation items, none of which, individually or in the aggregate, shall be material to any of the Companies or
their respective Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Companies and their respective Subsidiaries maintain a system of internal
accounting controls sufficient to provide reasonable assurances (i)&nbsp;that transactions are recorded in the Books and Records of the Companies as necessary to permit preparation of financial statements in accordance with GAAP, (ii)&nbsp;that
receipts and expenditures of the Companies and their respective Subsidiaries are being made in accordance with appropriate authorizations of management and the applicable Company&#146;s board of directors and (iii)&nbsp;regarding prevention or
timely detection of unauthorized acquisition, use or disposition of assets of the Companies and their respective Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except for reserves or allowances set forth on the face of the Interim Financial Statements, all of the accounts
receivable of the Companies and their respective Subsidiaries are valid and enforceable claims arising from bona fide arm&#146;s length transactions in the Ordinary Course of Business, and are not subject to any pending, or, to the Knowledge of the
Companies, threatened, <FONT STYLE="white-space:nowrap">set-off</FONT> or counterclaim. From and after January&nbsp;1, 2019, the Companies and their respective Subsidiaries have collected their respective accounts receivable in the Ordinary Course
of Business. All accounts receivable payable to or for the benefit of the Companies or their respective Subsidiaries reflected in the Financial Statements, or acquired by the Companies or their respective Subsidiaries after the date thereof and
before the Closing Date, constitute bona fide receivables resulting from the sale of inventory, services or other obligations in favor of the Companies and their Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Except for reserves or allowances set forth on the face of Interim Financial Statements, all accounts payable and
notes payable of the Companies and their respective Subsidiaries arose in bona fide arm&#146;s length transactions in the Ordinary Course of Business, and no such account payable or note payable is delinquent in its payment. From and after
June&nbsp;30,&nbsp;2019, the Companies and their respective Subsidiaries have paid their respective accounts payable in the Ordinary Course of Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Companies and their respective Subsidiaries have no outstanding or unpaid principal, accrued interest, accrued
fees or other charges or payment obligations relating to outstanding indebtedness of the Companies and their respective Subsidiaries for borrowed money, which shall include the current and long term portion of all such indebtedness of the Companies
and their respective Subsidiaries and any prepayment premium, termination fees, expenses, breakage costs or penalties due upon payment of such indebtedness. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-18- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.05&nbsp;&nbsp;&nbsp;&nbsp;<U>Undisclosed Liabilities</U>. The Companies and their
respective Subsidiaries do not have any Liabilities except for liabilities (a)&nbsp;expressly and specifically reflected or reserved against on the face of the Audited Financial Statements (as opposed to in the footnotes thereto), (b) that have
arisen since January&nbsp;1, 2019 in the Ordinary Course of Business none of which results from or arises out of any breach of contract, breach of warranty, tort, infringement, environmental liability, misappropriation or violation of Law and none
of which is material (individually or in the aggregate) or (c)&nbsp;otherwise expressly disclosed on <U>Section&nbsp;5.05 of the Disclosure Schedule</U>. Without limiting the generality of the foregoing, neither the Companies nor any of their
respective Subsidiaries has any Liability in respect of, relating to or arising out of or in connection with any Excluded Businesses, and all Liabilities of the Companies and their respective Subsidiaries are limited solely and exclusively to those
in respect of, relating to or arising out of or in connection with the Business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.06&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence of Certain
Developments</U>. Since January&nbsp;1, 2019,<B> </B>except for the transactions contemplated by this Agreement and the Related Agreements, and except as otherwise set forth on <U>Section&nbsp;5.06 of the Disclosure Schedule</U>, there has not been
with respect to the Business, the Companies or their respective Subsidiaries, any: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;occurrence of any fact,
change, effect, circumstance, event, occurrence, condition, development or state of facts, that either individually or in the aggregate has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;damage, destruction, or loss, whether covered by insurance or not, having an uninsured cost in excess of
$200,000; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;entry into, amendment, termination, or waiver of any right under any employment, severance, or
termination Contract with any officer, director, or employee earning more than $200,000 per annum, of the Companies or their respective Subsidiaries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;increase in the compensation or benefits (including severance or termination payments) payable, or to become
payable, by the Companies or their respective Subsidiaries to any of their respective officers, employees, directors, independent contractors, consultants, or Affiliates or any adoption of, or increase in, any bonus, equity, severance, insurance,
pension, or other employee benefit plan, payment or arrangement made to, for or with any such officers, employees, directors, independent contractors, consultants or any Affiliate of the Companies or their respective Subsidiaries, except for such
increases which occurred in the Ordinary Course of Business for individuals whose annual compensation does not exceed, in the aggregate $200,000; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;change in accounting policies, principles, or methodologies or in the manner the Companies and their respective
Subsidiaries keep their respective Books and Records or any change by the Companies or their respective Subsidiaries of their current practices with regard to accounting for sales, receivables, payables, or expenses (including any change in
depreciation or amortization policies or rates); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-19- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;other than with respect to this Agreement or sales of inventory
in the Ordinary Course of Business, the sale, assignment, transfer, lease, license, or other disposition of, or entry into a Contract to sell, assign, transfer, lease, license, or otherwise dispose of, any asset or property having a value in excess
of $100,000 individually, or $250,000 in the aggregate; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;changes in the ownership of the Companies and their
respective Subsidiaries, including the issuance, repurchase, redemption, assignment, or transfer of any Equity Securities of the Companies or their respective Subsidiaries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;actions which, if taken after the date of this Agreement, would have required the consent of the Buyer pursuant to
<U>Section&nbsp;6.04</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;adoption, change or revocation of any material Tax election, adoption or change of
any material Tax accounting method, change in Tax classification (as a corporation, partnership or disregarded entity), settlement or compromise of any material Tax claim or assessment, amendment of any Tax Return, extension or waiver of any statute
of limitation in respect of Taxes, request for any Tax ruling, or entry into any Tax sharing or similar agreement; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;any Contract to consummate any of the foregoing. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.07&nbsp;&nbsp;&nbsp;&nbsp;<U>Litigation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <U>Section&nbsp;5.07 of the Disclosure Schedule</U>, there are currently no, and since the
Lookback Date, there have not been any material Proceedings pending or, to the Knowledge of the Companies, threatened against the Companies or their respective Subsidiaries (or against any of the Companies and their respective Subsidiaries in
respect of the Business) or, to the Knowledge of the Companies, pending or threatened against any director, officer or key employee thereof (in their capacity as such) and, to the Knowledge of the Companies, there is no basis for any of the
foregoing since the Lookback Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;None of the Companies nor their respective Subsidiaries is a party to or
subject to the provisions of any material judgment, Order, writ, injunction, decree, or award of any Governmental Authority. There is no Proceeding, demand, notice, warning, inspection, safety alert, import alert, recall, enforcement proceeding or
request for information pending or, to the Knowledge of the Companies, threatened relating to the Business of the Companies and their respective Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.08&nbsp;&nbsp;&nbsp;&nbsp;<U>Environmental Matters</U>. Except as set forth on <U>Section&nbsp;5.08(a) of the Disclosure Schedule</U>, since
the Lookback Date: (a)&nbsp;neither the Business nor the operation thereof has violated any applicable Environmental Law in any material respect and there has been no condition or occurrence which, with notice or the passage of time or both, would
constitute a material violation of or result in any material liability under any Environmental Law; (b)&nbsp;the Companies and their respective Subsidiaries possess all Environmental Permits required under any applicable Environmental Law for the
conduct or operation of the Business (or any part thereof), and the Companies and their respective Subsidiaries have operated in compliance with all of the requirements and limitations included in such Environmental Permits; (c)&nbsp;the Companies
and their respective Subsidiaries have not received any notice, Order, or claim indicating that the Business </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-20- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or the operation of any of their facilities is or may be in violation of any Environmental Law or any Environmental Permit or that they are or may be liable under any Environmental Law;
(d)&nbsp;there are no material outstanding or pending written claims, complaints, citations, reports or other written notices that have been issued to the Companies and their respective regarding any liabilities, including any investigatory,
remedial or corrective obligations, arising under applicable Environmental and Safety Requirements; (e)&nbsp;no Hazardous Material has been Released: (i)&nbsp;as a result of the Companies and their respective Subsidiaries&#146; operations;
(ii)&nbsp;at, to, on, under or from any real property currently or formerly owned, leased, or operated by the Companies and their respective Subsidiaries; or (iii)&nbsp;at, to, on, under or from any real property at or to which the Companies and
their respective Subsidiaries have disposed of, arranged for the disposal of, or transported any Hazardous Material, in the case of each of (i), (ii) and (iii), in an amount, manner, condition or concentration that would reasonably be expected to
result in any material liability to the Companies and their respective Subsidiaries under any Environmental and Safety Requirements; (f)&nbsp;the Companies and their respective Subsidiaries have not assumed (whether by contract or operation of Law)
any material liability (including any investigatory, corrective or remedial obligation) of any other Person arising under any Environmental and Safety Requirements; and (g)&nbsp;the Companies and their respective Subsidiaries has made available to
the Buyer true, complete and accurate copies of all material environmental audits, assessments and reports, and all other material documents bearing on environmental, health or safety compliance or liabilities (contingent or otherwise), which are in
their possession or reasonable control and relate to the Companies and their respective Subsidiaries, or any of the past or current operations, properties or facilities of the Companies and their respective Subsidiaries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.09&nbsp;&nbsp;&nbsp;&nbsp;<U>Title to Properties</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in <U>Section&nbsp;5.09(a) of the Disclosure Schedule</U>, and other than the Parent-Level
Agreements and Shared Agreements, the Companies or one of their respective Subsidiaries has good, valid and marketable title to, or valid leasehold interests in, and is the lawful owner of, all of the assets, properties and Contracts used by any of
the Companies and their respective Subsidiaries, free and clear of any Liens, other than Permitted Liens, and the assets, properties and Contracts owned by the Companies and their respective Subsidiaries (including as of the Closing Date, Related
Agreements), and the employees and consultants engaged or employed directly and exclusively by the Companies and their respective Subsidiaries, constitute all the assets, properties, Contracts, employees and consultants and related rights that are
required to permit the Buyer to carry on the Business immediately following the Closing in substantially all respects as it was conducted immediately prior to the Closing Date by the Seller and its Affiliates. Except as set forth on
<U>Section&nbsp;5.09(a) of the Disclosure Schedule</U>, to the Knowledge of the Companies, all equipment and other tangible assets owned or leased by the Companies or their respective Subsidiaries that have a net book value in excess of $50,000 are
in operating condition, ordinary wear and tear excepted, and are adequate for the purposes for which such properties and assets are presently used in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;5.09(b) of the Disclosure Schedule</U> sets forth a summary of each lease for leased assets that
have annual rental payments in excess of $100,000 and each real property lease (the &#147;<U>Real Property Leases</U>&#148;) regardless of annual rental payment amount, describing the name of the lessor and the address for the premises leased under
each applicable Real Property Lease (the &#147;<U>Leased Real Property</U>&#148;). Except for the Leased Real Properties, none </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-21- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Companies or their respective Subsidiaries is a party to any agreement (whether oral or written) pursuant to which it leases real estate (either as lessor or lessee). The Seller has made
available to the Buyer a true, correct, and complete copy of each real property lease and all amendments and modifications thereto, and such real property leases have not been modified or amended, in each case, in a material respect, since
June&nbsp;30, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;All of the Real Property Leases are in full force and effect, and valid and enforceable in
accordance with their respective terms. None of the Companies or their respective Subsidiaries have received any written notice of any event of default or event which constitutes (with notice or lapse of time or both) a material default by any of
the Companies and any of their respective Subsidiaries under any Real Property Lease. All rent and other amounts due and payable with respect to the Real Property Leases have been paid through the date of this Agreement or are otherwise reflected in
the Working Capital. The Companies and their respective Subsidiaries have not received written notice that the landlord with respect to any Real Property Lease would refuse to renew such Real Property Lease upon expiration of the period thereof upon
substantially the same terms, except for rent increases consistent with past experience or market rentals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The
Leased Real Property set forth in <U>Section&nbsp;5.09(b) of the Disclosure Schedule</U> constitutes all of the real property used or occupied by the Companies and their respective Subsidiaries. With respect to the Real Property Leases, (i)&nbsp;the
Companies&#146; and their respective Subsidiaries&#146; possession and quiet enjoyment of such Leased Real Property has never been disturbed, and there are no current disputes with respect to any such Leased Real Property, (ii)&nbsp;no security
deposit or portion thereof deposited with respect to any Real Property Lease has been applied in respect of a breach or default under such Real Property Lease which has not been redeposited in full, (iii)&nbsp;the Companies and their respective
Subsidiaries do not owe any brokerage commissions or finder&#146;s fees with respect to any Real Property Lease, and (iv)&nbsp;none of the Real Property Leases is subject to any sublease, license, or other right of another party to use or occupy
such Leased Real Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.10&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with Laws</U>. Except as set forth in <U>Section&nbsp;5.10 of the
Disclosure Schedule</U>, the Companies and their respective Subsidiaries are, and since the Lookback Date have been in all material respects, in compliance with all Laws applicable to the Companies, their respective Subsidiaries, or the Business,
including, but not limited to, all Health Care Laws. Since the Lookback Date, the Companies and their respective Subsidiaries have not received notice of, and there has never been, any citation, fine or penalty imposed or asserted against any
Company for any violation or alleged violation of such Laws. There have not been any material violations of any Law by any of the Companies or their respective Subsidiaries in its submissions or reports to any Governmental Entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.11&nbsp;&nbsp;&nbsp;&nbsp;<U>Permits</U>. The Companies and their respective Subsidiaries possess, and have possessed at all times since the
Lookback Date, in full force and effect all material Permits required by any Laws to own and operate their business as currently or previously conducted and operated. The Companies and their respective Subsidiaries (i)&nbsp;are not in material
violation of any Laws or Permits, and, to the Knowledge of the Companies, no Governmental Authority, or third party have threatened any such Proceeding, and (ii)&nbsp;have not received written notice that any Governmental Authority has taken or is
taking action to limit, suspend, modify, or revoke any Permits. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-22- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.12&nbsp;&nbsp;&nbsp;&nbsp;<U>Labor and Employment Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;5.12(a) of the Disclosure Schedule</U> contains a complete and accurate list of all current
employees of the Companies and their respective Subsidiaries as of the date of this Agreement, setting forth for each employee, his or her position or title; whether classified as exempt or <FONT STYLE="white-space:nowrap">non-exempt</FONT> for wage
and hour purposes; whether paid on a salary, hourly or commission basis and the employee&#146;s actual annual base salary or base hourly wage (as applicable); bonus target (except for any bonus that is discretionary); date of hire; business
location; status (i.e., active or inactive and if inactive, the type of leave and estimated duration); any visa or work permit status and the date of expiration, if applicable; and the total amount of bonus, retention, or severance and other amounts
required to be paid to such employee because of the Closing or the transactions contemplated herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section 5.12(b) of the Disclosure Schedule</U> contains a complete and accurate list of all of the independent
contractors, consultants, temporary employees, leased employees or other agents employed or used by the Companies and their respective Subsidiaries and classified by the Companies or their respective Subsidiaries as other than employees, or
compensated other than through wages paid by the Companies or their respective Subsidiaries through the Companies payroll department (&#147;<U>Contingent Workers</U>&#148;), showing for each Contingent Worker such individual&#146;s role in the
business and fee or compensation arrangements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Companies and their respective Subsidiaries is, and
for the past three years has been, in material compliance with all applicable laws and regulations respecting labor and employment matters, including fair employment practices, workplace safety and health, work authorization and immigration,
unemployment compensation, workers&#146; compensation, terms and conditions of employment, employee leave and wages and hours, including payment of minimum wages and overtime. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;None of the Companies nor their respective Subsidiaries is delinquent in any payments to any employee or Contingent
Worker for any wages, salaries, commissions, bonuses, fees, or other direct compensation due with respect to any services performed for it or amounts required to be reimbursed to such employees or Contingent Workers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Since the Lookback Date, to the Knowledge of the Companies, no allegations of sexual harassment have been made to
the Companies or their respective Subsidiaries against any employee of the Companies and their respective Subsidiaries who is employed as a senior level executive, officer or supervisor of the Companies or their respective Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;None of the Companies nor any of their respective Subsidiaries has, since the Lookback Date, experienced a
&#147;plant closing,&#148; &#147;business closing,&#148; or &#147;mass layoff&#148; or similar group employment loss as defined in the federal Worker Adjustment and Retraining Notification Act (the &#147;<U>WARN Act</U>&#148;) or any similar state,
local or foreign law or regulation affecting any site of employment of the Companies or any of their respective Subsidiaries or one or more facilities or operating units within any site of employment or facility of the Companies or any of their
respective Subsidiaries. Except as set forth on <U>Section&nbsp;5.12(f) of the Disclosure Schedule</U>, during the ninety&nbsp;(90) day period preceding the date hereof, no employee of the Companies or any of their Subsidiaries has suffered an
&#147;employment loss&#148; as defined in the WARN Act with respect to the Companies or any of their respective Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-23- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <U>Section&nbsp;5.12(g) of the Disclosure
Schedule</U>, all employees of the Companies and their respective Subsidiaries are employed <FONT STYLE="white-space:nowrap">at-will</FONT> and no employee is subject to any employment contract with the Companies or their respective Subsidiaries,
whether oral or written. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section 5.12(h) of the Disclosure Schedule</U> identifies each executive,
department head and division head, and other key employee (as the term &#147;key employee&#148; may be interpreted in good faith by the Company) that has signed a form of restrictive covenant agreement and includes a form of each such agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <U>Section&nbsp;5.12(i) of the Disclosure Schedule</U>, (a)&nbsp;the Companies and
their respective Subsidiaries are not, and have not been during the past three (3)&nbsp;years, a party to or bound by any collective bargaining agreement, (b)&nbsp;to the Knowledge of the Companies, there is currently no organized effort by any
labor union to organize any employees of the Companies and their respective Subsidiaries into one or more collective bargaining units, (c)&nbsp;the Companies and their respective Subsidiaries have not experienced any strike or material grievance,
claim of unfair labor practices, or other collective bargaining dispute since the Lookback Date and none are pending or expressly threatened in writing, and (d)&nbsp;the Companies and their respective Subsidiaries have not committed any material
unfair labor practice since the Lookback Date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.13&nbsp;&nbsp;&nbsp;&nbsp;<U>Employee Benefit Plans</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section 5.13(a) of the Disclosure Schedule</U> sets forth a list of all employee benefit plans within the meaning
of Section&nbsp;3(3) of ERISA whether or not subject to ERISA, employment agreements, and welfare, supplemental unemployment benefit, bonus, pension, retirement, severance, change in control, profit sharing, executive compensation, deferred
compensation, incentive compensation, stock compensation, stock purchase, stock option, stock appreciation, phantom stock option, health or other medical, dental, life, disability or other insurance plan, program, agreement or arrangement sponsored,
maintained or contributed to or required to be contributed to by (i)&nbsp;any of the Companies or their respective Subsidiaries, or (ii)&nbsp;with respect to such plans, agreements or arrangements under which any of the Companies or their respective
Subsidiaries could reasonably be expected to have any material Liability, any entity that would have ever been considered a single employer with any of the Companies or their respective Subsidiaries under Section&nbsp;4001(b) of ERISA or part of the
same &#147;controlled group&#148; as any of the Companies or their respective Subsidiaries for purposes of Section&nbsp;302(d)(3) of ERISA (&#147;<U>ERISA Affiliate</U>&#148;) for the benefit of their employees or former employees, director or
officer, and their dependents or beneficiaries (collectively, the &#147;<U>Plans</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Plans
that is intended to be qualified under Section&nbsp;401(a) of the Code has received either a favorable determination letter from the Internal Revenue Service or is a <FONT STYLE="white-space:nowrap">pre-approved</FONT> prototype or volume submitter
plan, and to the Knowledge of the Companies, no event or omission has occurred that would cause any Plan to lose such qualification. Each of the Plans is, and has been, operated in material compliance with the Code, ERISA, and all applicable Laws
and has been administered in all material respects in accordance with applicable Laws and its terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-24- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;With respect to the Plans, all required contributions have been
made or properly accrued in all material respects in accordance with the terms of the applicable Plan and applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Seller has made available to the Buyer true and complete copies of (i)&nbsp;plan documents, amendments, and
related trust agreements, (ii)&nbsp;all material correspondence with all Governmental Authorities with respect to each Plan with respect to events that occurred, or are alleged to have occurred, since the Lookback Date, and (iii)&nbsp;the latest
financial statements for the Plans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Companies and their respective ERISA Affiliates do not currently
maintain and have never maintained, and are not required currently and have never been required to contribute to or otherwise participate in, (i)&nbsp;any defined benefit pension plan or any plan, program or arrangement subject to Title IV of ERISA,
Section&nbsp;412 of the Code, Section&nbsp;302 of ERISA, (ii)&nbsp;any employee pension or welfare benefit plan to which more than one unaffiliated employer contributes and which is maintained pursuant to one or more collective bargaining agreements
(a &#147;<U>Multiemployer Plan</U>&#148;); (iii) any funded welfare benefit plan within the meaning of Section&nbsp;419 of the Code, (iv)&nbsp;any &#147;multiple employer plan&#148; (within the meaning of Section&nbsp;210 of ERISA or
Section&nbsp;413(c) of the Code), or (v)&nbsp;any &#147;multiple employer welfare arrangement&#148; (as such term is defined in Section&nbsp;3(40) of ERISA), and none of the Companies nor any ERISA Affiliate has ever incurred any liability under
Title IV of ERISA that has not been paid in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;All required reports and descriptions (including Form 5500
Annual Reports, Summary Annual Reports, and Summary Plan Descriptions) have been filed or distributed in compliance with the applicable requirements of ERISA and the Code with respect to each Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;No Proceeding with respect to any Plan or any fiduciary or service provider thereof (other than routine claims for
benefits) is pending or, to Knowledge of the Companies, threatened, and to the Knowledge of the Companies, there is no reasonable basis for any such Proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;None of the Plans provides health care or any other <FONT STYLE="white-space:nowrap">non-pension</FONT> benefits to
any employees after their employment is terminated (other than as required by Part 6 of Subtitle B of Title I of ERISA or similar state law) and none of the Companies has ever promised to provide such post-termination benefits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;(i) Each Plan may be amended, terminated, or otherwise modified by the Companies to the greatest extent permitted
by applicable Law. (ii)&nbsp;None of the Companies nor any ERISA Affiliates have announced its intention to modify or terminate any Plan or adopt any arrangement or program which, once established, would come within the definition of a Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Each Plan that constitutes in any part a nonqualified deferred compensation plan within the meaning of
Section&nbsp;409A of the Code has been operated and maintained in all material respects in operational and documentary compliance with Section&nbsp;409A </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-25- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Code and applicable guidance thereunder. No payment to be made under any Plan is reasonably likely, or to the Knowledge of the Companies, will be reasonably likely to be, subject to the
penalties of Section&nbsp;409A(a)(1) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;No Plan is subject to the laws of any jurisdiction outside
the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;Neither the execution and delivery of this Agreement, the shareholder approval of this
Agreement, nor the consummation of the transactions contemplated hereby could (either alone or in conjunction with any other event)&nbsp;(i) result in, or cause the accelerated vesting payment, funding or delivery of, or increase the amount or value
of, any payment or benefit to any employee, officer, director or other service provider of the Companies or any ERISA Affiliate; (ii)&nbsp;result in any &#147;parachute payment&#148; as defined in Section&nbsp;280G(b)(2) of the Code (whether or not
such payment is considered to be reasonable compensation for services rendered); or (iii)&nbsp;result in a requirement to pay any Tax <FONT STYLE="white-space:nowrap">&#147;gross-up&#148;</FONT> or similar &#147;make-whole&#148; payments to any
employee, director or consultant of the Companies or an ERISA Affiliate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.14&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Matters</U>. Except as set
forth on <U>Section&nbsp;5.14 of the Disclosure Schedule</U>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Companies, their respective
Subsidiaries, and/or the Seller has filed all material Tax Returns that are required to be filed by them (taking into account any extensions of time to file that have been duly perfected). All Taxes due and payable by any of the Companies and their
respective Subsidiaries have been fully paid, all such Tax Returns are true, complete and correct in all material respects, and all Taxes that any of the Companies and their respective Subsidiaries is obligated to withhold from amounts owing to any
employee, creditor or third party have been fully paid or properly accrued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;There are no material outstanding
Tax deficiencies, assessments, or adjustments with respect to each of the Companies or their respective Subsidiaries. Neither the Companies nor their respective Subsidiaries have (i)&nbsp;agreed to waive or extend the statute of limitation
applicable to the assessment or collection of any material Tax that has not yet been either paid or resolved or (ii)&nbsp;agreed in writing to extend the time within which to file any income and other material Tax Return of the Companies or their
respective Subsidiaries, which has not been since filed within the prescribed extended period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;There are no
ongoing Tax audits by any Taxing Authority against any of the Companies or their respective Subsidiaries and no material written claim has been received by any of the Companies or their respective Subsidiaries from a Taxing Authority to the effect
that it is or may be subject to either (i)&nbsp;Taxes assessed by such authority or (ii)&nbsp;a proposed material adjustment to any item with respect to Taxes applicable to the Companies or their respective Subsidiaries. Since the Lookback Date, no
written claim has been made by a Taxing Authority in a jurisdiction where any Company or its Subsidiaries does not file Tax Returns that such Company or Subsidiary is or may be subject to taxation by that jurisdiction. There are no Liens or
encumbrances upon any property or assets of the any Company or its Subsidiaries for Taxes, except for Liens or encumbrances for Taxes not yet due and payable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-26- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;None of the Companies or their respective Subsidiaries is a party
to any Tax allocation or sharing arrangement with any Person other than another Company or Subsidiary in respect of or pursuant to which they will have any obligation to make any payments after the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;None of the Companies or their respective Subsidiaries have been a party to any &#147;listed transaction,&#148; as
defined in Section&nbsp;6707A(c)(2) of the Code and Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.6011-4(b)(2).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;None of the Companies or their respective Subsidiaries have been a &#147;United States real property holding
corporation&#148; within the meaning of Section&nbsp;897(c)(2) of the Code during the applicable period specified in Section&nbsp;897(c)(1)(A)(ii) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;Neither of the Companies or any of their respective Subsidiaries has been, during the <FONT
STYLE="white-space:nowrap">two-year</FONT> period ending on the date of this Agreement, either a &#147;distributing corporation&#148; or a &#147;controlled corporation&#148; within the meaning of Section&nbsp;355 of the Code and the Treasury
Regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;Neither of the Companies or any of their respective Subsidiaries is or has
been, for any taxable period (or portion thereof) ending on or prior to the Closing Date, a controlled foreign corporation within the meaning of Section&nbsp;957 of the Code or a passive foreign investment company within the meaning of
Section&nbsp;1297 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section 5.14(i) of the Disclosure Schedule</U> sets forth the U.S. federal
income Tax classification for each of the Companies and their respective Subsidiaries as of (i)&nbsp;the date on which such entity was acquired, directly or indirectly, by the Companies and (ii)&nbsp;the date of this Agreement, and indicates whether
any classification election for U.S. federal income tax purposes for the Companies has been filed with the Internal Revenue Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Companies is classified as a &#147;C corporation&#148; for U.S. federal income Tax purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;Neither of the Companies or any of their respective Subsidiaries (i)&nbsp;has been a member of an affiliated group
of corporations within the meaning of Section&nbsp;1504(a) of the Code filing a combined federal income Tax Return since the Lookback Date (or if longer, the earlier of (i)&nbsp;five years prior to the date hereof and (ii)&nbsp;the date on which
such entity was acquired, directly or indirectly, by the Companies) (other than a group as to which Mednax, Inc. is the common parent) nor (ii)&nbsp;has any liability for Taxes of any other Person under Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any similar provision of <FONT STYLE="white-space:nowrap">non-U.S.,</FONT> state or local Law). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;Neither of the Companies or any of their respective Subsidiaries has any liability for Taxes of any other Person as
a transferee or successor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;Neither of the Companies or any of their respective Subsidiaries is a party to any
Tax allocation, indemnity, or sharing agreement (other than commercial agreements entered into in the Ordinary Course of Business, the principal purpose of which is not related to Taxes). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-27- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Companies nor their respective Subsidiaries will be
required to include any material item of income in, or exclude any material item of deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any: (i)&nbsp;change in method of accounting
for a taxable period ending on or prior to the Closing Date; (ii)&nbsp;use of an improper method of accounting for a taxable period ending on or prior to the Closing Date; (iii) &#147;closing agreement&#148; as described in Section&nbsp;7121 of the
Code (or any corresponding or similar provision of state, local, or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> income Tax Law) executed on or prior to the Closing Date; (iv)&nbsp;installment sale or open transaction disposition made on or
prior to the Closing Date; (v)&nbsp;prepaid amount or any other income eligible for deferral pursuant to Sections 455 or 456 of the Code, Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.451-5</FONT> and Revenue Procedure <FONT
STYLE="white-space:nowrap">2004-34,</FONT> <FONT STYLE="white-space:nowrap">2004-33</FONT> I.R.B. 991) received on or prior to the Closing Date; (vi)&nbsp;election made under Section&nbsp;108(i) of the Code prior to the Closing Date; or
(vii)&nbsp;Section 951 or Section&nbsp;951A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Companies nor their respective
Subsidiaries has, or will have after the Closing Date, any unpaid liability for Taxes pursuant to an election under Section&nbsp;965(h) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.15&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>. <U>Section&nbsp;5.15 of the Disclosure Schedule</U> lists each material insurance policy
maintained by the Companies and their respective Subsidiaries, including the name of the insurer and policy number (the &#147;<U>Insurance Policies</U>&#148;). The Insurance Policies are valid, outstanding, and enforceable policies subject to the
terms, conditions, exclusions, and limitations contained therein and such policies comply with all the contractual requirements of the Companies and their respective Subsidiaries and applicable Laws, and the Companies and their respective
Subsidiaries are not in material breach or material default thereunder. All premiums with respect to the Insurance Policies covering all periods up to and including the Closing Date have been or will be paid or accrued therefor, no written notice of
cancellation or termination, denial of coverage and material change in premium, has been received with respect to any such policy. None of the Companies and their respective Subsidiaries has or has ever had a self-insurance, <FONT
STYLE="white-space:nowrap">co-insurance,</FONT> or captive insurance program and none of the Companies and their respective Subsidiaries has any liability related to any such programs. A true, complete, and accurate claims history under the
Companies and their respective Subsidiaries&#146; Insurance Policies since the Lookback Date has been made available to Buyer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.16&nbsp;&nbsp;&nbsp;&nbsp;<U>Affiliated Transactions</U>. Except as set forth on <U>Section&nbsp;5.16 of the Disclosure Schedule</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;there are no (i)&nbsp;Contracts to which the Companies or their respective Subsidiaries are now, or have ever been,
a party, and to which the Seller, the Companies, or an Affiliate of the Seller or the Companies is also a party, or (ii)&nbsp;transactions, arrangements, or understandings between the Companies, the Seller, or any Affiliate of the Companies (each,
an &#147;<U>Affiliate Arrangement</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;neither the Seller nor the Companies or their respective
Subsidiaries, any officer or director of the Companies or their respective Subsidiaries or any immediate family member of any such officer or director, or manager (i)&nbsp;has any direct or indirect financial interest in any competitor, supplier, or
contractor of the Companies or their respective Subsidiaries; or (ii)&nbsp;owns, directly or indirectly, in whole or in part, or has any other interest in any tangible or intangible property which the Companies and their respective Subsidiaries use
or have used in the conduct of its business or otherwise; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-28- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;the Companies and their respective Subsidiaries do not have any
liability or any other obligation of any nature whatsoever to any Affiliate of the Seller, the Companies or their respective Subsidiaries, or any officer, director, or equity holder of any of the Companies or their respective Subsidiaries or any
immediate family member of any such officer, director, or equity holder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.17&nbsp;&nbsp;&nbsp;&nbsp;<U>Material Contracts</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;5.17(a) of the Disclosure Schedule</U> sets forth a list of all Contracts, including all amendments
and supplements thereto, to which any member of any of the Companies or their respective Subsidiaries is a party by which any of the Companies or their respective Subsidiaries is bound, meeting any of the descriptions set forth below (collectively
referred to herein as the &#147;<U>Material Contracts</U>&#148;): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;all Contracts relating to any completed
material business acquisition by the Companies or their respective Subsidiaries since the Lookback Date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;all
written Contracts for the employment of any current officer, individual employee or other person on a full-time or consulting basis with required annual payments in excess of $200,000; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;all Contracts relating to Debt of the Companies and their respective Subsidiaries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;all guaranties of any obligation for Debt; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;all Contracts under which any of the Companies or their respective Subsidiaries is lessee of, or holds or
operates, any personal property owned by any other party, for which the annual rental payments exceed $100,000; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;all Contracts under which any of the Companies or their respective Subsidiaries is lessor of or permits any third
party to hold or operate any personal property for which the annual rental payments exceed $100,000; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;all
Contracts under which (A)&nbsp;the Companies or any of their respective Subsidiaries are granted rights in the Intellectual Property of any other Person (other than
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;off-the-shelf</FONT></FONT> software&#148; that is made available for a total cost of less than $100,000 and is not a material component of a Company Product) or (B)&nbsp;the
Companies or any of their respective Subsidiaries have granted rights in Intellectual Property to any other Person; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp;each Contract that limits or purports to limit the freedom of the Companies or their respective Subsidiaries
(or, after Closing, Buyer or its Subsidiaries) or any of their respective Affiliates to compete in any line of business or within any geographic area with any Person, or materially restricts the Companies or their respective Subsidiaries (or after
Closing, Buyer or its Subsidiaries) or any of their respective Affiliates ability to solicit or hire any Person </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-29- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or solicit business from any Person, and each Contract that could require the disposition of any material assets or line of business of the Companies or their respective Subsidiaries (or after
Closing, Buyer or its Subsidiaries) or any of their respective Affiliates, other than Contracts that contain customary employee <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions entered into in the Ordinary Course of Business and
which account for less than $250,000 of revenue per annum; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix)&nbsp;&nbsp;&nbsp;&nbsp;each Contract (or group of related contracts with
respect to a single transaction or series of related transactions) with any Material Supplier; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;each Contract
(or group of related contracts with respect to a single transaction or series of related transactions) with any Material Customer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi)&nbsp;&nbsp;&nbsp;&nbsp;any Contract involving annual payment or annual receipt of royalties or other amounts more than $100,000, in the
aggregate, calculated based on the revenues or income of the Companies or their respective Subsidiaries or income or revenues related to any product of the Companies or their respective Subsidiaries during the preceding fiscal year; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii)&nbsp;&nbsp;&nbsp;&nbsp;each joint venture, partnership and other similar Contract involving the sharing of profits of the Companies or
their respective Subsidiaries with any third party; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;each Affiliate Arrangement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;each Parent-Level Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xv)&nbsp;&nbsp;&nbsp;&nbsp;each Shared Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;any Contract with a Material Customer or Material Supplier (or group of related Contracts with respect to a
single transaction or series of related transactions) that cannot be terminated by the Companies or their respective Subsidiaries on less than ninety (90)&nbsp;days&#146; notice (without monetary penalty); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvii)&nbsp;&nbsp;&nbsp;&nbsp;each Contract with a Material Customer or Material Supplier providing for the Companies or their respective
Subsidiaries to be exclusive or preferred provider of any product or service to any Person or that otherwise involves the granting by any Person to the Companies or their respective Subsidiaries of exclusive or preferred rights of any kind; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xviii)&nbsp;&nbsp;&nbsp;&nbsp;each Contract providing for any Person to be the exclusive or preferred provider of any product or service to
the Companies or their respective Subsidiaries, or that otherwise involves the granting by the Companies or their respective Subsidiaries to any Person of exclusive or preferred rights; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xix)&nbsp;&nbsp;&nbsp;&nbsp;each Contract containing a provision of the type commonly referred to as &#147;most favored nation&#148;
provision for the benefit of a Person other than the Companies or their respective Subsidiaries; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-30- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xx)&nbsp;&nbsp;&nbsp;&nbsp;each settlement or similar Contract pursuant to (i)&nbsp;which
the Companies or their respective Subsidiaries is obligated to pay consideration after the Closing Date, or that provides injunctive relief or grants specific performance; or (ii)&nbsp;any entered into since the Lookback Date that exceed $25,000 in
payment of consideration from the Companies or their respective Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxi)&nbsp;&nbsp;&nbsp;&nbsp;each Contract for the sale of
any of the assets of the Companies or their respective Subsidiaries, other than sales of inventory in the Ordinary Course of Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxii)&nbsp;&nbsp;&nbsp;&nbsp;each Contract under which the Companies or their respective Subsidiaries has advanced or loaned funds exceeding
fifty thousand dollars ($50,000); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxiii)&nbsp;&nbsp;&nbsp;&nbsp;each Contract with any Governmental Authority or any Person that is
prime contractor or subcontractor in respect of a Contract with any Governmental Authority; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxiv)&nbsp;&nbsp;&nbsp;&nbsp;each Contract
with any Person on an employment or consulting basis providing annual compensation in excess of two&nbsp;hundred thousand&nbsp;dollars&nbsp;($200,000) or is not cancelable by the Companies or their respective Subsidiaries without penalty on not less
than ninety (90)&nbsp;days&#146; notice; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxv)&nbsp;&nbsp;&nbsp;&nbsp;any Contract that provides for any severance, retention, change in
control or similar bonus or payment; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxvi)&nbsp;&nbsp;&nbsp;&nbsp;each Contract under which the Companies or their respective
Subsidiaries has advanced or loaned any amount to any of its directors, officers, or employees (other than under any Company&#146;s or their respective Subsidiaries&#146; 401(k) plan); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxvii)&nbsp;&nbsp;&nbsp;&nbsp;each collective bargaining or labor agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <U>Section&nbsp;5.17(b) of the Disclosure Schedule</U>: (i)&nbsp;all Material Contracts are
in full force and effect; (ii)&nbsp;no Material Contract has been materially breached, canceled (other than in accordance with the terms of such Material Contract) or repudiated by the Companies and their respective Subsidiaries that is a party
thereto, or, to the Knowledge of the Companies, any other party thereto; (iii)&nbsp;each of the Companies and their respective Subsidiaries has performed all material obligations required to be performed by it in connection with the Material
Contracts to which it is a party and none of the Companies and their respective Subsidiaries has received any written, or to the Knowledge of the Companies, other claim or notice of default or event that with notice or lapse of time would constitute
a default by any of the Companies and their respective Subsidiaries under any such Contract, nor to the Knowledge of the Companies, is any other party to any Material Contract in material breach or default thereunder; (iv)&nbsp;none of the Companies
and their respective Subsidiaries has any present expectation or intention of not fully performing any obligation pursuant to any Contract to which it is a party and to the Knowledge of the Companies, no other party thereto intends to cancel,
terminate, breach, or attempt to alter the terms of any such Material Contract, or to exercise or not to exercise any option to renew thereunder; (v)&nbsp;the Companies and their respective Subsidiaries have made available to Buyer true, correct and
complete copies of each Material Contract (together with all exhibits thereto and all amendments, waivers or other changes thereto); (vi) each Material Contract is in full force and effect, and (vii)&nbsp;each Material Contract is valid and binding
on, and is enforceable by and against, the applicable Companies and their respective Subsidiaries thereto and, to the Knowledge of the Companies, each other party thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-31- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.18&nbsp;&nbsp;&nbsp;&nbsp;<U>Intellectual Property</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section&nbsp;5.18 of the Disclosure Schedule</U> contains a true and complete list of all Company Registered IP, in each case including,
to the extent applicable, the date of filing, issuance or registration, the filing, issuance or registration number, the owner of such filing, issuance or registration, and the jurisdiction where the filing, issuance or registration was made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Companies and their respective Subsidiaries, collectively, exclusively own the Company Owned IP, free and clear
of all Liens other than Permitted Liens, and have adequate and enforceable rights to use all other Intellectual Property necessary for the Business as currently conducted. The Company Owned IP is valid, subsisting, and enforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Each item of Company Registered IP is registered or applied for, as applicable, in the name of one of the Companies
or one of their respective Subsidiaries, has been duly maintained and is currently in compliance with all formal Laws (including payment of all applicable fees). No Company Registered IP has been or is now involved in any reissue, reexamination,
inter partes review, post-grant review, covered business method review or opposition proceeding. A valid and enforceable assignment to one of the Companies or one of their respective Subsidiaries for each patent and patent application in the Company
Registered IP has been obtained and duly recorded with the U.S. Patent and Trademark office and all similar offices and agencies anywhere in the world in which foreign counterparts are registered or issued. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;There are no pending or, to the Knowledge of the Companies, threatened claims against any of the Companies or any
of their respective Subsidiaries alleging that any of the operation of the Business, or any activity performed by or on behalf of any of the Companies or any of their respective Subsidiaries, or the manufacture, sale, offer for sale, importation,
and/or use of any Company Product infringes, misappropriates or violates (or in the past infringed, misappropriated or violated) any right of any Person in or to any Intellectual Property or that any of the Company Owned IP is invalid or
unenforceable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Neither the operation of the Business, nor any activity performed by or on behalf of any of the
Companies or any of their respective Subsidiaries, nor the manufacture, use, importation, offer for sale and/or sale of any Company Product infringes, misappropriates or violates (or in the past infringed, misappropriated or violated) any right of
any Person in or to any Intellectual Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Companies, there is no, nor has there
been any, infringement, misappropriation or violation by any Person of any Company Owned IP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;There are no
Orders, settlements, covenants not to sue, consents, or similar litigation-related, inter partes or adversarial-related, or government-imposed obligations to which any of the Companies or any of their respective Subsidiaries is a party that
(i)&nbsp;restrict the rights of any of the Companies or any of their respective Subsidiaries to use any Intellectual Property, (ii)&nbsp;restrict the Business in order to accommodate the Intellectual Property of any other Person, or
(iii)&nbsp;permit any other Person to use any Company Owned IP. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-32- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;All former and current officers, directors, employees,
contractors, consultants and other individuals, with respect to each of the foregoing, involved in the creation or development of any Company Owned IP, have executed written instruments with one of the Companies or one of their respective
Subsidiaries that assign to one of the Companies or one of their respective Subsidiaries all rights, title and interest in and to any and all inventions, improvements, ideas, discoveries, writings, works of authorship and other Intellectual Property
relating to the Business or the Company Products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;The Companies and their respective Subsidiaries have taken
reasonable measures to protect the confidentiality and value of all trade secrets and other proprietary information in the Company Owned IP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;No funding, facilities, or personnel of any Governmental Authority, university, college, other educational
institution or research center or funding from any other Person was used directly or indirectly in the development of any Company Owned IP in such a manner as to give any of the foregoing any claim or right, current or contingent, in or to any
Company Owned IP. Neither the Companies nor any of their respective Subsidiaries have granted to any Governmental Authority, either expressly, or by any act or omission, any unlimited, unrestricted or government purpose rights, or any similar
rights, in any Company Owned IP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;The Companies and their Subsidiaries have not been a member or contributor
to, and have otherwise not been involved with, any industry standards body or similar organization which, as a result of such membership, contribution or involvement, has a legal right to compel any of the Companies or any of their respective
Subsidiaries to grant or offer to any other Person any license or right to any Company Owned IP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;Neither the
execution, delivery or performance of this Agreement or any Related Agreement nor the consummation of the transactions contemplated hereby or thereby will, with or without notice or the lapse of time, result in or give any other Person the right or
option to cause or declare: (i)&nbsp;a loss of, or Lien on, any Company Owned IP or any Company Intellectual Property exclusively licensed to any of the Companies or any of their respective Subsidiaries; (ii)&nbsp;a breach by any of the Companies or
any of their respective Subsidiaries of any Contract pursuant to which such Company or such Subsidiary grants or is granted rights in Intellectual Property; (iii)&nbsp;the release, disclosure or delivery of any Company Owned IP or Company
Intellectual Property exclusively licensed to any of the Companies or any of their respective Subsidiaries by or to any escrow agent or other Person; (iv)&nbsp;the grant, assignment or transfer to any other Person of any license or other right or
interest under, to or in any of the Company Owned IP; or (v)&nbsp;payment of any royalties or other license fees with respect to Intellectual Property rights of any third party in advance or excess of those payable by any of the Companies or any of
their respective Subsidiaries in the absence of this Agreement or the transactions contemplated hereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-33- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;None of the Companies nor any of their respective Subsidiaries
has provided or disclosed, directly or indirectly, any source code of any software included in or with any Company Product to any Person other than to employees, consultants and contractors pursuant to written obligations of confidentiality. None of
the Companies nor any of their respective Subsidiaries has granted, directly or indirectly, any current or contingent rights, licenses, or interests in or to any source code of any software included in or with any Company Product. No release or
request for release of any source code of any software included in or with any Company Product in or subject to escrow has occurred, and no circumstance has occurred or exists, that (with or without notice or lapse of time, or both) will, or would
reasonably be expected to, result in the disclosure or release of any source code included in or with any Company Product by any of the Companies or any of their respective Subsidiaries, its escrow agent(s) or any other Person to any third party.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;The Company Products do not contain any viruses, worms, spyware, malware, time bombs, <FONT
STYLE="white-space:nowrap">key-locks,</FONT> or any other code or devices intended to disrupt, damage interfere with, or unlawfully access the Company Products or equipment upon which the Company Products operate, or the integrity of the data,
information or signals the Company Products produce (&#147;<U>Contaminants</U>&#148;) in a manner adverse to any of the Companies or any of their respective Subsidiaries or any customer, licensee or recipient. The Companies and their respective
Subsidiaries take reasonable measures to prevent the introduction of Contaminants into the Company Products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section 5.18(o) of the Disclosure Schedule</U> contains a complete and accurate list of all Open Source Software
incorporated in, linked or called to by, distributed with, or otherwise used by any software included in or with any Company Product, specifying for each such item of Open Source Software, the name, version number, applicable license, and applicable
Company Product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;The development of any software included in or with any Company Product with any Open Source
Software, and the incorporation, linking, calling, distribution or other use in, by or with any software included in or with any Company Product of any Open Source Software, does not obligate any of the Companies or any of their respective
Subsidiaries to disclose, make available, offer or deliver any portion of the source code of such software included in or with such Company Product or component thereof to any other Person, other than the applicable Open Source Software. The
Companies and their respective Subsidiaries have fully complied and are currently in full compliance with the license of each item of Open Source Software listed or required to be listed in <U>Section&nbsp;5.18(o) of the Disclosure Schedule</U>,
including applicable obligations relating to notice, attribution, and distribution or making available of source code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q)&nbsp;&nbsp;&nbsp;&nbsp;The Company Systems are sufficient to operate the Business as currently conducted, and the Companies and their
respective Subsidiaries own or have valid and enforceable rights to use the Company Systems. The Companies and their respective Subsidiaries have appropriate backup and disaster recovery plans, procedures and facilities for the Business and have
taken reasonable steps to safeguard the Company Systems. There have been no unauthorized intrusions or breaches of the security of the Company Systems or infections by viruses or other harmful code. There has not been any material malfunction,
interruption, or loss of data with respect to the Company Systems that has not been remedied or replaced in all material respects. The Companies and their respective Subsidiaries have obtained and possess valid
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-34- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
licenses to use all of the software programs present on the computers and other software-enabled electronic devices that they own or lease or that they have otherwise provided to their employees
and other personnel. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.19&nbsp;&nbsp;&nbsp;&nbsp;<U>Privacy and Security</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of the Companies and their respective Subsidiaries is, and since the Lookback Date has been, in compliance in all material respects
with (i)&nbsp;HIPAA and applicable Privacy Laws; (ii)&nbsp;all contractual obligations binding upon the Companies and their respective Subsidiaries concerning Personal Information; and (iii)&nbsp;the Companies&#146; and their respective
Subsidiaries&#146; privacy and security policies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;None of the Companies or their respective Subsidiaries has,
since the Lookback Date, received any written communication from any Governmental Authority with respect to its HIPAA or Privacy Law compliance. There is no ongoing or imminently threatened litigation, investigation, or enforcement proceeding by any
Governmental Authority with respect to the HIPAA or Privacy Law compliance of the Companies and their respective Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;In each of the Companies&#146; and its respective Subsidiaries&#146; function as a &#147;Business Associate&#148;
as that term is defined under HIPAA, each has at all times implemented and enforced the requisite privacy and security policies, procedures and systems to materially comply with the terms of its business associate agreements and applicable Law. Each
of the Companies and its respective Subsidiaries have entered into business associate agreements with all &#147;Covered Entities&#148; as defined in 45 C.F.R. &#167; 160.103 who provide or for whom the Companies and their respective Subsidiaries
receive, create, maintain, transmit, or process Protected Health Information and all third parties acting as business associate subcontractors, as defined in 45 C.F.R. &#167; 160.103, of the Companies or their respective Subsidiaries. As of the date
of this Agreement, each of the Companies and their respective Subsidiaries are not, and have never been, in material breach of any business associate agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Companies and their respective Subsidiaries have conducted their business in material compliance with
the HIPAA regulations governing electronic transactions (45 C.F.R. Parts 160 and 162, Subparts I through R) and unique identifiers (45 Parts 160 and 162, Subparts D and F). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Companies and their respective Subsidiaries has implemented and maintained organizational, physical,
administrative and technical measures required by Privacy Laws, the contractual obligations applicable to the Companies and policies to which the Companies are subject and that consistent with standards prudent in the industry in which each of the
Companies and its respective Subsidiaries operates. Each Company and its respective Subsidiaries has implemented reasonable procedures, satisfying the requirements of applicable Privacy Laws, to detect data security incidents. Each Company and its
respective Subsidiaries has: (A)&nbsp;regularly conducted vulnerability testing, risk assessments, and audits of, and tracks security incidents related to, each Company&#146;s and its Subsidiaries&#146; systems and products (collectively,
&#147;<U>Information Security Reviews</U>&#148;); (B) timely corrected any material exception or vulnerability identified in such Information Security Reviews; and (C)&nbsp;made available true and accurate copies of all Information Security Reviews.
Each Company and its Subsidiaries provides its employees with regular training on privacy and data security matters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-35- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Since the Lookback Date, none of the Companies or their
respective Subsidiaries has experienced any: (i)&nbsp;breach of privacy, security, or confidentiality with respect to Personal Information; (ii)&nbsp;Breach of Unsecured Protected Health Information, as &#147;Breach&#148; and &#147;Unsecured
Protected Health Information&#148; are defined by HIPAA; or (iii)&nbsp;Security Incident that individually or in the aggregate would have a Material Adverse Effect, as &#147;Security Incident&#148; is defined by HIPAA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;None of the Companies or their Subsidiaries has supplied or provided access to Personal Information processed by it
to a third party for remuneration or other consideration in violation of the Privacy Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;None of the
Companies or their Subsidiaries are subject to or required to comply with the European General Data Protection Regulation or other Privacy Laws from jurisdictions outside of the United States. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.20&nbsp;&nbsp;&nbsp;&nbsp;<U>Health Care Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of the Companies and its respective Subsidiaries (i)&nbsp;are currently, and have been at all times since the Lookback Date, in
material compliance with all applicable Health Care Laws; and (ii)&nbsp;are not, and have not been, subject to or the target of any litigation or final adverse action, as that term is defined in 42 U.S.C.
<FONT STYLE="white-space:nowrap">&#167;1320a-7e(g),</FONT> based on acts or omissions for or on behalf of each of the Companies or its respective Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Companies nor any of their Subsidiaries have received notice from any Governmental Authority that
(A)&nbsp;alleges any material noncompliance with any Health Care Law, or alleges that any of the Companies, any of their Subsidiaries, or any of their officers, directors, employees, or agents, is or was under investigation or the subject of any
inquiry by any such Governmental Authority for such alleged material noncompliance with any Health Care Law or (B)&nbsp;would be reasonably likely to result in a fine or assessment or a cease and desist order, or the suspension, revocation or
limitation or restriction of participation in any Federal Health Care Program. Neither the Companies nor their respective Subsidiaries have ever entered into any agreement or settlement with any Governmental Authority with respect to noncompliance
with, or violation of, any Health Care Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Companies, nor their respective Subsidiaries, nor any
of their officers, directors, employees, or agents, (i)&nbsp;have been convicted of, charged with or investigated for any material violation of any Health Care Law; (ii)&nbsp;have been convicted of, charged with, or investigated for any violation of
a Federal Health Care Program-related material offense or applicable Law related to fraud, theft, embezzlement, breach of fiduciary responsibility, financial misconduct, obstruction of an investigation, or controlled substances; (iii)&nbsp;are, or
have ever been, excluded, suspended or debarred from participation, or otherwise ineligible to participate, in any Federal Health Care Program, or is subject to a governmental inquiry, investigation, Proceeding, or other similar action that could
reasonably be expected to result in debarment, suspension, or exclusion; or (iv)&nbsp;have been subject to any consent decree of, or criminal </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-36- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or civil fine or penalty imposed by, any Governmental Authority related to fraud, theft, embezzlement, breach of fiduciary responsibility, financial misconduct, or obstruction of an investigation
related to controlled substances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Companies nor their respective Subsidiaries (i)&nbsp;are the
subject of any third party audit or investigation and there is no such audit or investigation threatened; (ii)&nbsp;are or have been named as a defendant in any action under the False Claims Act; or (iii)&nbsp;have received or are currently
responding to any search warrant, subpoena, or civil investigative demand from any Government Authority with respect to any alleged violation of Law by the Companies or any of their respective Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;All billing practices, insurance verification, and revenue cycle management services offered by each of the
Companies and their respective Subsidiaries are and have been conducted in accordance with all rules, regulations, policies and procedures of each applicable Payor in all material respects, and, all claims for payment submitted by any of the
Companies or their respective Subsidiaries on behalf of any customer or health care provider have been true, fair and correct and prepared in an accurate and complete manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;None of the Companies nor their respective Subsidiaries nor any employee thereof has made any voluntary or
self-disclosure to any Governmental Authority regarding any potential <FONT STYLE="white-space:nowrap">non-compliance</FONT> with any Health Care Law. None of the Companies nor their respective Subsidiaries are subject to any corrective action plan,
corporate integrity agreement, deferred prosecution agreement, consent decree, settlement agreement, or similar undertaking with or imposed by any Governmental Authority arising from any alleged violation of any Law regulating health care fraud or
patient health information privacy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Companies and their respective Subsidiaries and all applicable
employees are, and since the Lookback Date have been, in compliance with all Permits necessary to conduct the Business and no suspension, limitation, adverse modification, revocation or cancellation of any such Permit is pending or threatened. All
applications that are required to have been filed for the renewal or upkeep of any Permit has been duly filed on a timely basis, or with appropriate extensions, each with the appropriate Governmental Authority and all fees or other amounts required
to be paid in connection therewith have been paid to the appropriate Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.21&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Brokers</U>. Except as set forth in <U>Section&nbsp;5.21 of the Disclosure Schedule</U>, the Companies and their respective Subsidiaries have not incurred any obligation for any finder&#146;s or broker&#146;s or agent&#146;s fees or commissions or
similar compensation in connection with the transactions contemplated hereby. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.22&nbsp;&nbsp;&nbsp;&nbsp;<U>Customers and Suppliers</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section&nbsp;5.22(a) of the Disclosure Schedule</U> sets forth a true, complete and correct list of the Companies&#146; top twenty
(20)&nbsp;customers for (i)&nbsp;fiscal year 2018 and (ii)&nbsp;the seven (7)&nbsp;month period ended on July&nbsp;31, 2019 (each a &#147;<U>Material Customer</U>&#148;) based on the aggregate net sales of the Companies and their respective
Subsidiaries, on a consolidated basis, to such Persons during such periods and sets forth opposite the name of each such Material Customer </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-37- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the dollar amount and percentage of net sales of the Companies attributable to such Material Customer during same such time periods. None of the Companies nor their respective Subsidiaries have
received any notice that any of its Material Customers has ceased, or intends to cease, to purchase goods from the Companies or to otherwise terminate or adversely modify or materially reduce its relationship with the Companies or any of their
respective Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section 5.22(b) of the Disclosure Schedule</U> sets forth a true, complete and
correct list of the Companies&#146; top twenty (20)&nbsp;suppliers for (i)&nbsp;fiscal year 2018 and (ii)&nbsp;the seven (7)&nbsp;month period ended on July&nbsp;31, 2019 (each a &#147;<U>Material Supplier</U>&#148;) based on the aggregate net sales
of the Companies and their respective Subsidiaries, on a consolidated basis, to such Persons during such periods and sets forth opposite the name of each such Material Supplier the dollar amount and percentage of net purchases of the Companies and
their respective Subsidiaries attributable to such Material Supplier during such time periods. The Companies and their Subsidiaries have not received any notice that any of its Material Suppliers has ceased, or intends to cease, to supply goods or
services to the Companies or the Subsidiaries or to otherwise terminate or adversely modify or materially reduce its relationship with the Companies or their respective Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.23&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment Company Act</U>. The Companies and their respective Subsidiaries are not, nor are they required to
be registered as, an &#147;investment company&#148; as defined in, or subject to regulation under, the Investment Company Act of 1940, as amended. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">PRE-CLOSING</FONT> COVENANTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.01&nbsp;&nbsp;&nbsp;&nbsp;<U>Further Assurances; Closing Conditions</U>.
During the Interim Period, the Buyer and the Seller shall, as promptly as practicable, (a)&nbsp;execute and deliver, or cause to be executed and delivered, such additional instruments and other documents and shall take such further actions as may be
reasonably requested by the other Party as necessary or appropriate to effectuate, carry out, and comply with all of the terms of this Agreement and the transactions contemplated hereby, and (b)&nbsp;use their reasonable best efforts to cause the
conditions set forth in <U>ARTICLE II</U> to be satisfied and to consummate the transactions contemplated herein as promptly as practical; <U>provided</U>, that, notwithstanding anything to the contrary in this Agreement, none of the Buyer, the
Seller nor any of the Companies or any of their respective Subsidiaries shall be required to pay any consent or similar fee to obtain any third party or governmental consents except as expressly set forth in <U>Section 6.01</U> and
<U>Section&nbsp;6.03</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.02&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices and Consents</U>. Without limiting the generality of
<U>Section&nbsp;6.01</U>, during the Interim Period, (a)&nbsp;the Seller will deliver the notices set forth in <U>Section&nbsp;6.02 of the Disclosure Schedule</U> to the third parties set forth on <U>Section&nbsp;6.02 of the Disclosure Schedule</U>
and will use commercially reasonable efforts (which shall not include the payment for a consent or similar fee) to obtain the third party consents and licenses set forth on <U>Section&nbsp;6.02 of the Disclosure Schedule</U>, and (b)&nbsp;the Buyer
will use commercially reasonable efforts to cooperate in all reasonable respects with the Seller and use commercially reasonable efforts to assist the Seller in the obtainment of all such consents and licenses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-38- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.03&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory Filings</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>General</U>. Each of the Buyer and the Seller shall, and the Buyer and the Seller shall cause their respective Affiliates to, use their
reasonable best efforts to (i)&nbsp;as promptly as practicable, obtain from any Governmental Authority any consent, approval, authorization, declaration, waiver, license, franchise, permit, certificate or order required to be obtained or made by the
Buyer, the Seller or any of its Subsidiaries, and to avoid any action or Proceeding by any Governmental Authority, in each case that is required by such Person in connection with the authorization, execution, and delivery of this Agreement and the
consummation of the transactions contemplated herein and (ii)&nbsp;as promptly as practicable make all necessary filings, and thereafter make any other required submissions, with respect to this Agreement required under any applicable Law. The Buyer
and the Seller shall, and the Buyer and the Seller shall cause their respective Affiliates to, cooperate with each other in connection with obtaining all such consents, approvals, authorizations, declarations, waivers, licenses, franchises, permits
or orders and the making of all such filings, including providing copies of all such <FONT STYLE="white-space:nowrap">non-proprietary</FONT> documents to the <FONT STYLE="white-space:nowrap">non-filing</FONT> Party and its advisors prior to filing
and, if requested, to accept all reasonable additions, deletions or changes suggested in connection therewith. The Buyer and the Seller shall, and the Buyer and the Seller shall cause their respective Affiliates to, promptly furnish to each other
all information required for any application or other filing to be made by the other in connection with the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory Approvals and Cooperation</U>. The Buyer shall, and shall cause its Affiliates to use their
reasonable best efforts, to (i)&nbsp;resolve as soon as practicable objections, if any, asserted by any Governmental Authority with respect to this Agreement or the transactions contemplated by this Agreement, and (ii)&nbsp;take all actions
necessary to obtain promptly all consents, approvals, authorizations, declarations, waivers, licenses, franchises, permits, certificates or orders from any Governmental Authority necessary in connection with the consummation of the transactions
contemplated by this Agreement, including by (A)&nbsp;seeking to prevent the initiation of, and defending any Proceeding challenging this Agreement or the consummation of the transactions contemplated hereby, (B)&nbsp;avoiding the entry of, or
causing to be lifted or rescinded any injunction, judgment, order or ruling entered by any Governmental Authority adversely affecting the ability of the Parties to consummate the transactions contemplated by this Agreement. Further, each of the
Buyer on the one hand and the Seller on the other hand shall, and shall cause their respective Affiliates to, coordinate and cooperate with the Seller or the Buyer, as applicable, in connection with their efforts to obtain all consents, approvals,
authorizations, declarations, waivers, licenses, franchises, permits, certificates or orders from any Governmental Authority necessary in connection with the consummation of the transactions contemplated by this Agreement, including
(1)&nbsp;cooperating in all reasonable respects with the Seller or the Buyer, as applicable. in connection with any investigation or other inquiry, (2)&nbsp;keeping the Seller or the Buyer, as applicable, promptly informed of any material
communication received by the Buyer, the Seller or any of their respective Affiliates, as applicable, from any Governmental Authority, including the Federal Trade Commission, U.S. Department of Justice, or similar
<FONT STYLE="white-space:nowrap">non-United</FONT> States Governmental Authority regarding any of the transactions contemplated hereby, (3)&nbsp;providing the Seller or the Buyer, as applicable, and their respective advisors with a reasonable
opportunity to (x)&nbsp;review any proposed communication by the Buyer, the Seller or their respective Affiliates, as applicable, with any Governmental Authority, (y)&nbsp;consult with the Buyer or the Seller, as applicable, prior to any meeting or
conference with any Governmental Authority, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-39- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and (z)&nbsp;to the extent permitted by such Governmental Authority, attend and participate in such meetings or conferences, and (4)&nbsp;providing such other information and assistance as the
Seller or the Buyer, as applicable, may reasonably request in connection with the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Obligations
Cumulative</U>. The Parties&#146; obligations in this <U>Section&nbsp;6.03</U> are cumulative, and a Party&#146;s obligations in any specific clause of this <U>Section&nbsp;6.03</U> shall not be interpreted to limit in any way the Parties&#146;
obligations in any other clause. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.04&nbsp;&nbsp;&nbsp;&nbsp;<U>Conduct of the Business</U>. During the Interim Period, except
(a)&nbsp;as set forth on <U>Section&nbsp;6.04 of the Disclosure Schedule</U>, (b)&nbsp;as otherwise expressly contemplated or expressly provided for by this Agreement, (c)&nbsp;as required by applicable Law, (d)&nbsp;as consented to in writing by
the Buyer (which consent will not be unreasonably withheld, conditioned, or delayed), or (e)&nbsp;for the use of available cash to repay any Transaction Expenses, or Taxes of the Seller prior to the Effective Time, the Seller shall carry on the
business of the Companies and their respective Subsidiaries in the Ordinary Course of Business and substantially in the same manner as previously conducted and to the extent consistent therewith, cause the Companies and their respective Subsidiaries
to use their respective commercially reasonable efforts to preserve their business organizations intact and maintain existing relations and goodwill with Governmental Authorities, customers, suppliers, distributors, creditors, lessors, employees and
business associates and keep available the services of the Companies and their respective Subsidiaries&#146; present employees and agents, including to the extent applicable promptly depositing any funds, credits or refunds received by a customer
that are to be remitted to patients of such customer into the Excluded Cash Accounts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in this <U>Section&nbsp;6.04</U> is
intended to result in the Seller, the Companies or their respective Subsidiaries ceding control to the Buyer of the Seller&#146;s, the Companies&#146; or their Subsidiaries&#146; basic Ordinary Course of Business and commercial decisions prior to
the Closing Date; <U>provided</U>, that, the Seller shall not, and shall cause the Companies and their respective Subsidiaries not to, take any of the following actions without the prior written consent of the Buyer (which consent may be withheld,
conditioned, or delayed in the sole and absolute discretion of the Buyer): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;amend, restate or otherwise adopt
or propose any change in the Organizational Documents of the Companies or any of their respective Subsidiaries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;merge or consolidate the Companies or any of their respective Subsidiaries with any other person or restructure,
reorganize or completely or partially liquidate or otherwise enter into any agreements or arrangements imposing material changes or restrictions on their respective assets, operations or businesses; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;acquire assets from any other Person with a value or purchase price in excess of $200,000 in any transaction or
series of related transactions, other than acquisitions of inventory or raw materials made in the Ordinary Course of Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;issue, sell, pledge, dispose of, grant, transfer, encumber or authorize the issuance, sale, pledge, disposition,
grant, transfer or encumbrance of, any Equity Securities of the Companies or their respective Subsidiaries, or securities convertible or exchangeable into or exercisable for any shares Equity Securities, or any options, warrants or other rights of
any kind to acquire any shares of such capital stock or such Equity Securities or exchangeable securities; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-40- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;create or incur any Lien on any assets of the Companies or their
Subsidiaries, other than Permitted Liens; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;make any loans, advances, guarantees or capital contributions to or
investments in any Person (other than the Companies or their respective Subsidiaries) in excess of $200,000 in the aggregate, or declare, set aside or pay any dividend or other distributions (whether in stock, cash, property or otherwise); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;incur any Debt Amount (excluding income Taxes) or guarantee for such Debt Amount of another Person, or issue or
sell any debt securities or warrants or other rights to acquire any debt security of the Companies or their respective Subsidiaries, except for (i)&nbsp;Debt Amount incurred in the Ordinary Course of Business, not to exceed $200,000 in the
aggregate, (ii)&nbsp;indebtedness in replacement of existing Debt Amount on terms substantially consistent with or more beneficial than the indebtedness being replaced, or (iii)&nbsp;intercompany indebtedness solely between and among the Companies
and their respective Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;enter into any binding commitment for capital expenditures in excess of
$200,000 in the aggregate that are not contemplated by the current budget of the Companies and their respective Subsidiaries (a true, complete and accurate copy of which has been made available to the Buyer) or fail to make any capital expenditures
contemplated by such annual budget; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;amend, modify, terminate, permit to lapse or waive any material right
under any Material Contract (or enter into any Contract that would have been a Material Contract had it been entered into prior to the date hereof except in the Ordinary Course of Business), including any change in pricing or fees thereunder or any
issuance of rebates or credits in respect of services performed thereunder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;commence, settle or compromise any
then pending or threatened Proceeding or claim or otherwise settle any material liabilities of the Companies or their respective Subsidiaries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;make or change any material election in respect of Taxes, adopt or change any material accounting method in respect
of Taxes, settle any material claim or assessment in respect of Taxes, consent to any extension or waiver of the limitation period applicable to any claim or assessment in respect of Taxes, make or request any Tax ruling, enter into any Tax sharing
or similar agreement or arrangement (other than commercial agreements entered into in the Ordinary Course of Business, the principal purpose of which is not related to Taxes), enter into any transaction giving rise to deferred gain or loss, or
amend, <FONT STYLE="white-space:nowrap">re-file</FONT> or otherwise modify any Tax Return, in each case, if the effect of such action would affect the Tax liability or Tax position of the Buyer, the Companies or their respective Subsidiaries after
the Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;(i) increase the base salary or base compensation, bonus opportunities or other compensation of
any director, officer or employee of the Companies or any of their respective Subsidiaries other as required pursuant to existing contractual obligations, (ii) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-41- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
make any material change in employment terms for any director, manager, officer, employee earning an annual base salary greater than $200,000, (iii)&nbsp;hire or terminate any employee or engage
any independent contractor or other service provider with a required annual compensation in excess of $200,000, (iv) enter into, adopt or amend any employment agreement, change of control, severance, bonus, transaction-related or similar agreement,
(v)&nbsp;pay any bonus related to or arising out of the transactions contemplated by this Agreement, or (vi)&nbsp;other than (x)&nbsp;pursuant to the terms of any existing agreement or employee benefit plan, (y)&nbsp;as may be required by applicable
Law, or (z)&nbsp;changes to plans that generally affect all employees of Mednax, Inc. and its Subsidiaries not specific to the Companies or their employees, adopt, materially amend, materially modify or terminate any employee benefit plan for the
benefit of any of the Companies or their respective directors, managers, officers or employees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;pay any
transaction bonuses; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;implement any plant closing or layoff employees that could implicate the WARN Act; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;transfer, sell, lease, license, mortgage, pledge, surrender, encumber, divest, cancel, abandon or allow to lapse or
expire or otherwise dispose of any material assets, licenses, operations, rights, product lines, businesses or interests therein of the Business, the Companies or their respective Subsidiaries, including any Equity Security of any of the
Companies&#146; Subsidiaries, except (i)&nbsp;in the Ordinary Course of Business, or (ii)&nbsp;transfers solely between and among the Companies and one or more of their respective Subsidiaries; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;agree in writing to do any of the foregoing </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.05&nbsp;&nbsp;&nbsp;&nbsp;<U>Access to Information</U>. During the Interim Period, the Seller shall provide the Buyer and the Buyer&#146;s
authorized agents and Representatives reasonable access at reasonable times, and upon reasonable notice, to the senior management of each of the Companies and their respective Subsidiaries and to the Books and Records of each of the Companies and
their respective Subsidiaries; <U>provided</U>, that (a)&nbsp;all such access shall be coordinated in advance through Guggenheim Securities, LLC and Barclays Capital Inc., (b)&nbsp;such access does not unreasonably interfere with the operation of
the Companies&#146; or their Subsidiaries&#146; respective business and shall be subject to the Companies&#146; and their Subsidiaries&#146; reasonable security measures and insurance requirements, (c)&nbsp;the Buyer and its authorized agents and
Representatives shall not contact or otherwise communicate with the employees, customers or suppliers of the Companies or their respective Subsidiaries relating to the transactions contemplated by this Agreement unless, in each instance, approved in
writing in advance by the Seller, and (d)&nbsp;nothing herein shall require the Seller, the Companies or their respective Subsidiaries to furnish to the Buyer or provide the Buyer with access to information that legal counsel for the Seller, the
Companies or their respective Subsidiaries reasonably conclude may give rise to antitrust or competition Law issues or that is subject to attorney-client privilege (it being agreed that the Seller shall give notice to the Buyer of the fact that it
is withholding such information or documents, shall withhold only that portion of such information that is reasonably necessary to be withheld not to violate applicable Law, fiduciary or other duty or obligation and to preserve attorney-client
privilege and thereafter, the Seller Companies and their respective Subsidiaries shall use reasonable best efforts to provide such information in a manner that would not reasonably be expected to violate such Law, restriction or waive
attorney-client privilege). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-42- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.06&nbsp;&nbsp;&nbsp;&nbsp;<U>Exclusivity</U>. During the Interim Period, the Seller shall
not, and shall direct the Companies, their respective Subsidiaries and its and their respective directors, officers, employees, investment bankers, and other Representatives not to directly or indirectly, (a)&nbsp;solicit, initiate or knowingly
encourage the initiation of any Acquisition Proposal, (b)&nbsp;participate in any discussions or negotiations with any third party regarding, or furnish to any third party any information in connection with, any Acquisition Proposal or
(c)&nbsp;except as otherwise required by applicable Law, order of a Governmental Authority or similar compulsion, provide any nonpublic financial or other confidential or proprietary information regarding the Companies or their respective
Subsidiaries (including this Agreement and any materials containing the Buyer&#146;s proposal) to any Person (other than the Buyer and its Representatives). In the event that any Person (other than the Buyer) offers to engage in negotiations or
discussions concerning any Acquisition Proposal, the Seller shall promptly notify the Buyer of the identity of such Person and the material terms of such offer. [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.07&nbsp;&nbsp;&nbsp;&nbsp;<U>Confidentiality Agreement</U>. Notwithstanding anything to the contrary in the Confidentiality Agreement, the
Parties acknowledge and agree that as of the date hereof, and continuing through the Closing Date, the Parties and each of their respective Affiliates, employees and advisors are and remain bound to the Confidentiality Agreement, which shall remain
in effect until the Closing, at which point it will automatically terminate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.08&nbsp;&nbsp;&nbsp;&nbsp;<U>Financing</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Prior to the Closing, the Buyer shall use its reasonable best efforts to take, or cause to be taken, all actions and
to do, or cause to be done, all things necessary, proper or advisable to arrange, obtain and consummate the Financing on the terms and conditions set forth in the Financing Commitments (including any &#147;flex&#148; provisions in any fee letters
entered into in connection therewith), as applicable, no later than the Closing Date, including using reasonable best efforts to (i)&nbsp;maintain in effect the Financing Commitments (subject to Buyer&#146;s right to replace, restate, supplement,
modify, assign, substitute or amend the Debt Commitment Letter solely in accordance with the terms of this <U>Section&nbsp;6.08</U>) until the funding of the Financing at the Closing, (ii)&nbsp;negotiate and enter into definitive agreements with
respect to the Financing contemplated by the Financing Commitments on terms and conditions set forth in the Financing Commitments (including any &#147;flex&#148; provisions in any fee letters entered into in connection therewith) or on other terms
that would not constitute a Restricted Debt Commitment Letter Amendment (such definitive agreements being referred to as the &#147;<U>Financing Agreements</U>&#148;), (iii) satisfy (or obtain the waiver of), no later than the Closing Date, all
conditions applicable to the Buyer contained in the Financing Commitments (or the Financing Agreements) that are within its control including, without limitation, the payment of any commitment, engagement or similar fees thereunder as required as a
condition to the Financing as and when they become due and payable, and (iv)&nbsp;upon satisfaction of such conditions and the conditions set forth in <U>Section&nbsp;2.02</U> (other than those conditions that by their nature are to be satisfied by
actions taken at the Closing (assuming the Closing were to occur at such time), but subject to the satisfaction or waiver of such conditions), consummate the Financing contemplated by the Financing Commitments prior to or substantially concurrently
with the Closing. The Buyer shall keep the Seller reasonably informed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-43- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
upon written request on a reasonable basis of the status of the Financing. The Buyer shall give the Seller written notice within two (2)&nbsp;Business Days (i)&nbsp;of any event that would
materially delay or make funding on the Closing Date less likely to occur, (ii)&nbsp;of any breach by any party to the Financing Commitments (that would permit any other party thereto to terminate any such Financing Commitment) or any cancellation
or termination of any Financing Commitment for any reason, in each case, of which it becomes aware, (iii)&nbsp;of the receipt, on or prior to the Closing Date, of any notice or other written communication from any financing source (including any
Debt Financing Source, as applicable) with respect to any actual, threatened or alleged breach, default, termination or repudiation by any party to the Financing Commitments or any Financing Agreement or any material dispute or disagreement between
the Buyer, on the one hand, and such financing sources, on the other hand, with respect to the obligation to fund the Financing at Closing or the amount of the Financing to be funded at Closing, or (iv)&nbsp;if for any reason the Buyer believes in
good faith it is likely that it will not be able to obtain all or a portion of the Financing contemplated by the Financing Commitments to the extent such inability would result in insufficient funds necessary to pay the Required Amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Prior to the Closing, the Buyer shall not, without the prior written consent of the Seller (not to be unreasonably
withheld, conditioned or delayed), replace, amend, supplement, modify or waive any provision of the Debt Commitment Letter to the extent such replacement, amendment, supplement, modification or waiver (i)&nbsp;would reduce the aggregate amount of
the Debt Financing such that the Buyer would not have sufficient proceeds to permit the Buyer to pay the aggregate amount of the applicable Financing to consummate the transactions contemplated by this Agreement (the &#147;<U>Required
Amount</U>&#148;) or (ii)&nbsp;would impose new or additional conditions, or otherwise expand the conditions to the receipt of the Debt Financing or the Financing Agreements in a manner that could reasonably be expected to materially delay or
prevent the Closing (the amendments, supplements, modifications, waivers or replacements in the foregoing clauses (i)&nbsp;and (ii), collectively, the &#147;<U>Restricted Debt Commitment Letter Amendments</U>&#148;); <U>provided</U>, that, subject
to the limitations set forth in this <U>Section&nbsp;6.08(b)</U>, the Buyer may replace, amend, supplement, modify or waive any Debt Commitment Letter (to the extent not prohibited by this <U>Section&nbsp;6.08(b)</U>) (including to add additional
agents, <FONT STYLE="white-space:nowrap">co-agents,</FONT> lenders, lead arrangers, bookrunners, syndication agents, managers or similar entities that have not executed such Debt Commitment Letter as of the date hereof, together with any conforming
or ministerial changes related thereto, but only if the addition of such parties, individually or in the aggregate, would not result in the occurrence of a Restricted Debt Commitment Letter Amendment). Upon any such replacement, amendment,
supplement or other modification of, or waiver under, the Debt Commitment Letter in accordance with this <U>Section&nbsp;6.08</U> the term &#147;<U>Debt Commitment Letter</U>&#148; shall mean the Debt Commitment Letter as so replaced, amended,
supplemented, modified or waived and the term &#147;<U>Debt Financing</U>&#148; as used in this Agreement shall be deemed to include any Debt Financing contemplated by any such Debt Commitment Letter as so replaced, amended, supplemented, modified
or waived. The Buyer shall promptly (and in any event within two (2)&nbsp;Business Days) deliver to the Companies true and correct copies of any termination, amendment, restatement, modification, supplement, waiver, substitution or replacement of
the Debt Commitment Letter and, if executed prior to the Closing, the Debt Financing Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;If any
portion of the Debt Financing becomes unavailable on the terms and conditions contemplated in the Debt Commitment Letter or the Debt Commitment Letter shall be terminated prior to the Closing for any reason not in accordance with this Agreement
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-44- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(other than due to the failure to satisfy a condition to the consummation of the Debt Financing resulting from a breach of any Specified Acquisition Agreement Representation (as defined in the
Debt Commitment Letter), warranty, covenant or agreement of the Seller or any Affiliate of the Seller in this Agreement or of a condition to Buyer&#146;s obligations to close the transactions set forth in <U>Section&nbsp;2.02</U>), and to the extent
other sources of debt or equity are not then available, then Buyer shall use its reasonable best efforts to arrange to obtain alternative financing (the &#147;<U>Alternative Financing</U>&#148;) from alternative sources of debt financing in an
amount, when added to the portion of the Equity Financing, the Debt Financing still available, if any, other available sources of debt or equity, and cash on hand, sufficient to pay the Required Amount, which Alternative Financing would not
(i)&nbsp;involve terms, conditions and costs that are less favorable to the Buyer than those contained in the Debt Commitment Letter and/or any fee letters entered into in connection therewith, or (ii)&nbsp;involve any conditions to funding the Debt
Financing that are not contained in the Debt Commitment Letter as of the date hereof. The Buyer shall keep Seller informed upon request on a reasonably current basis in reasonable detail of the status of its efforts to arrange such Alternative
Financing and shall, upon request, provide true and correct copies of all documents related to the Alternative Financing. The obligations under <U>Sections 6.08(a)</U>&nbsp;and <U>(b)</U>&nbsp;and <U>Sections 6.09(a)</U> and <U>(b)</U>&nbsp;shall
apply equally to any such Alternative Financing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.09&nbsp;&nbsp;&nbsp;&nbsp;<U>Financing Cooperation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Seller agrees to use reasonable best efforts to, and shall cause each of the Companies and their respective
Subsidiaries and Representatives to use their reasonable best efforts to, provide such cooperation as the Buyer may reasonably request in connection with the Debt Financing, including with respect to (i)&nbsp;having senior management assist in
preparation for and participation in a reasonable number of lender marketing meetings and calls and a reasonable number of other due diligence sessions with prospective lenders and ratings agencies in each case in connection with obtaining the Debt
Financing, including direct contact between such senior management and the Debt Financing Sources and other potential lenders in the Debt Financing, (ii)&nbsp;promptly providing pertinent and customary documentation and information regarding the
Companies and their respective Subsidiaries (including information required under &#147;know your customer&#148;, beneficial ownership and anti-money laundering rules and regulations at least three (3)&nbsp;Business Days in advance of Closing;
provided a written request from the Debt Financing Sources has been made to either Company at least ten (10)&nbsp;Business Days in advance of the Closing), including then-available financial statements and financial projections, the Required
Information and other pertinent financial information regarding the Companies and their respective Subsidiaries as may be reasonably requested by the Buyer in order to consummate the Debt Financing or that is customarily needed for financings of the
type contemplated by the Debt Commitment Letter, including for the avoidance of doubt, information to enable the Buyer to prepare pro forma financial statements, giving effect to the transactions contemplated by this Agreement (and in each case,
other than information for which the Companies are dependent on information to be provided by the Buyer, unless such information is provided to the Companies by the Buyer in a timely and reasonable fashion), (iii) assisting in making arrangements
for, the pledge of collateral and the granting of security interests in connection with the Debt Financing, to the extent required for closing under the Debt Commitment Letter and subject to any funds certain provisions contained therein, including
the execution and delivery of documents in connection with the pledge and perfection of liens and security (including customary pledge and security documents, control agreements, mortgages, currency or interest hedging arrangements or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-45- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other customary definitive financing documents, surveys, and title insurance) and the providing of guarantees supporting the Debt Financing and related documentation, including customary
officer&#146;s certificates, perfection certificates, schedules, documents and instruments and a solvency certificate from the chief financial officer or equivalent of the Companies in the form attached as Annex I to Exhibit C to the Debt Commitment
Letter and other customary documents as may be reasonably requested by the Buyer, (iv)&nbsp;causing the taking of corporate (or similar) actions by the Companies reasonably necessary to permit the completion of the Debt Financing, subject to the
occurrence of the Closing, (v)&nbsp;assisting in the preparation of and execution and delivery of the definitive documents with respect to the Debt Financing, subject to the occurrence of the Closing, (vi)&nbsp;permitting representatives of the
prospective Debt Financing Sources to conduct commercial field examinations, inventory and intellectual property appraisals, Phase I environmental assessments and an appraisal of the owned real property, and making audits and appraisals delivered
for the purposes of any credit facility available to the Buyer for purposes of the Financing, (vii)&nbsp;promptly following any request by the Buyer, delivering all necessary notices and other information required under the Existing Credit Facility
to arrange for the termination of any guarantee and Lien, as applicable, executed and delivered by the Companies and their respective Subsidiaries under the Existing Credit Facility and (viii)&nbsp;cooperating with the Buyer in order to satisfy on a
timely basis the conditions precedent to the Debt Financing; <U>provided</U>, that, in the case of each of the foregoing clauses, (A)&nbsp;neither the Seller, any of the Companies nor any of their respective Representatives shall be required to pay
(or agree to pay) any commitment or other fee prior to the Closing or provide any indemnities or incur any liability or enter into any agreement in connection with the Debt Financing (other than agreements entered into and liabilities incurred by
the Companies that only become effective upon the consummation of the Closing), (B) no personal liability shall be imposed on the Representatives of the Seller or any of the Companies involved, and (C)&nbsp;the Seller and the Companies and their
respective officers and employees shall not be required to take any action that would unreasonably interfere with the operation of the business of the Companies or require any director, officer or employee of the Seller or the Companies to execute
any solvency certificate or similar document that becomes effective prior to the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Buyer
(i)&nbsp;shall reimburse the Companies (upon delivery of reasonably detailed back up information) for all reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs incurred by the
Companies in connection with the cooperation contemplated by <U>Section&nbsp;6.09(a)</U> and (ii)&nbsp;shall indemnify and hold harmless the Seller, the Companies, their respective Affiliates and their respective directors, managers, officers,
employees, representatives, consultants, financial advisors, attorneys, accountants or other agents from and against any and all losses suffered or incurred by them in connection with the arrangement of the Debt Financing and the performance of
their respective obligations under <U>Section&nbsp;6.09(a)</U> and any information used in connection therewith (other than information provided by or on behalf of the Companies or their Affiliates); <U>provided</U>, <U>however</U>, that the
Companies (and not the Buyer) shall be responsible for (1)&nbsp;fees payable to existing legal, financial or other advisors of the Companies with respect to services provided prior to the Closing, (2)&nbsp;any ordinary course amounts payable to
existing employees of or consultants to the Companies or any of their Affiliates with respect to services provided prior to the Closing and (3)&nbsp;any amounts that would have been incurred in connection with the transactions contemplated hereby
regardless of the Debt Financing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-46- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Companies and the Seller hereby consent to the reasonable use
of all of the Companies&#146; and their respective Subsidiaries&#146; logos, names and trademarks in connection with the Debt Financing; <U>provided</U> that such logos, names and trademarks shall be used solely in a manner that is not intended or
reasonably likely to harm or disparage the Companies or their respective Subsidiaries, or their reputation or goodwill. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POST-CLOSING COVENANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.01&nbsp;&nbsp;&nbsp;&nbsp;<U>Further Assurances</U>. From and after the Closing, upon the reasonable request of the other Party and at such
Party&#146;s expense, each of the Buyer and the Seller shall execute, acknowledge, and deliver, or cause to be executed, acknowledged, and delivered, all such further documents and instruments and shall take, or cause to be taken, all such further
actions as the requesting Party may reasonably deem necessary or desirable to evidence and effectuate the transactions contemplated by this Agreement. Without limiting the generality of the foregoing, if following the Closing, any right, property,
asset or liability not forming part of the Business is found to have been transferred to the Buyer, the Companies or any of their respective Subsidiaries in error (for example, in cases where such right, property or asset relates to the Excluded
Businesses but was inadvertently transferred to the Companies), either directly or indirectly or otherwise in preparation for the separation of the Business from the Seller prior to Closing, the Buyer shall transfer, or shall cause its Affiliates
(including after the Closing, the Companies and their respective Subsidiaries) to transfer, at no cost to the Seller, such right, property, asset or liability as soon as practicable to the Seller. If, following the Closing, any right, property,
asset or liability forming part of the Business is found to have been retained by the Seller in error (for example, in cases where such right, property, asset or liability relates to the Business but was inadvertently retained by the Seller), either
directly or indirectly (including in preparation for the separation of the Business from the Seller), the Seller shall transfer, at no cost to the Buyer, such right, property, asset or liability as soon as practicable to the Buyer or an Affiliate of
Buyer, indicated by Buyer. Notwithstanding the foregoing, no Shared Agreement or Parent-Level Agreement will be transferred to the Buyer, the Companies or any of their respective Subsidiaries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.02&nbsp;&nbsp;&nbsp;&nbsp;<U>Director and Officer Liability and Indemnification</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;For a period of six (6)&nbsp;years after the Closing, the Buyer shall not, and shall not permit the Companies and
their respective Subsidiaries to, amend, repeal, or modify any provision of the Organizational Documents of the Companies or their respective Subsidiaries relating to the exculpation or indemnification of any Persons who, prior to the Closing, have
served as officers, directors, or managers of the Companies or their respective Subsidiaries (collectively, the &#147;<U>D&amp;O Indemnified Persons</U>&#148;) (unless required by Law), in each case, to the extent that any such amendment, repeal or
modification would result in terms that are materially less favorable to the D&amp;O Indemnified Persons than as are in effect as of the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;At the Closing, the Companies will obtain fully prepaid &#147;tail&#148; policies under each of the Companies&#146;
existing directors&#146; and officers&#146; liability insurance policy, which (i)&nbsp;has an effective term of six (6)&nbsp;years from the Closing, (ii)&nbsp;covers only those D&amp;O Indemnified Persons who are currently covered by each of the
Companies&#146; existing directors&#146; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-47- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
officers&#146; liability insurance policy in effect as of the date of this Agreement and only for matters occurring at or prior to the Closing, and (iii)&nbsp;contains coverage terms comparable
to those applicable to the current directors and officers of each of the Companies (the &#147;<U>D&amp;O Tail Policy</U>&#148;). The Buyer will, and will cause each of the Companies to, maintain the D&amp;O Tail Policy in full force and effect
during its full term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.03&nbsp;&nbsp;&nbsp;&nbsp;<U>Access to Books and Records</U>. From and after the Closing, subject to applicable
Law, the Buyer shall, and shall cause each of the Companies and their Subsidiaries solely for purposes of (i)&nbsp;the enforcement of rights by such Party under this Agreement (including, among other things, any insurance claims by, Proceedings or
Tax audits against or governmental investigations of the Seller or the Buyer or any of their Affiliates, any evaluation of any claim for indemnification hereunder or in order to enable the Sellers or the Buyer to comply with their respective
obligations under this Agreement and each other agreement, document or instrument contemplated hereby or thereby), (ii) the preparation of any Tax Return or the examination by any Taxing Authority or other action relating to any Tax Return of such
Party, or (iii)&nbsp;the preparation of financial reports to, provide the Seller and its Representatives with reasonable access (for the purpose of examining and copying), during normal business hours, to the Books and Records of each of the
Companies with respect to periods prior to the Closing Date; <U>provided</U>, all such access does not unreasonably interfere with the operation of the Companies&#146; or their Subsidiaries&#146; respective business and shall be subject to the
Companies&#146; and their respective Subsidiaries&#146; reasonable security measures and insurance requirements. Notwithstanding the foregoing, any Party may destroy or otherwise dispose of any Books and Records of the Companies, or any portions
thereof, relating to periods prior to the Closing Date at any time in their sole and absolute discretion; <U>provided</U>, that prior to such destruction, such Party shall first give reasonable prior written notice to the other Party and if the
other Party so requests within forty-five (45)&nbsp;days after receipt of such notice, to take possession of such Books and Records or such portions thereof. Notwithstanding any provision of this <U>Section&nbsp;7.03</U> to the contrary, no such
access shall be permitted or provision of documentation shall be required to the extent that it would require any Party to disclose information subject to attorney-client privilege, violate any Law, or conflict with any confidentiality obligations
to which any of the Companies or any of their respective Subsidiaries is bound; <U>provided</U>, the Companies shall use commercially reasonable efforts to provide such information in a manner that does not violate any such Law, confidentiality
obligations or privilege. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.04&nbsp;&nbsp;&nbsp;&nbsp;<U>Intercompany Obligations and Arrangements</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Seller shall, and shall cause its Affiliates to, take such action and make such payments as may be necessary so
that prior to or concurrently with the Closing, the Companies and their respective Subsidiaries, on the one hand, and the Seller and its Affiliates (other than the Companies and their respective Subsidiaries), on the other hand, shall settle,
discharge, offset, pay, repay in full, terminate or extinguish all intercompany loans, notes and advances (collectively, &#147;<U>Intercompany Balances</U>&#148;) regardless of their maturity, including any accrued and unpaid interest to but
excluding the date of payment, for the amount due. The Seller shall deliver to the Buyer all promissory notes or other instruments evidencing such Intercompany Balances marked &#147;cancelled&#148; including any global intercompany note executed in
connection with the Seller&#146;s Existing Credit Facility. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-48- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Seller shall, and shall cause its Affiliates to, take such
actions as may be necessary to terminate, concurrently with the Closing, all Affiliate Arrangements; <U>provided</U>, <U>however</U>, that this <U>Section&nbsp;7.04(b)</U> shall not apply to (i)&nbsp;any Affiliate Arrangement set forth in
<U>Section&nbsp;7.04(b) of the Disclosure Schedules</U>, (ii)&nbsp;any Contract between a third party, on the one hand, and the Seller or any of its Affiliates, on the other hand, to which the Companies or any of their respective Subsidiaries is not
a party, but under which the Companies or any of their respective Subsidiaries may otherwise derive benefits (&#147;<U>Parent-Level Agreements</U>&#148;), such as enterprise-wide licenses or &#147;master&#148; agreements, (iii)&nbsp;any Contract
among (x)&nbsp;a third party, (y)&nbsp;the Seller or any of its Affiliates (other than the Companies and their respective Subsidiaries) and (z)&nbsp;the Companies or any of their respective Subsidiaries (&#147;<U>Shared Agreements</U>&#148;), or
(iv)&nbsp;this Agreement or any Related Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;With respect to each Parent-Level Agreement set forth on
<U>Section&nbsp;7.04(c) of the Disclosure Schedules</U>, the Parties shall cooperate in good faith and use their respective commercially reasonable efforts to cause to occur, on or prior to the Closing, (i)&nbsp;an amendment, (ii)&nbsp;a separation,
(iii)&nbsp;the execution of a comparable Contract or (iv)&nbsp;other action (each a &#147;<U>Parent-Level Agreement Replacement</U>&#148;), such that the Companies and their respective Subsidiaries continue to derive substantially comparable use and
benefit of such Contract as was in place before such amendment, separation, execution of a new Contract or other action; <U>provided</U>, that none of the Seller nor any of its Affiliates shall be required to compensate any third party, commence or
participate in litigation or offer or grant any accommodation (financial or otherwise) to any third party in connection with this <U>Section&nbsp;7.04(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;With respect to each Shared Agreement set forth on <U>Section&nbsp;7.04(d) of the Disclosure Schedules</U>, the
Parties shall cooperate in good faith and use their respective reasonable best efforts to cause to occur, on or prior to the Closing, (i)&nbsp;an amendment, (ii)&nbsp;a separation, (iii)&nbsp;the execution of a comparable Contract or (iv)&nbsp;other
action (each a &#147;<U>Shared Agreement Replacement</U>&#148;) such that following the effectiveness of such Shared Agreement Replacement, the Seller and its Affiliates (other than the Companies and their respective Subsidiaries), on the one hand,
shall not have any rights, obligations or liabilities, or be entitled to any benefits, of such Shared Agreement or Shared Agreement Replacement as related to the Companies and their respective Subsidiaries, on the other hand, and vice versa;
<U>provided</U>, that none of the Seller nor any of its Affiliates shall be required to compensate any third party, commence or participate in litigation or offer or grant any accommodation (financial or otherwise to any third party in connection
with this <U>Section&nbsp;7.04(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;From the Closing Date until the six (6)&nbsp;month anniversary thereof,
the Buyer and the Seller shall each use commercially reasonable efforts to enter into any Parent-Level Agreement Replacement or Shared Agreement Replacement not previously entered into prior to the Closing. If the Seller is unable to enter into a
Parent-Level Agreement Replacement or Shared Agreement Replacement, as applicable, with respect to any particular Parent-Level Agreement or Shared Agreement, as applicable, prior to the Closing, until the earlier of such time as such Parent-Level
Agreement Replacement or Shared Agreement Replacement is entered into and six (6)&nbsp;months following the Closing Date, the Seller will, at the Buyer&#146;s request, if practicable and solely to the extent permitted under the terms of the
applicable Parent-Level Agreement or Shared Agreement, use commercially reasonable efforts to continue to provide goods and services to the Buyer and its Subsidiaries under such Parent-Level Agreement or Shared Agreement, as
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-49- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable, which goods and services shall be paid for by the Buyer at cost and shall, during such period, refrain from failing to renew, terminating, allowing to lapse, or amending or modifying
in any respect materially adverse to the Companies or their respective Subsidiaries, any Shared Agreement or Parent-Level Agreement without the prior written consent of the Buyer. For the avoidance of doubt, from and after six (6)&nbsp;months
following the Closing, the Buyer and its Subsidiaries shall have no right to receive any claims, rights, or benefits under any Parent-Level Agreement or Shared Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.05&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer Taxes</U>. The Buyer will pay, or cause to be paid all of the transfer Tax, stamp Tax, stock transfer
Tax, or other similar Tax imposed on the Companies and their respective Subsidiaries as a result of the transactions contemplated by this Agreement (collectively, &#147;<U>Transfer Taxes</U>&#148;). The Seller agrees to cooperate with the Buyer in
the filing of any returns with respect to the Transfer Taxes, including promptly supplying any information in its possession that is reasonably necessary to complete such returns and the payment of such amounts due under this
<U>Section&nbsp;7.05</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Post-Closing Actions</U>. None of the Buyer, the Companies or any of their
respective Subsidiaries shall (or shall cause or permit any other Person to): (a)&nbsp;amend, <FONT STYLE="white-space:nowrap">re-file</FONT> or otherwise modify any Tax Return relating to any of the Companies or their respective Subsidiaries with
respect to any taxable period (or portion thereof) ending on or before the Closing Date; (b)&nbsp;subject to <U>Section&nbsp;7.05(d)</U>, make any Tax election that has retroactive effect to any taxable period (or portion thereof) ending on or
before the Closing Date; (c)&nbsp;file any ruling request with any Taxing Authority that relates to Taxes or Tax Returns of any of the Companies or their respective Subsidiaries for any taxable period (or portion thereof) ending on or before the
Closing Date; or (d)&nbsp;enter into any voluntary disclosure with any Taxing Authority regarding any Tax or Tax Returns of any of the Companies or their respective Subsidiaries for any taxable period (or portion thereof) ending on or before the
Closing Date, in each case, without the prior written consent of the Seller (which consent will not be unreasonably withheld, conditioned, or delayed). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Election to Reduce Basis in Shares</U>. Seller shall make a timely and valid election pursuant to Treasury
Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-36(d)(6)(i)(A)</FONT> to reduce the basis of the shares of MedDirect Holding to the extent necessary to prevent any attribute reduction pursuant to Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.1502-36(d)(6)(i)(A)</FONT> with respect to MedDirect Holding and its Subsidiaries. Seller shall not, without the prior written consent of Buyer, make any election pursuant to Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.1502-36(d)(6)(i)(A)</FONT> or (C)&nbsp;to reattribute any of the Companies&#146; Tax attributes to Seller. The Parties agree to cooperate in good faith to implement a timely filed election as described in
this section and will provide the other Party any proof of such timely filed election. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section 336(e)
Elections</U>. Seller and each of MedData Holding and its U.S. corporate subsidiaries shall make timely and valid elections under Section&nbsp;336(e) of the Code (and any corresponding elections under state, local, or
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> income Tax Law) with respect to the purchase and sale of the Equity Securities of MedData Holding and the indirect purchase and sale of the Equity Securities of the U.S. corporate subsidiaries of
MedData Holding hereunder (collectively, the &#147;<U>Section&nbsp;336(e) Elections</U>&#148;).&nbsp;The Parties agree to cooperate in good </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-50- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
faith to implement any timely filed Section&nbsp;336(e) Elections (including executing and filing, any IRS forms, returns, elections, schedules and other documents required by Treasury Regulation
<FONT STYLE="white-space:nowrap">Section&nbsp;1.336-2(h)</FONT> to effect the Section&nbsp;336(e) Elections), and will provide the other Party any proof of such timely filed elections. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.06&nbsp;&nbsp;&nbsp;&nbsp;<U>Release</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;If and only if the Closing occurs, the Seller, for itself, its Affiliates and its successors and assigns, their
respective Affiliates (collectively, the &#147;<U>Seller Releasors</U>&#148;), hereby forever fully and irrevocably releases and discharges each of the Buyer, the Companies and the Financing Sources (including the Debt Financing Sources and the
Sponsors), their respective Affiliates, and each of their respective predecessors, successors, direct or indirect Subsidiaries and past and present equityholders, managers, directors, officers, employers agents and other Representatives
(collectively, the &#147;<U>Buyer Released Parties</U>&#148;) from any and all actions, suits, claims, demands, debts, agreements, obligations, promises, judgments, or liabilities of any kind whatsoever in law or equity and causes of action of every
kind and nature, or otherwise (including, claims for damages, costs, expense, and attorneys&#146;, brokers&#146; and accountants fees and expenses) arising out of or related to events, facts, conditions or circumstances existing or arising prior to
the Closing Date, which the Seller Releasors can, shall or may have against the Buyer Released Parties, whether known or unknown, suspected or unsuspected, unanticipated as well as anticipated (collectively, the &#147;<U>Seller Released
Claims</U>&#148;), and hereby irrevocably agree to refrain from directly or indirectly asserting any claim or demand or commencing (or causing to be commenced) any suit, action, or proceeding of any kind, in any court or before any tribunal, against
any Buyer Released Party based upon any Seller Released Claim. Each of the Seller Releasors&nbsp;acknowledges and agrees that it shall not initiate any Proceedings or otherwise make any claims against the Buyer Released Parties by reason of the fact
that such Person was a stockholder, member, director, manager officer or employee of any Company or was serving at the request of any Company as a director, manager, officer or employee of another entity (whether such claim is for judgments,
damages, penalties, fines, costs, amounts paid in settlement, losses, expenses or otherwise) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything to the contrary in this <U>Section&nbsp;7.06</U>, no &#147;Buyer Released Claims&#148; shall include, and the provisions of this <U>Section&nbsp;7.06</U> shall not release or otherwise diminish the obligations of any Party set forth in or
arising under any provisions of this Agreement or any Related Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.07&nbsp;&nbsp;&nbsp;&nbsp;<U>Litigation Support</U>. In the
event that either Party (or any of their respective Affiliates) is named as a party in any Proceeding relating to both the Excluded Business and the Business (a &#147;<U>Joint Litigation Matter</U>&#148;), each Party shall, and shall cause its
respective Affiliates and its and their respective directors, officers and employees, to reasonably cooperate with such other Party and its Representatives in the prosecution, contest and/or defense of such Proceeding, including by making available
its personnel, witnesses and Representatives, providing such testimony and access to its books and records and entering into a mutually agreeable joint defense agreement (which shall provide for, among other things, the treatment of privileged
communications and control of such Proceeding), in each case as shall be reasonably necessary in connection with such prosecution, contest and/or defense of such Proceeding. Without limiting the generality of the foregoing, any Joint Litigation
Matter shall be controlled by either the Seller (or one of its Affiliates), on the one hand, or the Buyer (or one of its Affiliates) on the other hand, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-51- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
based on whether the underlying act, circumstance, event, act, omission or other matter upon which such Joint Litigation Matter is based is primarily related to the Business or the Excluded
Business, and any such <FONT STYLE="white-space:nowrap">non-controlling</FONT> Party shall be entitled to participate in (but not control) such prosecution, contest and/or defense with counsel of its own choosing. Each Party shall bear its own costs
and expenses in connection with any such Joint Litigation Matter. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.08&nbsp;&nbsp;&nbsp;&nbsp;<U>Seller Restrictive Covenants</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;During the Restricted Period, the Seller hereby acknowledges and agrees not to (and to cause Mednax, Inc. and any of
its Affiliates, directly or indirectly, controlled by Mednax, Inc.), anywhere in the Restricted Area, directly or indirectly, engage in any Restricted Business and not to acquire, invest in, operate or control any Person that engages in the
Restricted Business; <U>provided</U>, that nothing herein shall prohibit the Seller or any of its Affiliates from (i)&nbsp;being a passive owner of less than three percent (3%) of the outstanding stock of any class of a Person whose stock is
publicly traded on a securities exchange, so long as neither the Seller nor its Affiliates has no active participation in the business or management of such Person or (ii)&nbsp;engaging in the Permitted Activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;During the Restricted Period, the Seller hereby acknowledges and agrees not to (and to cause Mednax, Inc. and any
of its Affiliates, directly or indirectly, controlled by Mednax, Inc. not to), anywhere in the Restricted Area, directly or indirectly, (x)&nbsp;induce, or attempt to induce, any customer, supplier, distributor, licensor or other business relation
of the Companies and/or any of their respective Subsidiaries to cease doing business with, or reduce its business with, the Companies and/or any of their respective Subsidiaries, provided, that this clause (x)&nbsp;shall not prohibit Seller, Mednax,
Inc. or their affiliates from soliciting any customer, supplier, distributor, licensor or other business relation that is not related to the Restricted Business or (y)&nbsp;in any way intentionally interfere with the relationship between any such
customer, supplier, distributor, licensee, licensor or other business relation and the Companies and/or any of their respective Subsidiaries (including intentionally making any negative statements or communications about the Buyer, the Companies,
any of their respective Subsidiaries, or their respective products or services). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;During the Restricted Period,
the Seller hereby acknowledges and agrees not to (and to cause its Affiliates not to), anywhere in the Restricted Area, directly or indirectly (x)&nbsp;divert, solicit, induce or attempt to divert, solicit or induce any Restricted Employee to leave
the employ or service of the Companies or any of their respective Subsidiaries or in any way intentionally interfere with the relationship between the Companies or any of its respective Subsidiaries, on the one hand, and any Restricted Employee, on
the other hand, or (y)&nbsp;hire any Restricted Employee. The foregoing restrictions shall not preclude general solicitations in newspapers or similar mass media not targeted towards a particular Restricted Employee; <U>provided</U>, that no
Restricted Employee that responds to any such general solicitation may be hired without the prior written consent of the Buyer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Seller hereby agrees with the Buyer that the Seller will not, and that the Seller will cause its Affiliates and
other Representatives not to, at any time on or after the Closing Date, directly or indirectly, without the prior written consent of the Buyer, disclose or use any information confidential or proprietary information involving or relating to any of
the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-52- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Companies or their respective Subsidiaries or the Buyer and their respective Affiliates (collectively, &#147;<U>Confidential Information</U>&#148;); <U>provided</U>, <U>however</U>, that the
information subject to the foregoing provision of this sentence will not include any information generally available to, or known by, the public (other than as a result of disclosure in violation hereof) at the time of disclosure by the Seller;
<U>provided</U>, <U>further</U>, that the provisions of this <U>Section&nbsp;7.08(d)</U> will not prohibit any retention of copies of records expressly required by applicable Law or bona fide document retention policy in existence prior to the date
hereof (which retained copies shall remain subject to the confidentiality obligations of this <U>Section&nbsp;7.08(d)</U> or disclosure (a)&nbsp;required by applicable Law (<U>provided</U>, that in such case, the Seller shall provide the Buyer with
prompt written notice of such requirement prior to disclosure thereof and shall, upon request therefor by the Buyer, reasonably cooperate with the Buyer and its Subsidiaries to obtain a protective order or other remedy) or (b)&nbsp;required to be
made in a forum of proper jurisdiction and venue in connection with the enforcement of any right or remedy under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Seller hereby acknowledges and agrees that the restrictions contained in this <U>Section&nbsp;7.08</U> are
essential in order to effectuate the transfer of the goodwill of the Companies and their respective Subsidiaries to the Buyer and that the Buyer&#146;s remedies for a breach or other failure to comply with the restrictions contained in this
<U>Section&nbsp;7.08</U> are not intended to be limited by reference to the value of any amount explicitly assigned by the Parties as specific consideration for the restrictions contained in this <U>Section&nbsp;7.08</U> (or any portion thereof) or
otherwise. The Seller acknowledges and agrees that in the event of a breach of any of the applicable provisions of this <U>Section&nbsp;7.08</U>, monetary damages will not constitute a sufficient remedy. Consequently, in the event of any such
breach, the Buyer shall be entitled to specific performance and/or injunctive or other relief, in addition to all other remedies available at law or equity, in order to enforce or prevent any violations of the provisions of this
<U>Section&nbsp;7.08</U> (without posting a bond or other security); <U>provided</U>, that, (i)&nbsp;to the extent any such breach is capable of being cured within twenty (20)&nbsp;Business Days, the Buyer shall provide written notice to the Seller
of any such violation or breach and the Seller shall have an opportunity to cure such breach within the twenty (20)&nbsp;Business Days after the date on which such written notice has been delivered and (ii)&nbsp;in the event of a breach of any of
the applicable provisions of this <U>Section&nbsp;7.08</U> that is not cured within such twenty (20)&nbsp;Business Day period, the Restricted Period shall be tolled until the date on which such breach ceases to be continuing and in effect, in order
that the Buyer, the Companies and their respective Subsidiaries shall have all of the agreed-upon temporal protection provided in this <U>Section&nbsp;7.08</U>. If a court of competent jurisdiction determines that the character or duration of the
provisions of this <U>Section&nbsp;7.08</U> are unreasonable, it is the intention and the agreement of the parties that these provisions shall be construed by the court in such a manner as to impose only those restrictions on the conduct of the
Seller that are reasonable in light of the circumstances and as are necessary to assure to the Buyer the benefits of this Agreement. If, in any judicial proceeding, a court shall refuse to enforce all of the separate covenants of this
<U>Section&nbsp;7.08</U> because taken together they are more extensive than necessary to assure to the Buyer the intended benefits of this Agreement, it is expressly understood and agreed by the Parties that the provisions hereof that, if
eliminated, would permit the remaining separate provisions to be enforced in such Proceeding, shall be deemed eliminated, for the purposes of such Proceeding, from this Agreement. The Seller acknowledges that during its ownership of the Companies
and its respective Subsidiaries, the Seller has become familiar with the trade secrets of and other Confidential Information concerning the Companies and their respective Subsidiaries. Therefore, in further consideration of the compensation to be
paid to the Seller under this Agreement, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-53- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Seller agrees to the covenants set forth in <U>Section&nbsp;7.08</U> and acknowledges that (w)&nbsp;the covenants set forth in this <U>Section&nbsp;7.08</U> are reasonably limited in time and in
all other respects, (x)&nbsp;the covenants set forth in this <U>Section&nbsp;7.08</U> are reasonably necessary for the protection of the Buyer, the Companies and their respective Subsidiaries, (y)&nbsp;the Buyer would not have entered into this
Agreement but for the agreement of the Seller to the restrictions set forth in this <U>Section&nbsp;7.08</U> and (z)&nbsp;the covenants set forth in this <U>Section&nbsp;7.08</U> have been made in order to induce the Buyer to enter into this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;For the avoidance of doubt, the terms of clauses (a), (b) and (c)&nbsp;of this
<U>Section&nbsp;7.08</U> shall not apply to (i)&nbsp;any Parent Acquirer or any of its Affiliates (other than Mednax, Inc. and any Affiliates directly or indirectly controlled by Mednax, Inc.) or (ii)&nbsp;to any Person from or after such time that
such Person is not controlled directly or indirectly by Mednax, Inc. (including any Person that ceases to be controlled by Mednax); <U>provided</U>, <U>however</U>, the terms of clause (c)&nbsp;of this <U>Section&nbsp;7.08</U> shall apply, to the
extent applicable, to any Parent Acquirer or any of its Affiliates (other than Mednax, Inc. and any Affiliates directly or indirectly controlled by Mednax, Inc.) in respect of Restricted Key Employees; <U>provided</U>, <U>further</U> that if Parent
Acquirer is an investment fund, such restrictions shall not apply to such investment fund (so long as it is not directing Mednax or its Subsidiaries to take any actions in violation of clause (c)&nbsp;of <U>Section&nbsp;7.08</U>) or any other
portfolio companies thereof. For purposes of this <U>Section&nbsp;7.08</U>, the term &#147;control&#148; shall mean the power, authority or ability of Mednax to, directly or indirectly, cause the applicable entity to comply with the applicable terms
of this <U>Section&nbsp;7.08</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;In the event that Seller or its Affiliates acquire all or any part of, or
invest in, a business or Person that is engaged in the Restricted Business, then such conduct shall not, by itself, constitute a violation of <U>Section&nbsp;7.08(a)</U> or <U>(b)</U>&nbsp;so long as (x)&nbsp;such acquired business or Person&#146;s
revenues in respect of such Restricted Business activities represent no more than twenty percent (20%) of the aggregate consolidated revenues of such acquired business or Person, as applicable, for such acquired business&#146;s or Person&#146;s most
recently completed fiscal year and (y)&nbsp;such Restricted Business activities are divested, wound-down or otherwise discontinued within twelve (12)&nbsp;months of the date of such acquisition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.09&nbsp;&nbsp;&nbsp;&nbsp;<U>A&amp;M Project</U>. Buyer shall use commercially reasonable efforts to cause the Companies to complete the
project currently being undertaken by Alvarez&nbsp;&amp; Marsal to make operational improvements the patient pay service line of the Companies and shall reasonably consult with Seller with regard to the completion of such project. Seller shall
reimburse the Company for the fees and costs paid to Alvarez&nbsp;&amp; Marsal to complete such project promptly following provision of appropriate documentation by the Companies; <U>provided</U>, <U>however</U>, in no event shall the Companies be
obligated to incur and Seller be obligated to reimburse, fees arising after the Closing in excess of $[***] (the &#147;<U>Expense Reimbursement Cap</U>&#148;); <U>provided</U>, <U>further</U>, that in the event Seller fails or refuses to make any
reimbursement of fees (including as a result of reaching the Expense Reimbursement Cap, then Buyer shall have no further obligation to continue any such operational improvements hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-54- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.10&nbsp;&nbsp;&nbsp;&nbsp;<U>Employees</U>. The Buyer shall use reasonable best efforts
not, and shall use reasonable best efforts to cause each of the Companies no to, take any action following the Closing that results in liability to the Seller under the Worker Adjustment and Retraining Notification Act of 1988, as amended, or any
similar state or local Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.11&nbsp;&nbsp;&nbsp;&nbsp;<U>Retention Bonuses</U>. The parties acknowledge and agree that a portion of the
Retention Bonus Obligations may become due and payable by the Companies or their Subsidiaries on the one (1)&nbsp;year anniversary of the Closing Date (the &#147;Retention Bonus Date&#148;). From time to time following the Retention Bonus Date, if
it is determined by the Buyer that all or any portion of the Retention Bonus Amount applicable to any Retention Bonus Recipient shall not become due and payable to such Retention Bonus Recipient in accordance with the terms of the applicable
Retention Bonus Agreement of such Retention Bonus Recipient (including, to the extent applicable, as a result of such Retention Bonus Recipient ceasing to remain employed with the applicable employer thereof), then the Buyer shall pay, or cause to
be paid, to the Seller, the applicable portion of the Retention Bonus Amount that has not become payable to such Retention Bonus Recipient(s) (together with any related employer&#146;s share of payroll, employment, or other Taxes associated with
such payments that were included in the Retention Bonus Obligations but which did not actually become paid or payable). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NO SURVIVAL; LIMITED INDEMNIFICATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.01&nbsp;&nbsp;&nbsp;&nbsp;<U>No Survival of Representations; Survival of Covenants</U>. The Parties, intending to modify any applicable
statute of limitations, agree that (a)&nbsp;representations and warranties in this Agreement and in any Related Agreement shall terminate effective as of the Closing and shall not survive the Closing for any purpose, and, except in the case of
Fraud, thereafter there shall be no liability on the part of, nor shall any claim be made by, any Party or any of their respective Affiliates in respect thereof, and (b)&nbsp;after the Closing, there shall be no liability on the part of, nor shall
any claim be made by, any Party or any of their respective Affiliates in respect of any covenant or agreement to be performed prior to the Closing, other than in the case of Fraud, which claim of Fraud (and the underlying representations and
warranties relating thereto) shall survive indefinitely. All covenants and agreements contained in this Agreement that contemplate performance thereof following the Closing or otherwise expressly by their terms survive the Closing will survive the
Closing in accordance with their terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.02&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification</U>. From and after the Closing, the Seller shall
have certain indemnification obligations in accordance with <U>Schedule 8.02</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-55- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.01&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>. This Agreement may be terminated at any time prior to the Closing Date: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;by mutual written consent of the Buyer and the Seller; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;by the Buyer, if (i)&nbsp;there has been a violation or breach by the Seller or any of its Affiliates of any
covenant, representation, or warranty contained in this Agreement or any Related Agreement, which has prevented or would prevent the satisfaction of any condition to the obligations of the Buyer to complete the Closing set forth in
<U>Section&nbsp;2.02(a)</U> and <U>Section&nbsp;2.02(b)</U> and (A)&nbsp;such violation or breach has not been expressly waived by the Buyer in writing, (B)&nbsp;the Buyer has provided written notice to the Seller of such violation or breach, and
(C)&nbsp;if such breach is capable of being cured prior to the earlier of (x)&nbsp;the Outside Date and (y)&nbsp;the date that is ten (10)&nbsp;Business Days after the date on which the written notice described in clause (B)&nbsp;of this
<U>Section&nbsp;9.01(b)</U> has been delivered (such earlier date, the &#147;<U>Seller Cure Deadline</U>&#148;), the Seller has not cured such violation or breach in all material respects prior to the Seller Cure Deadline, or (ii)&nbsp;the
transactions contemplated hereby have not been consummated by January&nbsp;8, 2020 (the &#147;<U>Outside Date</U>&#148;); <U>provided</U>, <U>however</U>, the Buyer shall not be entitled to terminate this Agreement pursuant to this
<U>Section&nbsp;9.01(b)</U> if (x)&nbsp;in the case of clause (i)&nbsp;hereof, the Buyer is then in breach of this Agreement such that the Seller would be entitled to terminate this Agreement pursuant to <U>Section&nbsp;9.01(c)</U> or (y)&nbsp;in
the case of clause (ii)&nbsp;hereof, the failure of the Buyer to perform or comply in all material respects with the covenants and agreements of the Buyer set forth in this Agreement was the primary cause of, or primarily resulted in, the failure to
consummate the transactions by the Outside Date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;by the Seller, if: (i)&nbsp;there has been a violation or
breach by the Buyer of any covenant, representation, or warranty contained in this Agreement or any Related Agreement which has prevented or would prevent the satisfaction of any condition to the obligations of the Seller to complete the Closing set
forth in <U>Section&nbsp;2.03(a)</U> and <U>Section&nbsp;2.03(b)</U> and (A)&nbsp;such violation or breach has not been expressly waived by the Seller in writing, (B)&nbsp;the Seller has provided written notice to the Buyer of such violation or
breach, and (C)&nbsp;if such breach is capable of being cured prior to the earlier of (i)&nbsp;the Outside Date and (ii)&nbsp;the date that is ten (10)&nbsp;Business Days after the date on which the written notice described in clause (B)&nbsp;of
this <U>Section&nbsp;9.01(c)</U> has been delivered (such earlier date, the &#147;<U>Buyer Cure Deadline</U>&#148;), the Buyer has not cured such violation or breach in all material respects prior to the Buyer Cure Deadline, or (ii)&nbsp;the
transactions contemplated hereby have not been consummated by the Outside Date; <U>provided</U>, <U>however</U>, the Seller shall not be entitled to terminate this Agreement pursuant to this <U>Section&nbsp;9.01(c)</U> if (x)&nbsp;in the case of
clause (i)&nbsp;hereof, the Seller is then in breach of this Agreement such that the Buyer would be entitled to terminate this Agreement pursuant to <U>Section&nbsp;9.01(b)</U> or (y)&nbsp;in the case of clause (ii)&nbsp;hereof, the failure of the
Seller to perform or comply in all material respects with the covenants and agreements of the Seller set forth in this Agreement was the primary cause of, or primarily resulted in, the failure to consummate the transactions by the Outside Date; </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-56- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;by either the Buyer or the Seller, if any Governmental Authority
shall have enacted, promulgated, issued, entered, or enforced any injunction, judgment, order, or ruling permanently enjoining, restraining, or prohibiting the transactions contemplated by this Agreement, which shall have become final and
nonappealable; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;by the Seller, in the event (a)&nbsp;all of the conditions set forth in
<U>Section&nbsp;2.02</U> shall have been satisfied or waived (other than those conditions that by their nature are to be satisfied by actions taken at the Closing, but subject to such conditions being satisfied at the Closing), (b) the Seller has
irrevocably and unconditionally confirmed to Buyer in a written notice (such notice, a &#147;<U>Closing Failure Notice</U>&#148;) that, if Buyer performs its obligations hereunder to consummate the Closing and the Financing were funded, the Seller
is ready, willing and able to (and shall) perform its obligations in connection with effectuating the Closing and (c)&nbsp;the Buyer shall have failed to consummate the Closing by the Outside Date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.02&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect of Termination</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;If any Party validly terminates this Agreement pursuant to <U>Section&nbsp;9.01</U>, all rights and obligations of
the Parties hereunder shall terminate without any liability of any Party to any other Party, except for this <U>Section&nbsp;9.02</U> and <U>ARTICLE X</U> and pursuant to the Confidentiality Agreement, each of which shall survive the termination of
this Agreement as applicable and in accordance with their terms; <U>provided</U>, <U>further</U>, that any termination of this Agreement pursuant to <U>Section&nbsp;9.01(b)(i)</U> shall in no way limit any claim by the Buyer that the Seller
willfully and materially breached the terms of this Agreement or any Related Agreement prior to or in connection with such termination, including by failing to consummate the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the event that this Agreement is validly terminated by (x)&nbsp;the Seller pursuant to
<U>Section&nbsp;9.01(c)(i)</U> as a result of a willful and material breach by the Buyer or (y)&nbsp;by the Seller pursuant to an amount equal to <U>Section&nbsp;9.01(e)</U>, then in either such circumstance, the Buyer shall promptly pay or cause to
be paid a cash amount equal to $15,000,000 (the &#147;<U>Buyer Termination Fee</U>&#148;) to the Seller, by wire transfer of immediately available funds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary in this Agreement, in the event this Agreement is terminated for any
reason by any Party, the Seller&#146;s receipt of the Buyer Termination Fee, if and solely to the extent payable pursuant to <U>Section&nbsp;9.02(b)</U>, shall be the sole and exclusive remedy of the Seller, the Companies or their respective
Affiliates or other Representatives against the Buyer or its Representatives for any liabilities, obligations, losses or damages of any kind, character or description suffered in connection with the preparation for any negotiation, execution and
delivery of this Agreement and the full or partial performance of any obligations hereunder, including as a result of the failure of the transactions contemplated hereby to be consummated. Upon payment of the Buyer Termination Fee, if payable
pursuant to this <U>Section&nbsp;9.02(c)</U>, neither the Buyer nor its Representatives shall have any further liability or obligation or any other obligation for any other liabilities, obligations, losses or damages of any kind, character or
description relating to or arising out of this Agreement and/or the Financing, and/or the transactions contemplated hereby or thereby. If the Buyer Termination Fee become payable pursuant to this <U>Section&nbsp;9.02(c)</U>, (x) under no
circumstances shall the Seller, the Companies or their respective Representatives be permitted to seek, or be entitled to receive, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-57- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
specific performance of this Agreement and (y)&nbsp;in no event shall the Buyer or its Representatives be subject to (nor shall the Seller, the Companies or their respective Representatives seek
to recover) monetary damages in excess of the Buyer Termination Fee for any and all liabilities, obligations, losses or damages of any kind, character or description suffered or incurred by any of Seller, the Companies or their respective
Representatives in connection with this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE X </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL PROVISIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.01&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>. All notices, demands and other communications to be given or delivered under this Agreement shall
be in writing and shall be deemed to have been given (i)&nbsp;when received, if personally delivered; (ii)&nbsp;when transmitted, if sent by fax transmission or other electronic means of transmitting written documents (including electronic mail)
prior to 5:00 pm (Central time) on a Business Day (otherwise, such transmission shall be deemed sent on the immediately following Business Day); or (iii)&nbsp;the day after they are sent, if sent by private overnight mail courier service, or three
(3)&nbsp;Business Days after being mailed by first class mail, return receipt requested. Notices, demands, and communications to the Parties shall, unless another address is specified in writing, be sent to the addresses indicated below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;if to the Buyer to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">FH MD Buyer, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">c/o Frazier
Healthcare </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">601 Union Street, Suite 3200 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Seattle, WA 98101 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention:
Nader Naini; Brian Morfitt </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: nader@frazierhealthcare.com; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">brian@frazierhealthcare.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with a copy to (which notice shall not constitute notice): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Goodwin Procter LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">The New
York Times Building </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">620 Eighth Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">New York, NY 10018 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention:
Christian Nugent; Jared Spitalnick </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: cnugent@goodwinlaw.com; jspitalnick@goodwinlaw.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;if to the Seller, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">MEDNAX Services, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">c/o
MEDNAX, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">1301 Concord Terrace </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Sunrise, Florida 33323 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: General Counsel </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: Dominic_Andreano@Mednax.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-58- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with a copy to (which notice shall not constitute notice): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">McDermott Will&nbsp;&amp; Emery LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">333 Avenue of the Americas, Suite 4500 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Miami, Florida 33131 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Roy Larson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: rlarson@mwe.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.02&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire Agreement</U>. This Agreement (including the Disclosure Schedule and Exhibits attached hereto), the
Related Agreements, and other documents delivered at the Closing pursuant hereto or thereto, contain the entire understanding of the Parties in respect of their subject matter and supersede all prior agreements and understandings (oral or written)
between the Parties with respect to such subject matter, other than the Confidentiality Agreement. The Disclosure Schedule, and Exhibits constitute a part hereof as though set forth in full above. In furtherance of the foregoing, the Parties
acknowledge that the execution of this Agreement is the culmination of extensive negotiations between them, all of which were intended to be <FONT STYLE="white-space:nowrap">non-binding</FONT> upon the Parties until memorialized in the executed copy
of this Agreement and none of which should be construed as having created any type of oral agreement between the Parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.03&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>. Whenever possible, each provision of this Agreement will be interpreted in such a manner as
to be effective and valid under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision will be ineffective only to the extent of such prohibition or invalidity, without
invalidating the remainder of such provision or the remaining provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.04&nbsp;&nbsp;&nbsp;&nbsp;<U>Expenses</U>.
Except as otherwise provided herein, the Parties shall pay their own fees and expenses incurred in connection with the preparation, negotiation, execution, and performance of this Agreement, including their own counsel fees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.05&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment; Waiver</U>. This Agreement may not be modified, amended, supplemented, canceled, or discharged,
except by written instrument executed by all of the Parties; <U>provided</U>, <U>however</U>, that notwithstanding anything in this Agreement to the contrary, <U>Section&nbsp;10.06</U>, <U>Section&nbsp;10.09</U>, <U>Section&nbsp;10.10(a)</U>,
<U>Section&nbsp;10.20</U>, <U>Section&nbsp;10.21</U> and this <U>Section&nbsp;10.05</U>, in each case together with any related definitions, may not be modified, amended, supplemented, canceled or discharged in a manner that is materially adverse to
the Debt Financing Sources without the written consent of the Debt Financing Sources specified in clause (a)&nbsp;of the definition thereof. No failure to exercise, and no delay in exercising, any right, power, or privilege under this Agreement
shall operate as a waiver, nor shall any single or partial exercise of any right, power, or privilege hereunder preclude the exercise of any other right, power, or privilege. No waiver of any breach of any provision shall be deemed to be a waiver of
any preceding or succeeding breach of the same or any other provision, nor shall any waiver be implied from any course of dealing between the Parties. No extension of time for performance of any obligations or other acts hereunder or under any other
agreement shall be deemed to be an extension of the time for performance of any other obligations or any other acts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-59- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.06&nbsp;&nbsp;&nbsp;&nbsp;<U>Binding Effect; Assignment</U>. The rights and obligations
of this Agreement shall bind and inure to the benefit of the Parties and their respective successors and assigns. Except as set forth in <U>Section&nbsp;7.02</U>, nothing expressed or implied herein or therein shall be construed to give any other
person any legal or equitable rights hereunder. Except as expressly provided herein, the rights and obligations of this Agreement may not be assigned by the Parties without the prior written consent of the other Party; <U>provided</U>,
<U>however</U>, that the Buyer may make a collateral assignment of its rights hereunder to any Debt Financing Source or any other lender to the Buyer without the prior written consent of the Seller or any other Person. Notwithstanding anything to
the contrary contained in this Agreement, the provisions of <U>Section&nbsp;10.05</U>, <U>Section&nbsp;10.09</U>, <U>Section&nbsp;10.10(a)</U>, <U>Section&nbsp;10.19</U>, <U>Section&nbsp;10.20</U> and this <U>Section&nbsp;10.06</U>, in each case
together with any related definitions, will inure to the benefit of the Debt Financing Sources, each of whom are intended to be third-party beneficiaries thereof (it being understood and agreed that <U>Section&nbsp;10.05</U>,
<U>Section&nbsp;10.09</U>, <U>Section&nbsp;10.10(a)</U>, <U>Section&nbsp;10.19</U>, <U>Section&nbsp;10.20</U> and this <U>Section&nbsp;10.06</U>, in each case and any related definitions, will be enforceable by the Debt Financing Sources. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.07&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U>. This Agreement may be executed in any number of counterparts, each of which shall be an
original but all of which together shall constitute one and the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.08&nbsp;&nbsp;&nbsp;&nbsp;<U>Interpretation;
Disclosure Schedule</U>. When a reference is made in this Agreement to an article, section, paragraph, clause, schedule or exhibit, such reference shall be deemed to be to this Agreement unless otherwise indicated. Whenever the words
&#147;include,&#148; &#147;includes&#148; or &#147;including&#148; are used in this Agreement, they shall be deemed to be followed by the words &#147;without limitation.&#148; All references to statutes or related regulations shall include all
amendments of the same and any successor or replacement statutes and regulations and all references to any Person shall be deemed to mean and include the successors and permitted assigns of such Person (or, in the case of a Governmental Authority,
Persons succeeding to the relevant functions of such Person). The Disclosure Schedule is incorporated herein and expressly made a part of this Agreement as though completely set forth herein. The headings contained herein and on the Disclosure
Schedule are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement or the Disclosure Schedule. All terms defined in this Agreement shall have the defined meanings when used in any certificates,
reports or other documents made or delivered pursuant hereto or thereto, unless the context otherwise requires. Terms defined in the singular shall have a comparable meaning when used in the plural, and vice versa. All references to &#147;$&#148; in
this Agreement shall be deemed references to United States dollars. Any item or matter required to be disclosed on a particular Disclosure Schedule shall be deemed to have been disclosed where required by the terms of this Agreement for any other
Disclosure Schedule to the extent the applicability of such disclosure is reasonably apparent on its face of such disclosure without review of any referenced underlying documents or information; <U>provided</U>, <U>however</U>, that the foregoing
shall not apply with respect to the representations and warranties set forth in any <U>Section&nbsp;5.04</U> (Financial Statements), <U>Section&nbsp;5.06(a)</U> (Absence of Certain Developments), <U>Section&nbsp;5.16</U> (Affiliate Transactions), or
any Fundamental Representation which, in each case, shall be qualified solely and exclusively by disclosures upon the face of the corresponding section of the Disclosure Schedule relating to such representations and warranties. The specification of
any dollar amount in the representations and warranties contained in this Agreement is not intended to imply that such amounts, or higher or lower amounts, or the items so included, are or are not required to be disclosed, and neither Party shall
use the fact of the setting of such amounts or the fact of the inclusion of any such item in the Disclosure Schedule in any dispute or controversy with any Party as to whether any obligation, item or matter not described
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-60- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
herein or included in a Disclosure Schedule hereto is or is not required to be disclosed (including whether such amounts or items are required to be disclosed as material). The information
contained in the Disclosure Schedule&nbsp;is disclosed solely for the purposes of this Agreement, and no information contained therein shall be deemed to be an admission by any Party to any third party of any matter whatsoever, including of any
violation of Law or breach of any agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.09&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law; Interpretation</U>. All matters relating to
the interpretation, construction, validity and enforcement of this Agreement shall be governed by and construed in accordance with the domestic Laws of the State of Delaware without giving effect to any choice or conflict of Law provision or rule
(whether of the State of Delaware or any other jurisdiction) that would cause the application of Laws of any jurisdiction other than the State of Delaware; <U>provided</U>, <U>however</U>, that all actions, matters or Proceedings (whether at law, in
contract or in tort) involving any Debt Financing Source that may be based upon, arise out of or relating to any Debt Financing, or the negotiation, execution or performance of any documentation (including the Debt Commitment Letter) in connection
therewith shall be governed by and construed in accordance with the Laws of the State of New York without giving effect to any choice or conflict of Law provision or rule (whether of the State of New York or any other jurisdiction) that would cause
the application of Laws of any jurisdiction other than the State of New York. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.10&nbsp;&nbsp;&nbsp;&nbsp;<U>Forum Selection and Consent
to Jurisdiction</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Any Proceeding against the Buyer or the Seller, arising out of, or with respect to, this
Agreement or any judgment entered by any court in respect thereof shall be brought exclusively in the federal or state courts located in Wilmington, Delaware (the &#147;<U>Designated Courts</U>&#148;), and the Parties accept the exclusive
jurisdiction of the Designated Courts for the purpose of any suit, action or proceeding; <U>provided</U>, <U>however</U>, that each Party hereto agrees that it will not bring or support any action, cause of action, claim, cross-claim or third-party
claim of any kind or description, whether in law or in equity, whether in contract or in tort, or otherwise, against any Debt Financing Source in any way relating to this Agreement or any of the transactions contemplated by this Agreement, including
but not limited to any dispute arising out of or relating in any way to the Debt Financing or the performance thereof or the transactions contemplated thereby, in any forum other than exclusively in the Supreme Court of the State of New York, County
of New York, or, if under applicable Law exclusive jurisdiction is vested in the Federal courts, the United States District Court for the Southern District of New York (and appellate courts thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;In addition, each Party hereto hereby irrevocably waives, to the fullest extent permitted by Law, any objection
which it may now or hereafter have to the laying of venue of any suit, action or Proceeding arising out of or relating to this Agreement or any judgment entered by any of the Designated Courts and hereby further irrevocably waives any claim that any
suit, action or proceedings brought in the Designated Courts has been brought in an inconvenient forum. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-61- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.11&nbsp;&nbsp;&nbsp;&nbsp;<U>Specific Performance</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Subject to <U>Sections 10.11(b)</U> and <U>10.11(c)</U>, each of the Parties agrees that this Agreement is intended
to be legally binding and specifically enforceable pursuant to its terms and that the Buyer and the Seller would be irreparably harmed if any of the provisions of the Agreement are not performed in accordance with their specific terms and that
monetary damages would not provide adequate remedy in such event. Accordingly, in addition to any other remedy to which a <FONT STYLE="white-space:nowrap">non-breaching</FONT> Party may be entitled at Law, a
<FONT STYLE="white-space:nowrap">non-breaching</FONT> Party shall be entitled to seek injunctive relief without the posting of any bond to prevent breaches of this Agreement and to specifically enforce the terms and provisions hereof. Each Party
further waives any defense that a remedy at Law would be adequate in any action for specific performance or injunctive relief hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing or any other provision contained in this Agreement, the right of the Seller to seek
specific performance or other appropriate form of equitable remedy, in each case, prior to the Closing, with respect to causing the Buyer to consummate the Closing, and in connection therewith, to force the Buyer to cause the equity financing to be
funded (&#147;<U>Closing Specific Performance</U>&#148;), shall be available if (and only if) each of the following shall have been satisfied: (i)&nbsp;all conditions set forth in <U>ARTICLE II</U> (other than those conditions that by their nature
cannot be satisfied other than at the Closing, but subject to such conditions being capable of being satisfied or waived by the Party entitled to the benefit thereof if the Closing would have occurred on such date and the actual satisfaction of such
conditions on the Closing Date) have been satisfied or waived by the Party entitled to the benefit thereof as of the Closing Date if the Closing would have occurred pursuant to the terms of the Agreement, (ii)&nbsp;the Buyer and shall have failed to
consummate the Closing by the date required under <U>Section&nbsp;2.01(a)</U> and the Seller has delivered to Buyer a Closing Failure Notice, (iii)&nbsp;the Debt Financing has been funded or will be funded at the Closing if the Equity Financing is
also funded at the Closing on the terms set forth in the Debt Commitment Letter, (iv)&nbsp;the Seller has irrevocably confirmed in writing that if specific performance is granted and the Equity Financing and Debt Financing are funded, then the
Closing will occur on the terms contemplated in this Agreement and (v)&nbsp;the Buyer fails to consummate the Closing on the earlier to occur of the third (3rd) Business Day after the Buyer&#146;s receipt of such notice described in clause
(iv)&nbsp;above and the second (2nd) Business Day preceding the Outside Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything in this
Agreement to the contrary: (x)&nbsp;no person other than the Seller shall be entitled to seek specific performance of this Agreement against the Buyer; (y)&nbsp;none of the Seller, the Companies, their respective Affiliates nor any of their
respective Representatives shall be entitled to specific performance to cause the Buyer, any of its Affiliates or any Representatives of the Buyer to enforce the terms of the Debt Commitment Letter; and (z)&nbsp;in no event shall any Company Related
Parties, collectively or individually, be entitled in respect of any action, <FONT STYLE="white-space:nowrap">non-action,</FONT> matter or event to both (A)&nbsp;a grant of Closing Specific Performance and (B)&nbsp;any monetary damages, including
all or any portion of the Buyer Termination Fee; <U>provided</U>, that the remedies described in (A)&nbsp;and (B) can be sought in the alternative prior to the termination of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.12&nbsp;&nbsp;&nbsp;&nbsp;<U>Arm&#146;s Length Negotiations; Drafting</U>. Each Party herein expressly represents and warrants to the other
Parties that before executing this Agreement, said Party has fully informed itself of the terms, contents, conditions and effects of this Agreement; said Party has relied solely and completely upon its own judgment in executing this Agreement; said
Party has had the opportunity to seek and has obtained the advice of counsel before executing this Agreement, which is the result of arm&#146;s length negotiations conducted by and among the Parties and their respective counsel. This Agreement shall
be deemed drafted jointly by the Parties and nothing shall be construed against one Party or another as the drafting Party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-62- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.13&nbsp;&nbsp;&nbsp;&nbsp;<U>Acknowledgement by the Buyer; Disclaimers</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Buyer acknowledges that it has conducted to its satisfaction an independent investigation and verification of
the financial condition, operations, assets, liabilities, and properties of the Companies and their respective Subsidiaries and, in making its determination to proceed with the transactions contemplated by this Agreement, the Buyer has relied and
will rely on the results of its own independent investigation and verification and the representations and warranties of the Seller expressly and specifically set forth in this Agreement, including the Disclosure Schedule. The Buyer further
acknowledges that, except as set forth herein, no promise or inducement for this Agreement was offered by the Seller, the Companies, their respective Subsidiaries, or any of their respective Representatives or relied upon by the Buyer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Buyer acknowledges that none of the Seller, the Companies or their respective Subsidiaries, nor any other
Person acting on behalf of the Seller, the Companies or their respective Subsidiaries or any of their respective Affiliates has made any representation or warranty, express or implied, as to the accuracy or completeness of any information regarding
the Companies or their respective Subsidiaries or their respective businesses or assets, except as expressly set forth in this Agreement or as and to the extent required by this Agreement to be set forth in the Disclosure Schedule. The Buyer further
agrees that neither the Seller nor any other Person shall have or be subject to any liability to the Buyer or any other Person resulting from the distribution to the Buyer, or the Buyer&#146;s use of, any such information, and any information,
document or material made available to the Buyer or the Buyer&#146;s Representatives in certain &#147;data rooms,&#148; management presentations, or any other form in expectation of the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;THE REPRESENTATIONS AND WARRANTIES OF THE SELLER SPECIFICALLY SET FORTH IN <U>ARTICLE IV</U> AND <U>ARTICLE V</U>
OF THIS AGREEMENT CONSTITUTE THE SOLE AND EXCLUSIVE REPRESENTATIONS AND WARRANTIES OF THE SELLER TO THE BUYER IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED HEREBY, AND THE BUYER UNDERSTANDS, ACKNOWLEDGES, AND AGREES THAT ALL OTHER REPRESENTATIONS
AND WARRANTIES OF ANY KIND OR NATURE, EXPRESS OR IMPLIED (INCLUDING, ANY RELATING TO THE FUTURE OR HISTORICAL FINANCIAL CONDITION, RESULTS OF OPERATIONS, ASSETS OR LIABILITIES, OR PROSPECTS OF THE COMPANIES), ARE SPECIFICALLY DISCLAIMED BY THE
SELLER. THE BUYER ACKNOWLEDGES THAT IT DID NOT RELY ON ANY REPRESENTATION OR WARRANTY NOT CONTAINED IN THIS AGREEMENT WHEN MAKING ITS DECISION TO ENTER INTO THIS AGREEMENT AND WILL NOT RELY ON ANY SUCH REPRESENTATION OR WARRANTY IN DECIDING TO
CONSUMMATE THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;In connection with the Buyer&#146;s investigation
of the Companies, the Buyer, or its Representatives has received from or on behalf of the Companies certain projections, including projected statements of operating revenues and income from operations of the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-63- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Companies and certain business plan information. Neither the Seller nor the Companies make any representations or warranties whatsoever with respect to such estimates, projections, and other
forecasts and plans (including the accuracy or veracity of purported factual data contained therein or the reasonableness of the assumptions underlying such estimates, projections, and forecasts) and the Buyer shall have no claim against Seller or
any other Person with respect to such estimates, projections or forecasts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.14&nbsp;&nbsp;&nbsp;&nbsp;<U>Confidentiality;
Publicity</U>. Except as may be required by Law, or as otherwise permitted or expressly contemplated herein, no Party or its respective Affiliates and Representatives shall disclose to any third party the existence of this Agreement or the subject
matter or terms hereof without the prior consent of the other Party; <U>provided</U>, <U>however</U>, that (a)&nbsp;the each Party and its Affiliates shall be permitted to disclose such information to the extent required by applicable Laws,
including as may be required under any applicable stock exchange rules (in which case the <FONT STYLE="white-space:nowrap">non-disclosing</FONT> Party shall, to the extent permitted by Law, have the right to review such disclosure (other than any
earnings or similar financial reports) prior to its issuance, distribution, or publication and consult with the disclosing Party with respect thereto, and the disclosing Party will reasonably consider, but have no obligation to accept, such
comments), and (b)&nbsp;the Parties and their respective Affiliates shall be permitted to disclose and use such Confidential Information in connection with enforcing their rights and fulfilling their obligations under this Agreement or any other
agreement entered into in connection with this Agreement. No press release or public announcement related to this Agreement or the transactions contemplated herein, or prior to the Closing, any other announcement or communication to the employees,
customers, or suppliers of the Companies and their respective Subsidiaries, shall be issued or made by the Buyer or the Seller without the approval of the other Party hereto unless required by Law (in the reasonable opinion of counsel) in which case
the <FONT STYLE="white-space:nowrap">non-disclosing</FONT> Party shall have the right to review such press release, announcement, or communication prior to its issuance, distribution, or publication and consult with the disclosing Party with respect
thereto and the disclosing Party will reasonably consider such comments. Notwithstanding the foregoing, following the Closing and without any further consent required, (i)&nbsp;nothing contained in this Agreement shall prohibit the Buyer and its
Affiliates from providing general information about the subject matter of this Agreement in connection with their or their Affiliates&#146; fund raising, marketing, informational or reporting activities or obligations of the kind customarily
provided with respect to investments of this kind or restrict the Buyer or the Debt Financing Sources or their respective Affiliates from making customary announcements and communications in connection with the arrangement of the Debt Financing, and
(ii)&nbsp;any Party may disclose (a)&nbsp;to its lenders and direct and indirect owners such information about this Agreement and the transactions consummated hereunder as is customary for transactions of this nature, and (b)&nbsp;to the public
generally, via press release, web site disclosures, published &#147;tombstones&#148; and the like, solely that information which the Parties have jointly agreed in writing to make known to the public generally. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.15&nbsp;&nbsp;&nbsp;&nbsp;<U>Made Available</U>. With respect to all materials that are described as having been posted in the electronic
data room provided by Intralinks at https://services.intralinks.com/ under the project name &#147;Project Marina&#148; at least two (2)&nbsp;Business Days prior to the date of this Agreement and maintained therein in a format that is accessible and
viewable by the Buyer and its Representatives during such time through the date of this Agreement, such materials shall be deemed to have been delivered or made available to the Buyer if the Buyer or any of its Representatives or agents have been
granted access to a dataroom, electronic dataroom or website in which such materials were available or by transmitting such materials to the Buyer or its Representatives or agents by any other electronic means. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-64- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.16&nbsp;&nbsp;&nbsp;&nbsp;<U>Electronic Delivery</U>. This Agreement (including the
Disclosure Schedule, Exhibits, and Schedules attached hereto), the Related Agreements, and each other agreement or instrument entered into in connection herewith or therewith or contemplated hereby or thereby, and any amendments hereto or thereto,
to the extent signed and delivered by means of a portable document format (.pdf), or similar reproduction of such signed writing using electronic mail shall be treated in all manner and respects as an original agreement or instrument and shall be
considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. At the request of any Party or to any such agreement or instrument, each other Party hereto or thereto shall <FONT
STYLE="white-space:nowrap">re-execute</FONT> original forms thereof and deliver them to all other Parties. No Party hereto or to any such agreement or instrument shall raise the use of an electronic mail to deliver a signature or the fact that any
signature or agreement or instrument was transmitted or communicated through the use of electronic mail as a defense to the formation or enforceability of a Contract and each such party forever waives any such defense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.17&nbsp;&nbsp;&nbsp;&nbsp;<U>Representation of the Companies</U>. Each of the Parties hereby agrees that, McDermott Will&nbsp;&amp; Emery
LLP has served prior to the Closing as counsel to the Seller, on the one hand, and the Companies and their respective Subsidiaries, on the other hand, in connection with the negotiation, preparation, execution, delivery, and Closing of this
Agreement and the Related Agreements and the consummation of the transactions contemplated hereby and thereby, and that, following consummation of the transactions contemplated hereby and thereby the (&#147;<U>Prior Representation</U>&#148;),
McDermott Will&nbsp;&amp; Emery LLP may serve as counsel to the Seller, in connection with any litigation, claim, or obligation arising out of or relating to this Agreement or the Related Agreements or the transactions contemplated by this Agreement
(including claims for indemnification, disputes relating to post-closing adjustments, and disputes involving other agreements entered into in connection with this Agreement) or the Related Agreements (a &#147;<U>Subsequent Representation</U>&#148;)
notwithstanding such Prior Representation and each of the Parties consents, and waives any conflict of interest arising from, such Subsequent Representation based on such Prior Representation, and each of such Parties shall cause any controlled
Affiliate thereof to consent to waive every conflict of interest. Each of the Buyer and the Companies, for its and such respective Representatives, acknowledges and agrees that all communications between any of the Companies and McDermott
Will&nbsp;&amp; Emery LLP made in connection with Prior Representation (the &#147;<U>Privileged Communications</U>&#148;) that, immediately prior to the Closing, would be deemed to be privileged communications of the Companies and its counsel and
would not be subject to disclosure to the Buyer in connection with any process relating to a dispute arising under or in connection with this Agreement, any Related Agreement, or otherwise, shall continue after the Closing and for all purposes be
deemed to be privileged communications between the Seller and such counsel and neither the Buyer nor any Person purporting to act on behalf of or through the Buyer shall seek to obtain the same by any process on the grounds that the privilege
attaching to such communications, belongs to the Companies and their respective Subsidiaries, and not the Seller. In addition, the Buyer will not, and will cause each of its Affiliates (including following the Closing, the Companies and their
respective Subsidiaries) not to, use any Privileged Communications in any dispute between the Sellers or its Affiliates, on the one hand, and the Buyer or its Affiliates, on the other hand. Upon and after the Closing, the Companies and their
respective Subsidiaries shall cease to have any attorney-client relationship with McDermott Will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-65- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&amp; Emery LLP with respect to the Prior Representation. Any such representation of the Companies and their respective Subsidiaries by McDermott Will&nbsp;&amp; Emery LLP after the Closing will
not affect the foregoing provisions hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.18&nbsp;&nbsp;&nbsp;&nbsp;<U><FONT STYLE="white-space:nowrap">Non-Recourse</FONT></U>.
This Agreement may only be enforced against, and any action or Proceeding based upon, arising out of, or related to this Agreement, the Related Agreements, or the negotiation, execution, or performance thereof may only be made against the Persons or
entities that are expressly named as parties hereto, and then only with respect to the specific obligation set forth herein, with respect to such party. No past, present or future Representative or any of their successors or permitted assigns
(together the &#147;<U><FONT STYLE="white-space:nowrap">Non-Party</FONT> Affiliates</U>&#148;), shall have any liability for any obligations or liabilities of any Party hereto under this Agreement or for any claim or Proceeding based on, in respect
of or by reason of the transactions contemplated by this Agreement, and each Party hereto waives and releases all such liabilities, claims and obligations against any such <FONT STYLE="white-space:nowrap">Non-Party</FONT> Affiliates. Notwithstanding
anything to the contract, <FONT STYLE="white-space:nowrap">Non-Party</FONT> Affiliates are expressly intended as third-party beneficiaries of this <U>Section&nbsp;10.18</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.19&nbsp;&nbsp;&nbsp;&nbsp;<U>WAIVER OF JURY TRIAL</U>. EACH PARTY HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY
MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DESCRIBED IN <U>SECTION 10.18</U> OR IN RESPECT OF THE DEBT FINANCING, INCLUDING ANY LEGAL ACTION AGAINST ANY DEBT FINANCING SOURCE. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A)&nbsp;NO
REPRESENTATIVE, AGENT, OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B)&nbsp;EACH SUCH PARTY UNDERSTANDS AND HAS CONSIDERED
THE IMPLICATIONS OF THIS WAIVER, (C)&nbsp;EACH SUCH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (D)&nbsp;EACH SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS
<U>SECTION&nbsp;10.19</U>. A COPY OF THIS <U>SECTION&nbsp;10.19</U> MAY BE SUBMITTED TO ANY COURT AS EVIDENCE OF THE CONTENT THEREOF. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.20&nbsp;&nbsp;&nbsp;&nbsp;<U>Debt Financing Sources</U>. Notwithstanding anything to the contrary contained in this Agreement,
(i)&nbsp;neither any Party nor any of their respective Affiliates, equityholders, members, officers, directors, employees and representatives, nor any Person claiming by, through or under any such Person, shall have any rights or claims against any
Debt Financing Source in any way relating to this Agreement or any of the transactions contemplated by this Agreement or in respect of any oral representations made or alleged to have been made in connection herewith or therewith, including any
dispute arising out of or relating in any way to the Debt Commitment Letter or the performance thereof or the Financings contemplated thereby, whether at law or equity, in contract, in tort or otherwise and (ii)&nbsp;no Debt Financing Source shall
have any liability (whether in contract, in tort or otherwise) to any Party or any of their respective Affiliates, equityholders, members, officers, directors, employees and representatives, or any Person claiming by, through or under any such
Person for any obligations or liabilities of any party hereto under this Agreement or for any claim based on, in respect of, or by reason of, the transactions contemplated hereby and thereby or in respect of any oral representations made or alleged
to have been made in connection herewith or therewith, including any dispute arising out of or relating in any way to the Debt Commitment </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-66- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Letters or the performance thereof or the Financings contemplated thereby, whether at law or equity, in contract, in tort or otherwise; <U>provided</U>, <U>however</U>, that the foregoing will
not limit the rights of the parties to the Debt Commitment Letter as set forth therein or to the Financing Agreements as set forth therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.21&nbsp;&nbsp;&nbsp;&nbsp;<U>No Strict Construction</U>. The language used in this Agreement will be deemed to be the language chosen by
the Parties to express their mutual intent. In the event an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the Parties, and no presumption or burden of proof will arise favoring or
disfavoring any Person by virtue of the authorship of any of the provisions of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.22&nbsp;&nbsp;&nbsp;&nbsp;<U>Captions</U>. The captions used in this Agreement are for convenience of reference only and do not constitute
a part of this Agreement and will not be deemed to limit, characterize or in any way affect any provision of this Agreement, and all provisions of this Agreement will be enforced and construed as if no caption had been used in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[SIGNATURES APPEAR ON THE FOLLOWING PAGE] </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-67- </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Parties have caused this Agreement to be duly executed and
delivered as of the day and year first above written.<B> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BUYER:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">FH MD BUYER, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Nader Naini</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Nader Naini</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">President</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Securities Purchase Agreement] </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Parties have caused this Agreement to be duly executed and
delivered as of the day and year first above written.<B> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SELLER:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MEDNAX SERVICES, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Stephen D. Farber</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Stephen D. Farber</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Executive Vice President &amp; Chief Financial Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Securities Purchase Agreement] </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Definitions </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used herein, the
following terms shall have the following meanings: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Accounting Principles</U>&#148; means GAAP; <U>provided</U>, that solely to
the extent consistent with GAAP, the &#147;Accounting Principles&#148; shall be applied using the policies, practices, principles and methodologies used by the Companies and their respective Subsidiaries in the preparation of the 2018 Audited
Financial Statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Acquisition Proposal</U>&#148; means any inquiry, proposal or offer from any Person (other than the Buyer)
relating to any (a)&nbsp;direct or indirect acquisition (whether in a single transaction or a series of related transactions) of a material portion assets of the Companies or their respective Subsidiaries (excluding sales of assets (other than
equity securities) in the Ordinary Course of Business permitted by this Agreement), (b) tender offer for, or direct or indirect acquisition (whether in a single transaction or a series of related transactions) of, any equity securities of the
Companies or their respective Subsidiaries, or (c)&nbsp;direct or indirect merger, consolidation, share exchange, business combination, recapitalization, liquidation, dissolution or similar transaction involving any assets or equity securities of
the Companies or their respective Subsidiaries; in each case, other than the transactions contemplated by the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; of any particular Person means any other Person controlling, controlled by or under common control with such
particular Person. For the purposes of this definition, &#147;control&#148; means the possession, directly or indirectly, of the power to direct the management and policies of a Person whether through the ownership of voting securities, Contract or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate Arrangements</U>&#148; has the meaning set forth in <U>Section&nbsp;5.16(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Agreement</U>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Allocation Statement</U>&#148; has the meaning set forth in <U>Section&nbsp;1.04(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Audited Financial Statements</U>&#148; has the meaning set forth in <U>Section&nbsp;5.04(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bankruptcy and Equity Exceptions</U>&#148; has the meaning set forth in <U>Section&nbsp;3.03</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Books and Records</U>&#148; means the books and records, files, correspondence, computer data, databases, computer tapes, electronic
media, information, lists and other materials and information maintained, created, prepared, owned or controlled by any of the Companies and their respective Subsidiaries or any Stockholder or Affiliate thereof solely with respect to the Companies
and their respective Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business</U>&#148; means the businesses of the Companies and their respective
Subsidiaries as currently conducted and as currently proposed to be conducted following the Closing, including the business of providing management care solutions, including a range of patient access and communications, revenue cycle management,
consulting and analytics services, billing and coding, patient pay/responsibility, including early out services, eligibility and disability, complex accounts receivable services, such as workers&#146; compensation and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-state</FONT></FONT> Medicaid eligibility, as well as offering advanced technology solutions through mobile-first engagement and communication software for patients and
providers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day, excluding Saturday, Sunday and any other day on which commercial banks in New
York, New York or Miami, Florida are authorized or required by law to close. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer</U>&#148; has the meaning set forth in the
Preamble. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer Cure Deadline</U>&#148; has the meaning set forth in <U>Section&nbsp;9.01(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer Released Parties</U>&#148; has the meaning set forth in <U>Section&nbsp;7.06(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer Termination Fee</U>&#148; has the meaning set forth in <U>Section&nbsp;9.02(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Cash Amount</U>&#148; means, as of the Effective Time, all unrestricted cash, cash equivalents, and marketable securities held by
each of the Companies and their respective Subsidiaries in their respective bank accounts at such time (reduced by any outstanding but uncleared checks issued by the Companies or any of their respective Subsidiaries), in each case, as determined in
accordance with GAAP. The &#147;Cash Amount&#148; shall expressly (i)&nbsp;exclude any amounts held as deposits or collateral by any third parties and the Patient Refund Cash and (ii)&nbsp;include the Patient Trust Cash. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing</U>&#148; has the meaning set forth in <U>Section&nbsp;2.01</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date</U>&#148; has the meaning set forth in <U>Section&nbsp;2.01</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Failure Notice</U>&#148; has the meaning set forth in <U>Section&nbsp;9.01(e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Payment</U>&#148; has the meaning set forth in <U>Section&nbsp;1.02</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Specific Performance</U>&#148; has the meaning set forth in <U>Section&nbsp;10.11(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Statement</U>&#148; has the meaning set forth in <U>Section&nbsp;1.04</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Commitment Letter</U>&#148; has the meaning set forth in <U>Section&nbsp;3.06</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Companies</U>&#148; has the meaning set forth in the Recitals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Intellectual Property</U>&#148; means the Company Owned IP and all other
Intellectual Property used or held for use by the Companies or any of their respective Subsidiaries in the Business or that was developed by or for the Companies or any of their respective Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Owned IP</U>&#148; means all Intellectual Property owned or purported to be owned by the Companies or any of their respective
Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Products</U>&#148; means all products and services currently or previously licensed, sold, distributed,
supported, performed, or otherwise made available by or on behalf of the Companies or any of their respective Subsidiaries, and all products and services currently being developed by or on behalf of the Companies or any of their respective
Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Registered IP</U>&#148; means all registrations and pending applications for registration of Company Owned
IP, including domain names. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Systems</U>&#148; means all computer and information technology systems, platforms and
networks owned, licensed, leased or used by the Companies and their respective Subsidiaries, including software, hardware, data, databases, data processing or management, record keeping, communication, telecommunication, computerized, automated or
other similar systems, platforms and networks, and documentation relating to any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Confidential
Information</U>&#148; has the meaning set forth in <U>Section&nbsp;7.08(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Confidentiality Agreement</U>&#148; means that
certain <FONT STYLE="white-space:nowrap">Non-Disclosure</FONT> and Standstill Agreement, dated January&nbsp;2, 2019, between the Parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Contaminants</U>&#148; has the meaning set forth in <U>Section&nbsp;5.18(n)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Contingent Workers</U>&#148; has the meaning set forth in <U>Section&nbsp;5.12(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Contract</U>&#148; means any contract or other legally binding agreement (whether written or oral). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Contributed Shares</U>&#148; is defined in the Contribution and Exchange Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>D&amp;O Indemnified Persons</U>&#148; has the meaning set forth in <U>Section&nbsp;7.02(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>D&amp;O Tail Policy</U>&#148; has the meaning set forth in <U>Section&nbsp;7.02(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Debt Amount</U>&#148; means, with respect to the Companies and their respective Subsidiaries on a consolidated basis and, in each
case, as of the Effective Time (but giving effect to any subsequent incurrence or accrual of debt that occurs prior to the Effective Time, and except as set forth in clause (ix)&nbsp;below): (i) the aggregate amount of all of the outstanding and
unpaid principal, accrued interest, accrued fees and other charges or payment obligations relating to outstanding indebtedness of the Companies and their </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respective Subsidiaries for borrowed money, which shall include the current and long term portion of all such indebtedness of the Companies and their respective Subsidiaries and any prepayment
premium, termination fees, expenses, breakage costs or penalties due upon payment of such indebtedness, (ii)&nbsp;all capitalized lease obligations, if any, as determined in accordance with GAAP or otherwise treated as capitalized in the Financial
Statements, (iii)&nbsp;all obligations evidenced by any note, bond, debenture or other similar instrument or debt security or which is secured by a Lien on any of the property, assets or Equity Securities of any of the Companies or their respective
Subsidiaries, (iv)&nbsp;all obligations under any interest rate or foreign exchange rate swap or other hedging arrangements (including swap breakage or associated fees due upon termination of such swap, collar or hedging arrangements), (v) all
indebtedness of a third party secured by a Lien on any property or assets of the Companies or any of their respective Subsidiaries, (vi)&nbsp;reimbursement obligations, contingent or otherwise, in connection with any letters of credit (to the extent
drawn) and bankers&#146; acceptances issued for the account of the Companies or any of their respective Subsidiaries, (vii)&nbsp;any obligations to pay the deferred purchase price of, or arising under forward sale or purchase agreements with respect
to, property, goods or services, including obligations under &#147;earnouts&#148; (but excluding trade payables and accrued expenses in the Ordinary Course of Business), (viii) all indebtedness in the nature of direct or indirect guarantees of the
obligations of other Persons described in the preceding clauses (i)&nbsp;through (vii), (ix) any unpaid income Taxes, reduced (but not below zero) by any overpayments of income Taxes for the current Tax period, of the Companies (and each of their
respective Subsidiaries) for any period (or portion thereof) ending on or prior to the Closing Date as determined as if the taxable year of each of the Companies (and each of their respective Subsidiaries) ended as of the end of the Closing Date,
(x)&nbsp;any amounts owed by the Companies and their respective Subsidiaries as a result of the application of Section&nbsp;965 of the Code (or any elections of the Companies or their respective Subsidiaries made thereunder), (xi) all obligations
arising from cash/book overdrafts, (xii)&nbsp;any unsatisfied obligation for &#147;withdrawal liability&#148; to an employee benefits or retirement plan and any unfunded and underfunded pension liabilities, (xiii)&nbsp;any payment obligations
(whether accrued or due and owing following the Closing) due to any former director, officer, or employee of any of the Companies or their respective Subsidiaries, including any severance payable as a result of any termination or separation thereof,
(xiv)&nbsp;an amount equal to $250,000 related to the Debt Matters, (xv)&nbsp;any liabilities in respect of any Affiliate Arrangements, including any Intercompany Balances, but excluding any Related Agreements and (xvi)&nbsp;the Patient Trust
Liabilities. Notwithstanding anything in this Agreement to the contrary, clause (ix)&nbsp;shall be calculated as of the end of the day on the Closing Date and shall take into account the effect of the transactions contemplated by this Agreement
(including any income Tax deductions for Transaction Expenses that are deductible (using a &#147;more likely than not&#148; standard) for federal (and, where applicable, state and local) income Tax purposes in any taxable period (or portion thereof)
ending on or prior to the Closing Date). For the avoidance of doubt, the Debt Amount shall not include any indebtedness of the Seller or its Affiliates provided, that (x)&nbsp;the Company and the Subsidiaries cease to have obligations under such
indebtedness following the Closing and (y)&nbsp;the assets the Company and its Subsidiaries are not subject to Liens under such indebtedness following the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Debt Commitment Letter</U>&#148; has the meaning set forth in <U>Section&nbsp;3.06</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Debt Financing</U>&#148; has the meaning set forth in <U>Section&nbsp;3.06</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Debt Financing Commitments</U>&#148; has the meaning set forth in
<U>Section&nbsp;3.06</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Debt Financing Sources</U>&#148; means (a)&nbsp;the entities that have directly or indirectly
committed to provide or otherwise entered into agreements in connection with the Debt Financing and (b)&nbsp;their respective Affiliates, including the lenders that are party to the Debt Commitment Letter and any joinder agreements or credit
agreements relating thereto, together with any of their respective former, current or future general or limited partners, direct or indirect shareholders or equity holders, managers, members, directors, officers, employees, Affiliates,
representatives or agents, together with their successors and assignees in such capacities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Debt Matters</U>&#148; is defined on
<U>Schedule 8.02</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Designated Courts</U>&#148; has the meaning set forth in <U>Section&nbsp;10.10(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disclosure Schedule</U>&#148; means the disclosure schedule delivered by the Seller to the Buyer on the date hereof regarding certain
exceptions to the representations and warranties in <U>ARTICLE&nbsp;IV</U> and <U>ARTICLE V</U> hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Effective Time</U>&#148;
has the meaning set forth in <U>Section&nbsp;2.01</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Environmental and Safety Requirements</U>&#148; means all Laws concerning
public health and safety, worker health and safety, or pollution or protection of the environment, including all those relating to the presence, use, production, generation, handling, transport, treatment, storage, disposal, distribution, labeling,
testing, processing, discharge, release, threatened release, control, or cleanup of any Hazardous Materials, substances or wastes, chemical substances or mixtures, pesticides, pollutants, contaminants, toxic chemicals, petroleum products or
byproducts, asbestos, or polychlorinated biphenyls. This includes, without limitation, laws referenced in the definition of &#147;Hazardous Materials&#148; herein, and any other international, federal, state, or local laws relating to Releases or
threatened Releases of Hazardous Materials or otherwise relating to the manufacture, generation, processing, distribution, use, advertising, packaging, labeling, sale, treatment, storage, management, disposal, cleanup, transportation, or handling of
Hazardous Materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Environmental Laws</U>&#148; means all Laws enacted and in effect on or prior to the Closing Date
concerning pollution or protection of the environment, including all those relating to the presence, use, production, generation, handling, transportation, treatment, storage, disposal, distribution, labeling, testing, processing, discharge,
release, control, or cleanup of any hazardous materials, substances or wastes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Equity Commitment Letter</U>&#148; has the
meaning set forth in <U>Section&nbsp;3.06</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Equity Financing</U>&#148; has the meaning set forth in <U>Section&nbsp;3.06</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Equity Financing Commitments</U>&#148; has the meaning set forth in <U>Section&nbsp;3.06</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Equity Securities</U>&#148; means (a)&nbsp;with respect to any Person that is not a
corporation, any partnership interests, membership interests, limited liability company interests, and any equivalent ownership interests (including any components thereof such as capital accounts, priority returns, or similar rights) in a limited
partnership or a limited liability company or joint venture, (b)&nbsp;with respect to a corporation, any and all shares, interests, participation, equity interests or other equivalents, however, designated, of capital stock of a corporation,
(c)&nbsp;any and all other securities, interests or participation that are derived from, or the value of which is dependent upon, any of the foregoing or confers on a Person the right to receive a share of the profits and losses of, or distribution
of assets of, the issuing entity (including any phantom stock, restricted stock units, profit participation, arrangements or the like), (d) any and all subscriptions, calls, puts, warrants, rights, options, or commitments of any kind or character
relating to, the grant, issuance, exchange, conversion, redemption, purchase, repurchase, voting or transfer of any of the foregoing or entitling any Person or entity to purchase or otherwise acquire membership or limited liability company interests
or units, capital stock, or any other equity securities, (e)&nbsp;any securities convertible into or exercisable or exchangeable for partnership interests, membership or limited liability company interests or units, capital stock, or any other
equity securities, (f)&nbsp;any and all bonds, debentures, notes or other indebtedness issued by such Person that has the right to vote (or which is convertible or exchangeable for securities having the right to vote) on any matters on which the
holders of capital stock or other equity securities are entitles to vote, or (g)&nbsp;any other interest classified as an equity security of a Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA</U>&#148; means the Employee Retirement Income Security Act of 1974, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA Affiliate</U>&#148; has the meaning set forth in <U>Section&nbsp;5.13(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Closing Payment</U>&#148; has the meaning set forth in <U>Section&nbsp;1.03</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Working Capital</U>&#148; has the meaning set forth in <U>Section&nbsp;1.03</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Transactions</U>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Excluded Businesses</U>&#148; means each current or former business operated by the Seller or its Affiliates (in each case, excluding
the Business) other than former businesses operated by the Company or its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Existing Credit Facility</U>&#148; means
that certain Credit Agreement, dated as of October&nbsp;30, 2017, by and among JPMorgan Chase Bank, N.A., Mednax Services, Inc., and the agents, arrangers, lenders and other parties thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Federal Health Care Program</U>&#148; shall have the meaning set forth under 42 U.S.C. &#167;
<FONT STYLE="white-space:nowrap">1320a-7b(f),</FONT> and includes Medicare, TRICARE, Medicaid, other similar federal, state and local programs for which the federal government pays, in whole or in part, directly or indirectly, for the provision of
services or goods to beneficiaries of the applicable program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fee Letters</U>&#148; has the meaning set forth in
<U>Section&nbsp;3.06</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Financial Statements</U>&#148; has the meaning set forth in <U>Section 5.04(a)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Financing</U>&#148; has the meaning set forth in <U>Section&nbsp;3.06</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Financing Agreements</U>&#148; has the meaning set forth in <U>Section&nbsp;6.08(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Financing Commitments</U>&#148; has the meaning set forth in <U>Section&nbsp;3.06</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fraud</U>&#148; means, with respect to any Party hereto, an actual intentional fraud with respect to the representations or
warranties of such Party (including by such Party&#146;s directors, officers, or employees) set forth in this Agreement made with the intent to mislead and deceive the other Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fundamental Representations</U>&#148; means the representations and warranties set forth in <U>Section&nbsp;4.01</U> (<I>Status</I>),
<U>Section&nbsp;4.02</U> (<I>Power and Authority; Ownership</I>), clause (a)&nbsp;of <U>Section&nbsp;4.04</U> (<I>No Violations; Consents and Approvals</I>), <U>Section&nbsp;4.05</U> (<I>No Brokers</I>), <U>Section&nbsp;5.01</U> (<I>Corporate
Status</I>), <U>Section&nbsp;5.02</U> (<I>Capitalization; Subsidiaries</I>), clause (a)&nbsp;of <U>Section&nbsp;5.03</U> (<I>No Violation; Consents and Approvals</I>), and <U>Section&nbsp;5.21</U> (<I>No Brokers</I>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>GAAP</U>&#148; means United States generally accepted accounting principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Authority</U>&#148; means any foreign, federal, state, provincial, or local governmental or regulatory department,
arbitration panel, commission, board, bureau, agency, court, or regulatory or administrative body or instrumentality of any government or country state or other political subdivision thereof (whether now or hereafter constituted and/or existing) and
any entity exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Hart-Scott-Rodino Act</U>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended and the rules and
regulations promulgated thereunder, and any successor to such statute, rules or regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Hazardous Materials</U>&#148; means
any chemicals, materials, wastes or substances that are defined, regulated, determined or identified as toxic or hazardous under any Environmental and Safety Requirements (including, without limitation, substances defined as &#147;hazardous
substances&#148;, &#147;hazardous materials&#148;, &#147;hazardous waste&#148;, &#147;pollutant or contaminant&#148;, &#147;petroleum&#148;, &#147;toxic substance&#148;, &#147;natural gas liquids&#148; or words of similar meaning in CERCLA, the
Hazardous Materials Transportation Act, the Resource Conservation and Recovery Act, or comparable state and local statutes or in the regulations pursuant to said statutes), or any other Environmental and Safety Regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Health Care Laws</U>&#148; means Laws relating to the regulation of the Business or the ownership or use of any of its assets,
including the following Laws: (a)&nbsp;all federal and state fraud and abuse Laws that relate to health care, including the federal Anti-Kickback Statute (42 U.S.C. <FONT STYLE="white-space:nowrap">&#167;1320a-7b),</FONT> the Stark Law (42 U.S.C.
&#167;1395nn), the civil False Claims Act (31 U.S.C. &#167;3729 et seq.), the Program Fraud Civil Remedies Act (31 U.S.C. &#167;&#167;3801-3812), the Civil Monetary Penalties Law </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(42 U.S.C. <FONT STYLE="white-space:nowrap">1320a-7a</FONT> and <FONT STYLE="white-space:nowrap">1320a-7b),</FONT> the Exclusion Laws (42 U.S.C.
<FONT STYLE="white-space:nowrap">&#167;1320a-7),</FONT> 42 U.S.C. <FONT STYLE="white-space:nowrap">&#167;1320a-7k(d),</FONT> (b) TRICARE, (c)&nbsp;HIPAA, (d) Medicare, including Medicare Advantage and Part D, (e)&nbsp;Medicaid, (f)&nbsp;the Patient
Protection and Affordable Care Act (P.L. <FONT STYLE="white-space:nowrap">111-148),</FONT> (g) the Health Care and Education Reconciliation Act of 2010 (P.L. <FONT STYLE="white-space:nowrap">111-152),</FONT> and (h)&nbsp;any and all other applicable
health care Laws, manual provisions, policies, administrative guidance, and any other requirements of Law relating to the business, each of (a)&nbsp;through (h) as may be amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HIPAA</U>&#148; means the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information
Technology for Economic and Clinical Health Act, and any implementing Laws and Orders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Holdings</U>&#148; has the meaning set
forth in the Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness Holders</U>&#148; has the meaning set forth in <U>Section&nbsp;2.02(j)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Independent Auditor</U>&#148; has the meaning set forth in <U>Section&nbsp;1.04(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Information Security Reviews</U>&#148; has the meaning set forth in <U>Section&nbsp;5.19(e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Initial Submissions</U>&#148; has the meaning set forth in <U>Section&nbsp;1.04(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Insurance Policies</U>&#148; has the meaning set forth in <U>Section&nbsp;5.15</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intellectual Property</U>&#148; means any and all intellectual property and proprietary rights, in any jurisdiction throughout the
world, including: (a)&nbsp;copyrights, and all applications and registrations in connection therewith; (b)&nbsp;patents and patent applications, together with all <FONT STYLE="white-space:nowrap">re-issuances,</FONT> continuations, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> divisionals, revisions, reviews, extensions and <FONT STYLE="white-space:nowrap">re-examinations</FONT> thereof; (c)&nbsp;trademarks, trade names, trade
dress, logos, slogans, product designations and service marks, together with all goodwill associated therewith, and all applications (pending or in process) and registrations therefor; (d)&nbsp;Internet domain names and the corresponding Internet
sites and rights in social media accounts; and (e)&nbsp;proprietary computer software, including but not limited to source code, object code, operating systems, databases, application programs, file and utility programs; (f)&nbsp;trade secrets and
other confidential or proprietary information (including business, pricing and customer information, technology, methods, plans, <FONT STYLE="white-space:nowrap">know-how,</FONT> inventions and invention disclosures, ideas, research in progress,
algorithms, data, data collections, designs, testing procedures, and testing results) and rights enforceable under applicable trade secret Law in the foregoing; (g)&nbsp;rights of publicity and privacy and moral rights; and (h)&nbsp;and licenses
therein, thereto and thereof any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intercompany Balances</U>&#148; has the meaning set forth in
<U>Section&nbsp;7.04(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interim Financial Statements</U>&#148; has the meaning set forth in <U>Section&nbsp;5.04(a)</U>.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interim Period</U>&#148; means the period commencing on date of this Agreement and
ending on the earlier to occur of the Closing or termination of this Agreement pursuant to <U>ARTICLE IX</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Joint Litigation
Matter</U>&#148; has the meaning set forth in <U>Section&nbsp;7.07</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Knowledge</U>&#148; when used to qualify any
representation or warranty, means that such Party has no actual knowledge that such representation or warranty is not true and correct to the same extent as provided in the applicable representation or warranty. For the purpose of this definition,
the &#147;actual knowledge&#148; of the Companies or the Seller means the actual knowledge, after reasonable inquiry, of Emily Fisher, Brian Shure, Chris Gamache, Barb Astler, and Jeff Harper, and the &#147;actual knowledge&#148; of the Buyer means
the actual knowledge of Nader Naini and Ryan Lucero. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Latest Balance Sheet Date</U>&#148; has the meaning set forth in
<U>Section&nbsp;5.04</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Law</U>&#148; means any federal, state, local, municipal, foreign, Order, constitution, law,
ordinance, rule, regulation, statute, treaty, codes, rules, regulations, ordinances, directives, judgments, standards, requirements, policies, guidelines, decrees and the like of any Governmental Authority, including common law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Leased Real Property</U>&#148; has the meaning set forth in <U>Section&nbsp;5.09(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liabilities</U>&#148; or &#147;<U>liabilities</U>&#148; means any and all debts, liabilities, losses and obligations, whether accrued
or fixed, absolute or contingent, matured or unmatured, known or unknown, due or to become due. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Lien</U>&#148; means any lien
(statutory or otherwise), charge, mortgage, deed of trust, encroachment, pledge, security interest, hypothecation, claim, preference, priority, defect or default in title, assessment, license, right of first refusal, security agreement,
encroachment, option, easement, covenant, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-way,</FONT></FONT> charge, restriction or other encumbrance or adverse interest of any kind or nature whatsoever (including any
conditional sale or other title retention agreement and any lease having substantially the same effect as any of the foregoing and any assignment or deposit arrangement in the nature of a security device). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Lookback Date</U>&#148; means (x)&nbsp;for purposes of the representations and warranties in <U>Sections 5.08</U>, <U>5.19</U> and
<U>5.20</U>, the date that that is five (5)&nbsp;years prior to the date of this Agreement and (y)&nbsp;for all other purposes under this Agreement the date that that is three (3)&nbsp;years prior to the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Adverse Effect</U>&#148; means any change, effect, circumstance, event, occurrence, condition, development or state of
facts, which individually or in the aggregate, is, has had, or would reasonably be expected to have, a material adverse effect on: (a)&nbsp;the businesses, assets, Liabilities, operations, condition (financial or otherwise) or results of operations
of any of the Companies and their respective Subsidiaries, taken as a whole; or (b)&nbsp;the ability of the Seller, the Companies and their respective Subsidiaries to timely perform their respective obligations under
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Agreement or any other Related Agreements; <U>provided</U> that in the case of clause (a)&nbsp;alone, the term &#147;Material Adverse Effect&#148; shall not include any adverse change,
effect, event, occurrence, state of facts or development, to the extent resulting from the following: (i)&nbsp;the execution, delivery, announcement or pendency of this Agreement or the transactions contemplated by this Agreement;
(ii)&nbsp;conditions generally affecting the economies as a whole or the capital, credit or financial markets in general or the markets in which the Companies and their respective Subsidiaries operate; (iii)&nbsp;any change in GAAP or any change in
applicable Laws or the interpretation thereof by a Governmental Authority, in each case, first occurring after the date of this Agreement; (iv)&nbsp;any acts of war (whether or not declared), armed hostilities, sabotage or terrorism occurring after
the date of this Agreement or the continuation, escalation or worsening of any such acts of war, armed hostilities, sabotage or terrorism; (v)&nbsp;any earthquakes, hurricanes, floods or other natural disasters; or (vi)&nbsp;the failure by the
Companies or their respective Subsidiaries to meet any projections, estimates or budgets for any period prior to, on or after the date of this Agreement (<U>provided</U> <U>however</U>, that the underlying facts giving rise to such failure may be
taken into account in determining whether there has been or will be a Material Adverse Effect); except to the extent that such change, occurrence, event or effect referred to in clause (ii)&#150;(v) has a disproportionate effect on the Companies and
their respective Subsidiaries, individually, or in the aggregate, relative to other Persons engaged in the industries in which the Companies or their respective Subsidiaries operate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Contracts</U>&#148; has the meaning set forth in <U>Section&nbsp;5.17(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Customer</U>&#148; has the meaning set forth in <U>Section&nbsp;5.22(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Supplier</U>&#148; has the meaning set forth in <U>Section&nbsp;5.17(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>MedData Holding</U>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>MedDirect Holding</U>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Medicaid</U>&#148; means the means-tested entitlement program under Title XIX of the Social Security Act, which provides federal
grants to states for medical assistance based on specific eligibility criteria, as set forth at Section&nbsp;1396, et seq. of Title 42 of the United States Code, as the same may be amended, and any successor law in respect thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Medicare</U>&#148; means the government-sponsored entitlement program under Title&nbsp;XVIII of the Social Security Act, which
provides for a health insurance system for eligible elderly and disabled individuals, as set forth at Section&nbsp;1395, et seq. of Title&nbsp;42 of the United States Code, as the same may be amended, and any successor law in respect thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>MSA</U>&#148; means that certain Master Services Agreement, being entered into by and between
<FONT STYLE="white-space:nowrap">Med-Data,</FONT> Incorporated, and Mednax Services, Inc. on the date hereof substantially contemporaneously with the execution and delivery of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Multiemployer Plans</U>&#148; has the meaning set forth in <U>Section&nbsp;5.13(e)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Negative Adjustment Amount</U>&#148; has the meaning set forth in
<U>Section&nbsp;1.06(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Negotiation Period</U>&#148; has the meaning set forth in <U>Section&nbsp;1.04(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-Party</FONT> Affiliates</U>&#148; has the meaning set forth in <U>Section&nbsp;10.18</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Objection Disputes</U>&#148; has the meaning set forth in <U>Section&nbsp;1.04(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Objection Statement</U>&#148; has the meaning set forth in <U>Section&nbsp;1.04(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Open Source Software</U>&#148; means any software (in source or object code form) that is subject to (A)&nbsp;a license or other
agreement commonly referred to as an open source, free software, copyleft or community source code license or (B)&nbsp;any other license or other agreement that requires, as a condition of the use, modification or distribution of software subject to
such license or agreement, that such software or other software linked with, called by, combined or distributed with such software be (1)&nbsp;disclosed, distributed, made available, offered, licensed or delivered in source code form,
(2)&nbsp;licensed for the purpose of making derivative works, (3)&nbsp;licensed under terms that allow reverse engineering, reverse assembly, or disassembly of any kind, or (4)&nbsp;redistributable at no charge, including without limitation any
license defined as an open source license by the Open Source Initiative as set forth on www.opensource.org. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Order</U>&#148;
means any order, judgment, injunction, decree, ruling, decision, binding determination, verdict, sentence, subpoena, writ, or award issued, made, entered, rendered, or otherwise put into effect by or under the authority of any Governmental Authority
or arbitrator (whether public or private). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Ordinary Course of Business</U>&#148; means an action taken by or on behalf of a
Person that is recurring in nature, is consistent (including with respect to frequency and magnitude) with the past practices of such Person and is taken in the ordinary course of the operations of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Organizational Documents</U>&#148; means (a)&nbsp;with respect to a corporation, the certificate, or articles of incorporation,
bylaws and any voting or stockholders agreement; (b)&nbsp;with respect to any other entity, any charter, certificate of formation or similar document adopted or filed in connection with the creation, formation, or organization of such entity and any
voting or operating agreement; and (c)&nbsp;any amendment to any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Outside Date</U>&#148; has the meaning set
forth in <U>Section&nbsp;9.01(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Outstanding Securities</U>&#148; has the meaning set forth in the Recitals </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent Acquirer</U>&#148; has the meaning set forth in <U>Section&nbsp;6.06</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent Acquisition</U>&#148; has the meaning set forth in <U>Section&nbsp;6.06</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent Guarantee and Restrictive Covenant Agreement</U>&#148; has the meaning set
forth in the Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent-Level Agreement Replacement</U>&#148; has the meaning set forth in <U>Section&nbsp;7.04(c)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parent-Level Agreements</U>&#148; has the meaning set forth in <U>Section&nbsp;7.04(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Party</U>&#148; or &#147;<U>Parties</U>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Patient Trust Cash</U>&#148; means any cash held by the Companies or their respective Subsidiaries in connection with any
corresponding Patient Trust Liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Patient Trust Liabilities</U>&#148; means any Liability of the Companies or their
respective Subsidiaries to pay amounts collected from patients of any customer to such customer, including outstanding checks related thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Patient Refund Cash</U>&#148; means any cash that is to be remitted to patients of any customer of the Companies or their
Subsidiaries on behalf of such customer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Patient Refund Liabilities</U>&#148; means any Liability of the Companies or their
respective Subsidiaries to pay any amounts due back to patients of any customer of the Companies or their Subsidiaries on behalf of such customer, including to the extent any such amounts have become subject to escheatment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Payor</U>&#148; means a nongovernmental payor, private insurer, health maintenance organization, preferred provider organization,
health care service plan or other third party payor, under any applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permits</U>&#148; means all licenses,
certificates, accreditations, clearances, permits, franchises, approvals, authorizations, registrations, consents or Orders of, or filings with, or notifications to, any Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Activities</U>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Liens</U>&#148; means (a)&nbsp;statutory Liens for current Taxes or other governmental charges not yet due and payable or
the amount or validity of which is being contested in good faith by appropriate proceedings by the Companies and for which appropriate reserves have been established in accordance with GAAP; (b)&nbsp;mechanics&#146;, carriers&#146;, workers&#146;,
repairers&#146; and similar statutory Liens arising or incurred in the Ordinary Course of Business; (c)&nbsp;zoning, entitlement, building and other land use regulations imposed by any Governmental Authority having jurisdiction over Leased Real
Property which are not violated by the current use and operation of the Leased Real Property; (d)&nbsp;covenants, conditions, restrictions, easements and other similar matters of record affecting title to the Leased Real Property which do not
materially impair the occupancy or use of the Leased Real Property for the purposes for which it is currently used or proposed to be used in connection with the Business; (e)&nbsp;Liens arising under worker&#146;s
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compensation, unemployment insurance, social security, retirement and similar legislation; and (f)&nbsp;purchase money Liens on personal property that is not, individually or in the aggregate,
material to the Business or the Companies and their Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means an individual, partnership, limited
liability company, corporation, business trust, joint stock corporation, estate, trust, unincorporated association, joint venture, Governmental Authority, or other entity, of whatever nature. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Personal Information</U>&#148; means Protected Health Information, Social Security Numbers, financial account numbers, driver&#146;s
license numbers, or state identification numbers, or other &#147;personal information&#148; or similar terms such as &#147;personally identifiable information,&#148; as defined by applicable Privacy Laws or other information concerning an identified
or identifiable natural person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Plans</U>&#148; has the meaning set forth in <U>Section&nbsp;5.13(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Positive Adjustment Amount</U>&#148; has the meaning set forth in <U>Section&nbsp;1.06(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Statement</U>&#148; has the meaning set forth in <U>Section&nbsp;1.03</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Prior Representation</U>&#148; has the meaning set forth in <U>Section&nbsp;10.17</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Privacy Laws</U>&#148; means all Laws and other binding legal requirements, to the extent not preempted by HIPAA, that govern the
privacy, security, or confidentiality of Personal Information, medical records, or other records generated in the course of providing or paying for health care services. &#147;Privacy Laws&#148; includes the Fair Credit Reporting Act, 15 U.S.C.
&#167; 1681 et. seq., as amended, the Fair Debt Collection Practices Act, 15 U.S.C. &#167; 1692 et seq., as amended, the Telephone Consumer Protection Act, 47 U.S.C. &#167; 227, as amended, the Telemarketing and Consumer Fraud and Abuse Prevention
Act, 15 U.S.C. &#167;&#167; 6101-6108, as amended, state Personal Information breach notification laws, and the Payment Card Industry Data Security Standard and other binding requirements of the payment card brands. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Privileged Communications</U>&#148; has the meaning set forth in <U>Section&nbsp;10.17</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Proceeding</U>&#148; means any action, suit, charge, complaint, litigation, arbitration or mediation, inquiry, investigation, audit,
written demand, notice of claim, proceeding (including any civil, criminal, administrative, or appellate proceeding), prosecution, or hearing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Protected Health Information</U>&#148; has the meaning set forth at 45 C.F.R. &#167; 160.103. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchase Price</U>&#148; means $250,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchased Securities</U>&#148; means the Outstanding Securities, excluding the Contributed Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Real Property Leases</U>&#148; has the meaning set forth in
<U>Section&nbsp;5.09(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Related Agreements</U>&#148; means the assignment of Purchased Securities, the TSA, the MSA, each
of the SOWs, the Contribution and Exchange Agreement, the Parent Guarantee and Restrictive Covenant Agreement, and each of the other documents, certificates, and instruments to be delivered hereunder or thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Representative</U>&#148; means, with respect to any Person, any Affiliate of such Person, any equityholder, director, officer,
manager, member, partner (whether limited or general), principal, attorney, employee, agent, advisor, consultant, accountant, or any other Person acting in a representative capacity for such Person or such Person&#146;s Affiliates, and in the case
of the Buyer, any existing or potential financing source (including lenders and <FONT STYLE="white-space:nowrap">co-investors).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Required Amount</U>&#148; has the meaning set forth in <U>Section&nbsp;6.08(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Required Information</U>&#148; means, in each case as required by the Debt Commitment Letter, the financial statements necessary to
satisfy the conditions set forth in paragraph 5 of Exhibit C of the Debt Commitment Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Area</U>&#148; means
anywhere in North America. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Business</U>&#148; means [***]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Debt Commitment Letter Amendments</U>&#148; has the meaning set forth in <U>Section&nbsp;6.08(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Employee</U>&#148; means any Person who is or was an employee of any of the Companies or their respective Subsidiaries at
any time during the Restricted Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Key Employee</U>&#148; means any Restricted Employee who has annual
compensation in excess of $100,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Period</U>&#148; means 5 years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Retention Bonus Agreements</U>&#148; means those retention bonus agreement listed in item (d)(2) of <U>Section&nbsp;5.06 of the
Disclosure Schedule</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Retention Bonus Obligations</U>&#148; means all Retention Bonuses (including the employer&#146;s share
of payroll, employment, or other Taxes associated with such payments), whether payable prior to, at or following the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Retention Bonus Recipient</U>&#148; means each employee party to a Retention Bonus Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Retention Bonuses</U>&#148; means all bonuses or similar payments, if any, payable
to officers and employees of the Companies or their Subsidiaries in connection with the consummation of the transactions contemplated by the Retention Bonus Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Section&nbsp;336(e) Elections</U>&#148; has the meaning set forth in <U>Section&nbsp;7.05(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; means the Securities and Exchange Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller</U>&#148; has the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Cure Deadline</U>&#148; has the meaning set forth in <U>Section&nbsp;9.01(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Released Claims</U>&#148; has the meaning set forth in <U>Section&nbsp;7.06(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Releasors</U>&#148; has the meaning set forth in <U>Section&nbsp;7.06(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Shared Agreement Replacement</U>&#148; has the meaning set forth in <U>Section&nbsp;7.04(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Shared Agreements</U>&#148; has the meaning set forth in <U>Section&nbsp;7.04(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>SOW</U>&#148; means each Statement of Work, being entered into by and between <FONT STYLE="white-space:nowrap">Med-Data,</FONT>
Incorporated and Mednax Services, Inc. or Affiliates thereof on the date hereof substantially contemporaneously with the execution and delivery of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sponsors</U>&#148; means one or more investment funds affiliated with each of Frazier Healthcare Growth Buyout Fund IX, L.P. and
Edgewater Growth Capital Partners IV, L.P. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsequent Representation</U>&#148; has the meaning as set forth in
<U>Section&nbsp;10.17</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148; or &#147;<U>Subsidiaries</U>&#148; of any Person means any corporation,
partnership, limited liability company or other legal entity in which such Person (either alone or through or together with any other Subsidiary), owns, directly or indirectly, fifty percent (50%) or more of the Equity Securities, the holder of
which is generally entitled to elect a majority of the board of directors or other governing body of such legal entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax
Return</U>&#148; means any declaration, estimate, return, report, information statement, schedule, or other document (including any related or supporting information) with respect to Taxes that is filed or required to be filed with any Taxing
Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Taxes</U>&#148; means all federal, provincial, territorial, state, municipal, local, domestic, foreign or other
taxes, imposts and assessments including, ad valorem, capital, capital stock, customs and import duties, disability, documentary stamp, employment, excise, franchise, gains, goods and services, gross income, gross receipts, income, intangible,
inventory, license, mortgage recording, net income, occupation, payroll, personal property, production, profits, property, real property, recording, rent, sales, social security, stamp, transfer, transfer gains, unemployment, use, value added,
windfall profits, and withholding, together with any interest, additions, fines or penalties with respect thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Taxing Authority</U>&#148; means the Internal Revenue Service and any other
Governmental Authority that has the right to impose Taxes on any of the Companies or their respective Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transaction
Expenses</U>&#148; means the aggregate fees, costs and expenses of the Companies and their respective Subsidiaries arising from, incurred in connection with preparation for and negotiation, execution and delivery of this Agreement or incident to the
transactions contemplated by this Agreement, including (a)&nbsp;all fees and expenses payable by the Companies in respect of services rendered prior to and on the Closing Date to Guggenheim Securities, LLC, Barclays Capital Inc., McDermott
Will&nbsp;&amp; Emery LLP, and any other professional advisors, (b)&nbsp;all bonuses or similar payments, if any, payable to officers and employees of the Companies or their Subsidiaries in connection with the consummation of the transactions
contemplated by this Agreement (including the employer&#146;s share of payroll, employment, or other Taxes associated with such payments), including all Retention Bonus Obligations (whether such Retention Bonus Obligations are payable, in whole or
in part, prior to, on or after the Closing, regardless of the conditions to payment therefor) and (c)&nbsp;all fees, costs, expenses, premiums and other amounts payable in connection with the obtainment and binding of the D&amp;O Tail Policy. For
the avoidance of doubt, for purposes of avoiding any &#147;double counting&#148; of assets or liabilities, the &#147;<U>Transaction Expenses</U>&#148; shall expressly exclude all items included in the Debt Amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transaction Expenses Amount</U>&#148; means an amount equal to all Transaction Expenses that have not been paid prior to the
Effective Time, but after giving effect to any subsequent incurrence or accrual of such Transaction Expense whether or not the Companies have been billed for such expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transfer Taxes</U>&#148; has the meaning set forth in <U>Section&nbsp;7.05(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>TRICARE</U>&#148; means the program administered pursuant to 10 U.S.C. Section&nbsp;1071 et. seq), Sections <FONT
STYLE="white-space:nowrap">1320a-7</FONT> and <FONT STYLE="white-space:nowrap">1320a-7a</FONT> of Title 42 of the United States Code and the regulations promulgated pursuant to such statutes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>TSA</U>&#148; means the Transition Services Agreement, to be entered into by the Seller and each Recipient (as defined therein) at
the Closing, in the form attached hereto as <U>Exhibit C</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>WARN Act</U>&#148; has the meaning set forth in
<U>Section&nbsp;5.12(f)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Withholding Party</U>&#148; has the meaning set forth in <U>Section&nbsp;1.05</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Working Capital</U>&#148; means, as of the Effective Time (a)&nbsp;the current assets (excluding any Cash Amount and any income Tax
assets) of the Companies and their respective Subsidiaries, <U>minus</U> (b)&nbsp;the current liabilities (excluding Transaction Expenses and Debt and any income Tax liabilities) of the Companies and their respective Subsidiaries. The calculation of
Working Capital </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall be prepared in accordance with the Accounting Principles. An example statement of the calculation of the Working Capital as of August&nbsp;31, 2019 is included on <U>Exhibit B</U> attached
hereto for illustrative purposes only. For the avoidance of doubt, for purposes of avoiding any &#147;double counting&#148; of assets or liabilities, the &#147;<U>Working Capital</U>&#148; shall expressly exclude all items included in Cash, the Debt
Amount and Transaction Expenses, but expressly include Patient Refund Liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Working Capital Deficit</U>&#148; means the
amount by which the Working Capital as of the Closing Date is less than the Working Capital Target. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Working Capital
Surplus</U>&#148; means the amount by which the Working Capital as of the Closing Date is greater than the Working Capital Target. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Working Capital Target</U>&#148; means $21,157,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Written Responses</U>&#148; has the meaning set forth in <U>Section&nbsp;1.04(c)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A - 17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Closing Statement Methodology </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(<I>See attached</I>) </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form of Transition Services Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(<I>See attached</I>) </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d811805dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g811805g1009171648598.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR MORE INFORMATION: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Charles Lynch </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Strategy and Investor Relations
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">954-384-0175</FONT></FONT> ext. 5692 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>charles_lynch@mednax.com </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>FOR IMMEDIATE RELEASE
</U></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX Reaches Agreement to Sell MedData Business to Frazier Healthcare Partners </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FORT LAUDERDALE, Fla</B>., October&nbsp;10, 2019 &#150; MEDNAX, Inc. (NYSE: MD) (&#147;MEDNAX&#148; or &#147;the Company&#148;) and Frazier Healthcare
Partners (&#147;Frazier&#148;) today announced that they have entered into a definitive agreement under which MEDNAX will sell its MedData business to Frazier. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MedData is a leading provider of technology-enabled management services for hospitals, health systems and healthcare providers. For four decades, MedData has
been providing innovative solutions to the medical community and serving hundreds of millions of patients across numerous medical specialties. MedData currently serves more than 10,000 physicians at a network of 3,000+ facilities nationwide from its
headquarters in Brecksville, Ohio, and more than 20 regional offices across the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nader Naini, Managing Partner of Frazier, said, &#147;We
are excited to be partnering with MedData&#146;s 2,000 dedicated employees to continue to provide <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> patient financial and advocacy services to the
company&#146;s broad base of customers. As part of our growth strategy, we are committed to bringing additional resources to accelerate and enhance its offerings to help our customers reduce costs, recover revenue and optimize their
operations.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stephen D. Farber, Executive Vice President and Chief Financial Officer of MEDNAX, said, &#147;This agreement is an important step
forward in MEDNAX&#146;s ongoing transformation. The sale of MedData will better position MEDNAX, both financially and strategically, for long-term shareholder value creation by allowing it to focus on its core physician services business and
significantly reducing the Company&#146;s leverage and future capital expenditures. This transaction also aligns MEDNAX, a key customer of MedData&#146;s, to participate in the success of that organization under Frazier&#146;s ownership.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2018, MEDNAX announced the initiation of a process to divest MedData to allow the Company to focus on its core physician services business. In
connection with the divestment, the Company classified MedData as discontinued operations beginning in the first quarter of 2019. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the purchase agreement, MEDNAX will receive cash consideration of approximately
$250&nbsp;million at closing, as well as economic consideration of up to $50&nbsp;million that is contingent on both short and long-term performance of MedData. MEDNAX also anticipates certain cash tax benefits from the transaction in the coming
quarters. Finally, in connection with the transaction, MEDNAX has entered into a long-term services agreement with MedData, effective as of the closing, and will be one of MedData&#146;s largest customers following the closing of the transaction.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously announced with the initiation of the sale process, MEDNAX expects to use net proceeds from the sale for debt repayment, share repurchases
and strategic acquisitions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further transaction details can be found in a Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed by MEDNAX today with the
Securities and Exchange Commission. The transaction is subject to customary closing conditions and is expected to close during the fourth quarter of 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays and Guggenheim Securities LLC are serving as financial advisors and Cleary Gottlieb Steen&nbsp;&amp; Hamilton LLP and McDermott, Will&nbsp;&amp;
Emery LLP are serving as legal counsel to MEDNAX on the transaction. Goodwin Procter LLP is serving as legal counsel to Frazier Healthcare Partners. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About MEDNAX </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MEDNAX, Inc. is a national health solutions
partner comprised of the nation&#146;s leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based
tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX
provides services through a network of approximately 4,200 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two
complementary businesses, consisting of a management services company and a consulting services company. Additional information is available at <U>www.mednax.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Frazier Healthcare Partners </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Founded in 1991,
Frazier Healthcare Partners is a leading provider of private equity capital to healthcare companies. With more than $4.2&nbsp;billion total capital raised, Frazier has invested in more than 170 companies with investment type ranging from company
creation and venture capital to buyouts of profitable lower-middle market companies. Frazier has offices in Seattle, WA, and Menlo Park, CA, and invests broadly across the U.S., Canada and Europe. For more information about Frazier Healthcare
Partners, visit www.frazierhealthcare.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995, Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities </I></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than
statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as
&#147;believe,&#148; &#147;hope,&#148; &#147;may,&#148; &#147;anticipate,&#148; &#147;should,&#148; &#147;intend,&#148; &#147;plan,&#148; &#147;will,&#148; &#147;expect,&#148; &#147;estimate,&#148; &#147;project,&#148; &#147;positioned,&#148;
&#147;strategy&#148; and similar expressions, and are based on assumptions and assessments made by MEDNAX&#146;s management in light of their experience and their perception of historical trends, current conditions, expected future developments and
other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future
events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from
forward-looking statements are described in MEDNAX&#146;s most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and its Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> including the sections entitled
&#147;Risk Factors&#148;, as well MEDNAX&#146;s current reports on Form <FONT STYLE="white-space:nowrap">8-K,filed</FONT> with the Securities and Exchange Commission, and include the effects of economic conditions on MEDNAX&#146;s business; the
effects of the Affordable Care Act and potential changes thereto or a repeal thereof; MEDNAX&#146;s relationships with government-sponsored or funded healthcare programs, including Medicare and Medicaid, and with managed care organizations and
commercial health insurance payors; MEDNAX&#146;s ability to consummate the proposed disposition of MedData; the performance of MedData subsequent to its disposition; the timing and contribution of future acquisitions; the effects of share
repurchases; and the effects of MEDNAX&#146;s shared services and operational initiatives. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MEDNAX Investor and Media Contacts: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Charles Lynch </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Strategy and Investor Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">954-384-0175,</FONT></FONT> x 5692 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>charles_lynch@mednax.com </U></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Andy Brimmer / Jim Golden / Tanner Kaufman /
Jeffrey Kauth </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joele Frank, Wilkinson Brimmer Katcher </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-355-4449</FONT></FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Frazier Contacts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Frazier Healthcare Partners </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Carol Eckert </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Director of Investor Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">206-621-7200</FONT></FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>carol.eckert@frazierhealthcare.com </U></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>md-20191010.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.8.2 - Release 2019.2 -->
<!-- Creation date: 10/10/2019 2:23:02 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:md="http://www.mednax.com/20191010"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.mednax.com/20191010"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="md-20191010_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="md-20191010_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>md-20191010_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.8.2 - Release 2019.2 -->
<!-- Creation date: 10/10/2019 2:23:03 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>md-20191010_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.8.2 - Release 2019.2 -->
<!-- Creation date: 10/10/2019 2:23:03 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="md-20191010.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g811805g1009171648598.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g811805g1009171648598.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !- 0T# 2(  A$! Q$!_\0
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M_B*]'_X4/X<_Z".J_P#?R/\ ^(K">(A%\K-X4)R5T?/@ '04M?07_"A_#?\
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M0BZ+!/*SSN/0?7VK?ZS5[F/U>GV,KP+X23P;X<73?.6>=I&EFF5=H=CTP/0
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=GCKBO1ZA^QVWE1Q?9XO+C8,B;!A3Z@=C4U '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>d811805d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="md-20191010.xsd" xlink:type="simple"/>
    <context id="duration_2019-10-10_to_2019-10-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000893949</identifier>
        </entity>
        <period>
            <startDate>2019-10-10</startDate>
            <endDate>2019-10-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2019-10-10_to_2019-10-10">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2019-10-10_to_2019-10-10"
      id="Hidden_dei_EntityCentralIndexKey">0000893949</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2019-10-10_to_2019-10-10">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2019-10-10_to_2019-10-10">2019-10-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2019-10-10_to_2019-10-10">MEDNAX, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2019-10-10_to_2019-10-10">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2019-10-10_to_2019-10-10">001-12111</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2019-10-10_to_2019-10-10">26-3667538</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2019-10-10_to_2019-10-10">1301 Concord Terrace</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2019-10-10_to_2019-10-10">Sunrise</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2019-10-10_to_2019-10-10">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2019-10-10_to_2019-10-10">33323</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2019-10-10_to_2019-10-10">(954)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2019-10-10_to_2019-10-10">384-0175</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2019-10-10_to_2019-10-10">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2019-10-10_to_2019-10-10">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2019-10-10_to_2019-10-10">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2019-10-10_to_2019-10-10">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2019-10-10_to_2019-10-10">Common Stock, par value $.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2019-10-10_to_2019-10-10">MD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2019-10-10_to_2019-10-10">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2019-10-10_to_2019-10-10">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6627304048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 10, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000893949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 10,  2019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MEDNAX, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-3667538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1301 Concord Terrace<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Sunrise<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(954)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">384-0175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M/_RNPCY8MW?_V/@BJ%KX]2_4%U!+ P04    " !6-DI/F5R<(Q &  "<)P
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M]01W.8$FIKFO@F 6 17<Z@0ZF2Y]%02S"JC@?B?0SG3MJR"834 %]SR!CL[
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M<U!+ 0(4 Q0    ( %8V2D\GZ(<.@@   +$    0              "  >D
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 5C9*3_F7_5WN    *P(
M !$              ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ 5C9*3YE<G",0!@  G"<  !,              ( !M@(  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " !6-DI/Q#F]'Z "  "3"P  &
M        @ 'W"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ 5C9*3WN3*')' @  V04  !0              ( !S0L  'AL+W-H87)E
M9%-T<FEN9W,N>&UL4$L! A0#%     @ 5C9*3[JA.8K7 0  ,@8   T
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52P4&      H "@"  @  _Q,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d811805d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d811805d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "md-20191010_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "md-20191010_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "md-20191010.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 97,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "md",
   "nsuri": "http://www.mednax.com/20191010",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d811805d8k.htm",
      "contextRef": "duration_2019-10-10_to_2019-10-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d811805d8k.htm",
      "contextRef": "duration_2019-10-10_to_2019-10-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-19-265496-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-19-265496-xbrl.zip
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MP.OC@$ZG !&+&ON??"V&3#IJ=YL$7ZY*_)NDU_%$;W,YGIA+81M!G;,KKC#
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MKLB5%+=ZC(% C+LH5)& C7AD:ZAMAKF[169/2N0')#;(&C+5^UV394X[PS2
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M30'!F(\K=.YYE,!SBW^S(30$WS:*3-E>Y&KR)"SAS\2<J\45HBI\6>H4+QI
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M? >_Q@).CL>]Q=(KV#G+=&A>KA&T707Q,:$9#[(I*L-)E"\O@[X6O<ZB]YB
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MY\O3.><,].)U>$ZUB_<48; :_XBS1."UNE4WD\5/)GEV'25%\%__L?MBYVW
MK*)+V+'58;]XB&&_R[//*E^QP;T@_H=[#NX@RR<9*%]%*G>ZC/.D.JB]^P\J
MFL1EE,3_%J#MTH?T[$'W7M&V^59@I/?7,A(;B1)K!*S"P.ZO1SZE0ZY(4$/3
MC8BR-$L?V\M[CVV_#^(X4$2@J?(RBM/@4%VK))NLROJ]NO<8+5'["@SG]5:T
M?>\1]=+K.,^H3!"VFVFYL?3!O7F(P9W"6+(4QG6:8U/+<AGN0WU@_?L/[!A[
M5&#'J)4:V^[.O0>&B>LD1OAW<!.75U@TLP+2N+OW$-)X'/6E(5T/!IG=LF^[
M*CL.QO@ @@E&"8*D<61_9OGG51G9X =8O=$#' 9V9,=9L1K#NGP8H<RC03D%
M;6F'N!*CN[K_Z'37#J4E4ZV"00ECBQ]JT_6^#-1D6:'.ZKB>/8C5)0L5O%.I
M&L5E<)I$[NA^^;XY9M8D,X\G7+FTC7;_,(+71'#IBN/^T8.C5)IIK\!H'B!>
M,!K%8.KCN44)D6BP*BK^U4.H>! \E6,(2UL?JS&R![#QZR/307%S4*_ 4%\_
MP'8K,<C/=N/J>-E[]X_XU],9#F!\Z>-[$&?[(IL$!],"?K 2VG_O0;QK'!0V
MB$SB%1C4RX=(TPCCMTM%L0H#N[_M 8,93KDMPKMI$:=J^>XT=BY_""D$+9],
MAW!LFQ/<HA=68Y /$.XYC7(8SI-CS&"LVO"&]Q_>^16,;]@XL,UO!3OY>/%[
M[ZPKXF1W;PTY^2X@)T*S%NP^D*3N)TDVD-[(.AG\;7>A?ETSM-?W//GT=96&
M;W5?U=F*WV4@Z/I[CP-]L[GZY1UJQ//>P:>SHXLC4(:GG\X.?M\_[P7[OYWU
M>A]@(*(?WY&.A+$TZN:]EG=SH=K/_W-!77UQ%1?!['?;*O$:)-!Y]18&XJ 9
M/_V*G[Y^NQW !31:.'?BM,R"J$#KZ..@S/HJ9P'=W0F#O9W=-R'RG*!-V%?E
MC5)I\/[WX,/AY@;1GH3!43IX&@81UEQ'-W"0!0.!,.$NVL("6/,F] OG+4*Z
M[8?>X<G^/PWZTM[Q?9+E\3":<4,-_#)W?!H8K!&,#,8W+H(I9F?[TS)(,S !
MX??Y35RH8(B@7?@&_E9Q&A1749($5]&UHJ+=L8J0*!",X6*0QWV\689?C(,L
MA?7^9)"H^_CT )1%A!J)[E9F3X,+S0M#0\0[2E]OG*%<C52>\ST'&;FU,9@V
MM_I=8#&\88+]P\@4/4ZZJ8(G!L@S?!T/P2N&G\/O(O]7M_B;I_*C&;*Z]_RK
M[:.SWL'1Q?[QN;=E6JR9K[)C_@3+IK=_'FYN.,N0W:1%@/I)5VG'13&%%<&)
MS:9E449"X/R_T[B\A5\-ICG!@RH2^-&YUE[D[C2X_P<U/(S**/@]2^C"@VS&
MCC&WKORJOF_@^SC'=F\M]]W<:+^Q]\.*8)79I<)MPEG_RFN$OF@ZL0KS>BQI
MRUAB?+?-#5GBH2I@E 5NL@(^D0VL=V5"W87CL@BH_ 1^&I>)XIF-23,691"G
M,B'TR]-I/K@BK(==Z=#L;[ZO\]")7!Z,\FSLJ0!^MOU$<YW=[TTV-^ B4@H#
M^"H,IA-8=;R:U2#^O)CVL9.[OLT _&(N6X 9*F&*\Q(U2D#GASDVEKB<I-!&
MTYRD,48GGHL0<"SX'4JX#$&/2>:85!#N"3K=_ &Q")_#]!197K#.]P[#+%5!
ME@=CL'N")!['&!:_G$9Y!!?AD@\I4,Y')MX*_R;=G8U"G+\16+JYO\3V]_A2
M \'D32).\&?]1*!LYIXBIGE,]1=3F,F<SAWQ0$F9HCZE_^,#FWM9PFE$MW!'
M''B24##!HR*YQ0/G^UKAQF-U]GK+\+UU(BM&:S58U./C T='ZL]=35YY9%UN
MRJNH-&M+ ?D8[ [-[MK[ GLVO53NBX&.**814[[>7,6#*YB1<99>;FZ0H8(#
MH9>[TTZ6U0W=ER8S!QY2,C4)E_>$^'M^685WU(,7^A+]%6@;C%046C4%2H^(
MG@0/#>U/V9ZB4[6R-?4$*3Y:M8I#R=_<,+^'Q0==JFTO,8RVBBFHM]+)4%6.
M(S/'?A;+.9KPU5=1VC<WZ,L6:5]<O.'83J,O;$R#J%;-?:N/:$9RP:U@S=<@
MNU8IRJ1OZ7 0+OC-^]V9\[L#_;LFAZ.[J-=>W+PI[[X&7:DW)(R/%"5K#WP+
M-K%%X/@Y>GB%O6K,T/V&O6/EY9LZ>:X]@VLS80\AN#0$YOULB,:H?U@TZ*>(
M:A%HZKP#05_K[B72 FH\2>AXPPGHW^)YMKEQ?ZN"I_.I#D%\?_&3%^OPR4)N
MWPJ$2DX^_AD&&-?NO?]XUB/+#&030Y&Y1] UGE)6V2B&$+:<2^0E!QZX5*B'
M<-O)<32.AF*GLVJYS#+V(*^C9(H,B&2]V ?J_3Q0\:24K3,:Q8-8I8-;?!O2
MBQ0BX-T71)9Q=LB_EEA 2.<F^YVP[_I@J*I+"@+T,]"!(2LVU&FC+$FRF^+G
M9;C_NIWU47!'Q_^>SX?%W]RX.-L_.=\_N#CZ>'+7U[B7&.X^W=EUH]!>1/K3
MK^^B(AZX]@J%;&:MULN'R/E\>B#OL&Y+V@.);4#M!\.5 S#Y<MDRT0#Q*57G
M.&1;J&JQD@<?\FDUHJNHH189KM?JEN\X9-;'NJ/?R:]VO/)F1W^4B]$S2%1$
M[EV4<F 4?WH,F[B8N6RMN;K[2M?>#.G20PE.P4Q3)%KPJ4GO?4T)._?%*1K^
M-2U*-K7J\H0GAE86^'(L1M$EB-DEFK6^XH;?MBY4<!/#<O1QJ=# G*:4]P?C
MY0H]C@CC0)L;B&IA[YEGRKT93Q48K,FT"#!'7[WP .^U3[<.@W&<XF6#^F7$
M+%6Y;%B_S-GY@>X!6_V9JO],A@9G!!\:6.%!,4".?V. /U$%NG!1RF&QZA47
ML+X*GA&3(.OQCN[T*%@F!**9I]6N\1]6<2TTR\1I=%MQ&V9OJ"[J^LVB&PI$
M8\9^:GC5I\'^; TX\^CM-(C=9PN/(FX=!;RZZR;@/WM%&8_)ZJ^,[V'\G[N\
M_LSW)Y>WKV!R1[X/&/J,JR8Z&^>N&P6:"91)'.5TR9Q-",I".ZBH44!X)Z"Y
M8CX]T=?FL ]L@DETBT:?6%QDF5FI$%&^A^&QN"3W9TFRK' A(HP'M7PB&ML$
MTEW/72MK#PBSJP./?%:#[D7+F!0&'/?FU*: ^WBLA@A3PG25)@H/1F"RSCD\
MOY9I]FS&%+5N"YZSDZST="S:!UO/9,XUT"PX!+\OF.1Q9@P3?;-#N+4;G-O<
MX/EKMF."&SC?P.0'GU%S\?A:="[?ZVFNGLBSA>[517'8."?)LS:[G(!()5M!
MWLXHPAR1DHG"%3;ZLW94&GFLGHZPQ0;;'4]$.$+YRNH)XT^&7;K*==6 ;I_,
M![&%6W\5-AYJY],<#TU[A(I94KT.^:$&L7/4DHT+ISJ/Q'L%C!9<9I0D2*(I
MCAPF] F,.O1D1P2Q==2SCE3,3=]+6$ST:! E@ZF08%#T***4N@[7:DL,G.E)
MQ+''S0U';/K>060\@7=9]KF0\.(@RX=%C4E[OEHGPWZ O[;URWB+??AL2F6Q
M:.:E@WB2V-LQ)B"N#D?'KBZJ3@D8/5C2W@==-L@0DHY;P#R*]RV\1UP6FQNY
MNHY!\<A([C_]_ ;:+,;'.!.+I]0@&XLV-^\RAI-?(QS@Y&H>DM8^H-*F$\YT
MW>MM-S<PG;:UVZ 79ZE%[5>YGWHGE#YE..([.S.&!Q0!V=TS2@LO#'!*CZ#D
MPH.,^3N.<[[\H>*<][4>GG=W%> 4P%!+G$;W"O)\ ]_&,PK -$3S!31OR0BC
M2584<1\#*8BIBMDD5M<X0E1]\$$*&[P$'^_-CCQMB"90-"K%VY#G;&Y8 \B+
M%_%IT132T0 *4$UI-!U28AY58);$O&O[44+ZOKA2JKS+L6&3^MRZ'2_ ::R
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MF)+%)@FPA(C#P42&3FG8]#4ZR7'.I[03]<%4]XQ\Z=<J/'TQJ[R(4)S:'&B
MKB#/.4<C/#AL\Q"6@(;U!U W"JS54(](;AE0%N<A&FRC*K[1,/H9PU!@507C
M*;+1MMVHIJ""<N\6Q[YPT4-SP4-#D;<(H]%!L\;,!H-7&P*#:L.W.F;,MJZ7
M-'N+,\EB8F+@06]3)VF,61JRQQW74F,-,2]C+>UB.AY[B]#.?D)^@<^")BI&
M UN5+1T:4=\%*NH9Q/E@.N:4;2%$CHC= "747.U@O4K%5-X<527PL:DQ'\ *
M#,&_+R2PQAXX06MR@;FAGJDBK%<."5O;\>^;2B5KD/#0K7@AY4M7SX1U;V[X
M59Z-$=,,V3=4#E\KW:TK9$%)2F8"$3F3/X@P2 I0PCF!U3E878XMI.+N<_34
M!G9:,<%ZUTQ\[=264*#KR35EX=,N4TI4_YQ5I+!K#4B8Z?!DL*43G--T..6@
M:YY/)RY)E5G50HML%7HO# T<6$XQ2 R*3*<4[,]%>&#_8X9#[!5)*MC0,FPK
MC$_V75 $ BLJ 62;B"F#&X4X+.WM:A]'EQHTS[56+'+R.I%J'^>VU1R+J ?+
MG(EQH'A6CMF( Q'U3*J^<^PCFQ6%5NE>J;H!CU1"ZSPU199@? /-#F-(2-@X
MN=7PBE9W]06U)/CTZW;;?5@\*_NU(IY61YHY4TXJ@(Q*J[T%/5;FH DH4>[D
M!B@F&7-)=5X5>\*3-+Y%U:_UMQJM&LT"A]>KN] /HS?!@Y91IOQR?B5WBV7!
MBM;0O; ?7PL_-B^G$^)PR2=M>.-GLM6_.52OW7 [:K:N$&X[$NBS$\*IVTO-
MP^0]@3:0&G*ZK[725C@*\=JBRDYX2BX(G#O[UE)AR\?S94H$^)FTU%9;F17#
MH%_,R<_.7V_WN'!C6JT3X9[/'-F*N/99SF83TA/&JM91^QGS[SB8]&8=3'H
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MS>^DMP3!5*US SM%8/Y#X<1NZ#^9*Z>8R'=1LYQJ_U$<XG2JD0@\Y%!3;KA
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MP5J.N\ZE'2=;.7JQT+61H'Q8S=%5:R<Q$@-RIJV=H;CXI$3,'743)VL*W5T
M:GU5N_V0]D,9E[A'$W6)B21Z1WX5TY76BU0Z9EVH'3SFS+J,,#!",ECW07"G
MD@\2.DRA''H<*QTJU(V+?%J*?I1^1@:W <$2J$%&BO_.E0N1"[&_#?8BB*=C
M<@QUB1"IXLBD3BGPE0A.DOC)B"&\X,W _:R*X%*E2'TJ)9?RU^8&;F_.,CHM
M%?QRRG?F;=FQ8DI;;O@6^_VCEG(,/)^Q<TZRX(\X$Q9,9#PET%O!P)1]Y$X
M\7 .SZ^HNWRF^T;S'2Z)327P(JJ<82<88C/!R&L:MO(),8RT?W3D##G.;3[*
MH\<S<2CW;B9\A*RWCE0C):/;&L$-F'C[R7V #MV #39-#&&/>40_ETRNAM[H
MS>T$#8=J%.%OMR@5J<E^: 4H]!@*L1@='*#&(B8+X#H;-FXNN:\;X7$T,2.(
MZ%4X^Y';@50TPN67F"K.8RZ1CZ2+'-Q0R'+$DI+GF1YS!AP$$@&7#7'/#^,1
M^G>@)(8RB8@%2(C>DO,2%.R(!N5L'Y$:NU+7%)CG86V>2?HPLR55^?'8=)<3
M#DG$2$G_6IOA-7/ AR8]Q@G@&K9J9Y$Q1J[,\\F>,+*OF.<QDJVH']T2M-/)
M9DJB,D/"4PTYR11CPL=*E;S8<YE>YEZ 6NA)-GK"L'(AA-&\,-1?QQK(O\.<
M/SD?@&)[<@9KF&;!/O9?R:=PU=$8AR?Z89^)97??O'H9!KLOB)KZX"F23C!S
MU.N(H5]CZCEM586SU7+JQEQM5;'[<G/CX.G[IV=/B=LG>+VS2^1"EB/PNXQ]
M/?MA8U]W.0UG<8+#:?@NSSZ#,#?Y0L+US#4PM,ULMG:44<NT6R1'&SIV-JA)
MNJ'S 1'TZK^IX0AI[K'IE>)8,M1-*RT,T?N]T^N+GLK+L?5GD8F^A^. X%!-
M2]0>!=, !\$T5,H!2'L;[#FVUT&E#;L#2S\%ET-+5#K]DMU*#R2"16C54/-@
MN'G<NG7D<)$SLS8E-+ CGH;3":XXA<<7&MN#[Y\DC/I*;BLD@&)V'MBW/*:W
MM-:G:U3IBSR4,MT!4P656S0_R2R$\TR_':'+<F:/83-7Y'?QJP@*4I/4. P^
MBA\V,@_3.5)F6K/ZO10B%J?3!!<VU2_9:AC.YH8G6&8,6.Q,5I,6@R$VL:G)
M0OBU5UY  '+HB>2AA8:"CO]O^1E=[(#0)&,;08<"T"61Q='*&0C_QQO@Y=.=
MUYK^Q9DIZM\S0\#8$2ZS2T7VA\6<MXAFY?:U[XONLMO\:@WO[ZQSL]S.&43C
MKRO/F;\SC.*@][;7GV=3< :*MJW3?'5E(X55J \YX>S1-5:UE+K[N+/M?+0R
M/K9E!\[?7_Y+VVEH(QNJ5B4VU*96)T+8RY,BT\T80KL?-C><#1%6B#'W$R1.
M8II1>S_#Y^@:TG@J9GW;@:*><_7?DQ EC?=O&D,7D<.Z<.\(\%BM.+JB"SZK
M)Z4)0.PW88Q"MPV2:A;R2HMH8WZ30Q;COS!1SW4<N2)F.MQ(3G6';2B.0QSF
MT4WJ]@]R@.-T<P, Y2<,-*D$JS0<\7 (ZA=U0!%N;B0J A7)X';LF-#/LL_Y
M%-LJLDK5-A5"G EH='.5V3$9_=X@7HY>:41HA5BE(N2.\MZA]])F:O@KF1T1
M9POJ#PWSFYVAR!#6-2]*7*77BBJ-AEI_B<D[/"^GW )8&D@J0_3ANO9X%S=<
M."-:6(V+RG[[O^ R)FIXJ2J^+_Z3%UXZ4]HCSR\(L$H-5-E]0H664J@2)[01
M0%(0')C1Q/4M44,I3]#J5F[AQ@H1*D[[N'7K^4O$>831E(YY'] G%'(^F#/-
M7*T^ 8M641_$6@5(K>=JHUC,?$L30='M')6.1R"2E":6.0*87R J366_&[R"
M;1M+7,UY<PY?X4)@M8/A-8;%OHY@W_H0MT[3)7GFEO$8WD+T&PRU 9VU'!#3
MNQ#9L#CJ%09)-"F\X!@'P>;Q%WA!,AV.(]^0!-Q+)AB;IL52T=F&QD%Y28CY
M):Q-MI_ANK1I$5.HZDH!>\0R:%Z&)(89Y76/2\.F.TUUD0[?Y[;Z<J(A< TY
MR,C1*3MZ3[\U85PSJ0_U?V9BOGVA]A))2BKFS6)2D]JJ=.W(I)ECA+:89RA!
M!*UUGLMH0VX2SLUJ8.3ZO'0/@?;M6BN"E%=QK62;TJNZR\15O*4;(QAH(WRZ
M;8X&VK'H?% NU!R$1HG66Z:Z/>",_3G[%,.1ZS:K'&WUD)-5-/25UW/.(5NU
M]*[\<HZ451*U]D<^%W>7U[7EN?6WK!FL,QM6;V[(23GXK,_'0F^@PN!ZD5N4
M#,] (DSR2HXOJ145Y=/DR//>?UOB.J2Y[;QP1VDW(=R0-'=;@=FY]>).31C8
M[[A?QN[S=4QU@7C=+#;_PRG6B\+;H5'0%+/3,;DAF=";&W%Z#<9RU:)<I,H?
MR>!*(M@MG/HO4F(.&[Q6)&@QD5_B: ^WF9<^S_A:W<++>/"+O%AS!%?'&+\J
M(F2Q[H)-8)AE!()?SQ"L(Y(3FA:?=[ )ZC5 Y:\-(]TJ8^CVG<6P VG"F]0T
M+[ K)/=W#FN80]TH8O8][6N:J ;.*RIBNG\44$<]5/+<PK>($M4D*MQ?$A3U
M  OX+)I;5Z\4]L'PZVN=UC<F.O=VI?0"P=.<Z]$3JDY9JD,),!OD_%#8 P>3
MY3I45G"#3@Z(G*E+W4/TT"T5L%@5\SP/@'Y@<A].0,^Y>']0NN_FG94F:%Q8
M"W!.?1&9@GZ1;:V?Z.8&MO+QZJ'(P*O7O6_#W&/V4PV5<>PY6)F"]12/;LF-
MI>UL>#385HA\J]R&FW3QJRV'",VB\><W5Q(I$JXB-,:H;>],,]<4(C>U>V0(
M@$OU<8>TDHM*KE.<,S=I$K,1C^]"L^"U==5E6!$WW^".JKAI8,Q1660XDQY5
M"6DZD+488P3P#^F&%VJ&%@H%N/(0:EF@EF 8/ $O,#+6RK?5;V]F(C2+\HEI
MJ"2!#=9M^];-0U8<-];3J811DT85U:! ;57G<%77B]4K1V(3_58#7X%/*:M?
M3HN5O9\#>">S(1;H>7O['[V\&"%T U66J<*AVVBR8D':QB#%:#)@(H6BR@*'
MT>7D6:?3U'6>"4M<;4WN-RAN-"S<Z[=#09M&#&768>'@,L^F$]IB%!HLLB3F
MY%0_*N(B=+!03J]@'3M#;]FVL!7RP"A&"$O^&83E.DJF2G-SLRH13 M,FB6&
MP!_3I7B1'".VP"Z)V;4AWB [:A/_*9WE<:^UQP[IB?^=9A1@(8<-1<U$\!"J
M.:.)H@L5T<<B!0-M28O7WHR+;$UTD?PW\/4S##-;T26QG*9.&*@8<T=@;BA-
M3Y9D3A:H]!*!5O!R.".VU6SN1F^%L%F"4_A,I!"[S41\' <1FZ9%!45.,/Q$
MW=JY&RZMQ<<<9ABMX(-LFG,(2Y=H+$/Q[>[,4'S'L;;^C26'O7%S/$&"4PN^
M#B9*(D9Y2.#S67%F2W2#)&6P'5*?Y*2&O0O$'C0\&QAK*0G3Q_7L'-4-F0T5
MO3[ZU^TL>)8FB38"PH'#2K0PLBP5%'.GIU#8/=:'EO( SPV.@@D#W:NG^/?L
MP;_XH3SXAZJ,^N.[*(PZ[QT?+ZLRJF>P[+6$2H-[X'6WG%-*):9!MTJJKS.X
MYXN54KG4HU^_ENI] EIT&'W[\^KYPJ54;X./-YAXOHHGM=GJ5%:UN>'U,_L!
MRJHPQF*/]EEE59829Q7JJOAM[E9816.N559]8]%>1F&5A55Z-5!5]C//T_V&
M554&F]#U=UVJJAH[@NGZK;8R$!N@ZE1>5;$+ZT56-+HY]4I+"/4^OU.54M!0
MI-1T/&?S<M[X>!,::3C%+1;RZ]<_:8EH*X!RPRT/60C%\'6W$DH<Q]F%4/IU
MOUXEE'G"5RJ%VMRHU4*QKG_$I5":G-(KA@H>O!:JF2H:4RQ-/)>$-,!8DA19
M2_54)?]W[W(II_]S<[W4$L[@18I2FC3<7/7VPIC3,]6;8Z+.J78)OIMBE\V-
M[CH8!U;=)?6HMD?I.B/=:XY?U&G+.55G5=(TQ]D((^*$V=PH6RN8TY:AF]B:
M[J"&2243[TKBSX+=U21>7)W-!%^,DO&1?M;8IU@!-Y=O@H0W++(< XOX*;S6
MXJ;,J>70;9+:9@RY?YNGC*+7#7/68/GY63L;C+2'NCP_<W3MQYR\CNYWJX)M
M<?&Z-%PR\4N[QM0LS^\X2(:3,!:.$***QR[E?2S)VSCZ3+4%"=G/!EY& "^'
M%0[S[_E(Y1KSY)XV/TA@\^4ZL+EX8//[B&L>?/QPNG^"GW]OH4U1GZL?X7PQ
M.\)Y8,)2;JRS=\=V,\2/UAP+137)P="P8S24_OT7V-#%,!Y48=US75P<M[Y)
MBPEX]W%>";-+4T@SRW7\87-#YW)OR=8C?[/.(U6#-'.X<3@=E'ZJE&%^=/K=
MP!FD>:NG>/8LP=IZ,:>'/&>!Q95^ZTT@S_[<!=R;LX !Y>%)(!# Y" JTNFX
M+XAS(FWE_+IC,4@0R'72%NJ$YXZFQJ",@H'!*XZ&@:4SB@=$KXLQ<LW)2#91
M_34:"QTXA%QW,HFLT/PR5R;QH*EJ$=%^2S!S?LFY!!=IECY!G[0HR(;7U!87
M[<YMI6J*^*CGSK0WPVU!K'E5NQTD1)NLDDQWWXL+FL"[YB"@@4D5%-BX1AP0
M1F8*I^,3<M<.\IA^8'[/%Q?N1THC_<PS\CKVAOP%UYUW_2UR76<H($2QXQ*3
M.ZFD:J%AILF1 (<6'NJ;F P05:YU/'/1EJ-?9H7JW1CI5PB1XM._78CTH5#+
M"_ ^=8EV$C="QP9L]PR)SHJ(+O02]X^:(IBJ"X/4]QDU;0J:?C C-^'3C.*#
M8ZP#4,D=^O&%OKYQ">G@"ZJ^$E,;XYZ>P&N@UC=CJ=K<\&FJ%ASEU^2RFJ5U
M7W\EK3LK,R7U5=@"6,.SM36W.JU-*N"#62!QCP'\9]2:8)@S]K\?)91]+*Y4
MHVP8N]# R!ND(^7BLQHFE<V\0S50:*CR:S_;#8.]G=U7=&?]52"?OK89LES.
M#P.0IWN9;81L&I%0ZK/3H9%[!$J.BJM@A,ZH88ZY55&.J52L**X^UG\9[SU?
M@\T]@Y]G7Z:Q36(,-XAG/$_3A:=_QMZ</?O[T\MI4<K![PWM3872XS@B;K=W
M_$I@=>,[4>&L,Y+.ZV,F7I'2WGJ][;W#&*3^"I$7,;C'RJWS]E\CL&]1>=TC
MC,;$X]:I#RWSBV'AP-C:]QHA?+6.$+9IR<T-8ZG,VI#-A#YM>Y;A74T788<@
M1/=(5"QLZ]4QP99G$S0TXD&#1]A)M[9VML%;C<S+N>9!Y2&EY_%["H>\[\+9
MTFA_-.UC]PZ\9PNJP<B5 P"S'HA3Q3VK_RB>PIL;'7S;YE5PF:P5'@9._>:[
M+/O, SNC($5C/Y7?]O=/@XB=^[C $L!$"(M5@RW8014+9,?4K,U246!_9U(\
M-4J(L [4-(@S.%5SXQ=XECT!I:D#%]'PKVEAB20"N;/48,$"9"7\K:A#(,^Q
M6RKCEA:!CZP0?*09$80Y8W[.R)2'&4E%>[ZI1>9<O__>N?J';#QUL6#0= P3
MSD7]07$+,C7F(A/BBT(3G&M0=5U,GB58]8(-76/%9 6:J\ODWA3Q?^3<J,RI
M"D,9<YUF;I&)$FZ]COHVJ.N'PN^FR8QRLJ6,QV(UC7/>MVPIO_ K*E&[#50\
M*1U&"5#2)(5W#+]S7)A,WN8Z(%L/[N()Z7FPXM&E'ZMP/'9IRZK!#?TLRJEC
MN>VS6Z%BP@V0<X)84J#DLH&,@Y11QZM2F7Z,:/AIN"1'IUAMA^@K2@]/S]-K
M\=CFSM+](UD/V8^LYS8K+%1^+7 +3!>Q7'OG!!UMD07CSE*CH5O@+[NK$(F[
MIA6]HXA91BPW8#-(HIC*TN+"4,KU89O"!D'W*Q]KP4E4>HEF0*6E%X>C6JNV
MA!$RY[):AP^*XEH,0 AG83:<6):+00CGGRFP D^RT4@?*9GIC4Q#?AJ\9_:\
MH11+_D^43F$,O+[B3X1W2#%1,2>Y5ZKA8KV@@;.>S;-(=H0M?L-,0M./)]&M
M=H^E+I^,(LI>E(M'1O3A;35NLXQ2-,KGSUG@(142T-)RYB"_#A6IT1V]'J).
M!,X*J)V)0JP](\5X!^(HH/,*%5F&S;QPM[+UJJ/[+MX9C8OH.LMG;;)EJZ7V
M3GWW4$OS59*1/BURM%QHAMF/[J2:N'/IPVL=PW8H-!GF):D]O-TZ,1,RI_\[
M9>H,2JM(N+:J)C8W_F>:*HDZ[(3"179W54%44NU:PKQBQ_+8;RN([1WZ%C4R
MA7C!2V9AO#FE^1&:0JQ70)*/*2DG;.99E.:3S0T-VQ1*K2L8+7^@(^]^FU0G
ML.T\%.>B#]J/BYP7E^81)0SR/+N!EQR#SU'I2BR\KQQKEA::>-<DPW<!2Q4<
MW]SM 4@2//.MF#)WSB9+AY))4GHVX)]CZDCC%) 3]#4T%&DAI5T^8YYDD!72
M54J!V4]92BQSH7B]F=]1_6V_9P3;ZQ\J/G7?],,L;/BG5!QUV!3'EBC!UAPN
M$D+2P0!N.DV9(W-'MY^WP\A@TZJVOIXH4>'^1!N2,$FQ6#[V^+18UP8K?E9D
M+D!BGFPRR82O4!2X#EP8^MAMRK]R@ 4'!)L9<X=I %H=GM1DE'8X#/QHAPF#
MD5F$]@ ^@I #.K=ETJOLQ,-)&SJ?628:,*$H.CA"9*N@BU5Z'>>93HP9[%08
MC./".JZ2]_/HGBBW3 =URN:N8-V=UM9;\P(UVY3*&[C<S!2GLPMM1:\Y8O=B
M+M[L3Y>U4%?Y"8F'@P''77^9D4.3JKB\4E5 ?EI!Y+>+.!7?.J)-]$R:]0B3
MX)7$K';?9$EYGIJ(N<!"Q/-G:$1%XZ#PK'$WTAV=3%W#IPG]*3P"CRR8")R<
MO R=FP<8CYMT_O;E,"]F5RWL]PLEY;<'*L< VN;&H8))R"9.]O6\=9>'O[S[
ME>"UCD:;#2M9I(U*J%=FX?CVRX[0+5V;P_7#M%XN:Y>'%U@T>0^"_/.W#ZFV
M)ZX=-NG,\DR'FQN,)PNEJ@!<V#@?3,=H;"+[&@770H>+.K2$IUAS8(3%<N%A
MX!(+T:4'@6B9>3J2%N,J8DK[.1S0> AU"8]'!GT2[ \12:>"'HWRK:0D5R/:
M/8S&$:[ $&MWIL*YAL9!AH*G">ITY@<;]Z42FA8W,<0982X(<$?H6VJR4Y"G
MB#NH8 Z(O^WM[(0[.SMOO[UDML<IX7XY5:-DH4OZ[Y'YHU (GS\++X.2-"7
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M"(1_QN[&.-@28@UNPLJ]:UEQZ ZPA>%,A"OPQT&EDPY,-)4.C ANL<WTAM0
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M*>5AD _!V2 A/BKOLA& XF710#(9K2W\B8?B.[^#TP]2K\@ZF>;*E G?P+C
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MK&C&0IPUKQ=4L,C6YH=<0/? 1W22&^J+N+4I?NLIB%*WY.?ADD#8 -EGZ*!
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M@O7O[<:TFBAK>SNJL#('@ZUFOPD_=/;;<GPA6,TQ^5[-$FV/M#>N 6=J&:7
MY*",2YAVA!J!4P+;I-02-HOSO7F(+R=CP)5"R(E=(CHNM.GR\8((M<5D=*W'
M!LX%@( ]ECKP-4(WUF3F"DNUE?>L:^ 2]IZ_)-)ZMJ@[6[[J/;K6L.D6W=W9
M>RPX)SD-W#K;(MLQ\"X>IL9/VR3JQ):SEQO^]I[PF  6*NM^DW>OQI?\ NP2
M#;I.P7I9TEDML;(3,!0R#2S?SD#6O&)K).%>TB=YAIKAAPI S)$I(7L%#0<+
MR0;]?=F25(//L6W I #^)=%]B'])K!^;0?(WMZ5/1=!2W>I-7UZR(JIN+RT>
MLR1!6!;$2-S+7. !O/>[^AC  $:M!,XU1R!\^-J'WO8VKWE-_[F;CI7N+E3W
M\]N'36MC[IY8SNSJXQ(NRP6AL/$(AH:@@%V@;PA?;W+PAV\J.;@EF Y]TW^)
M:TI!)N+>%WS^+$S"I6]M *<.'^BF?5N9^WC)M4(D1DN.TQQ[SSH['7\DMCQB
MU\5,-_8Y(#6,+Z8-V@0HLW9+K'WG(KQVY/B^5W0-+@1[YVE!=W<.EU>(L;@N
M?=3%7ARCRBR+J%0G^RIRW-HIEV3V24H>*-(]O!ZV>*#*6#6"WKMEZZ5Y>V_C
MBS_G+ [HW'AN%L82FUS9;3KKF-(8G+'NCH'9OW  =U)8?#8$C.=^&TU;4\L-
MO;(!P /57)U?5?A,XKIBUK.UQ2R-\$$\5&%7OJH;G,7(6B"?*($;9$42KJ N
MW"),U(8Y1O>]L?\>^\ST\H%?MJ$*Z_F*0+YTMG'54"J"6'?C];.<F4T-V_>R
MG(ZQ]8W24PQ=&Y?38E6.]_$?VG,K#42\;#U=Z*B@)!'T9U)H=>;]E>SH][D7
MHCTK?O<80#9$>MK"WXC]#X[_,Y1;3>2P$*4Q(UNFQ-"WD=N@^.D=QCX-",(M
M&WJTH,^+V_ 75$_D'R'*600L4;KENJJ7;<!;RXE]<T 8$F%-[.4^2-N.B-TF
M@>RW-BA_HM),<RT_]I-H")M1LK+@UELA=2;17%AR"B'$SP'/B.L,CX3DJ8>U
M#NWIR#,%ZQI=/R3!&;F-4-%_3MV@0F(<0DET6=!I&-C-9FAL$=FKK=S;3K%*
MB) L3S &3W;EXXG@59MMK,'1N$1TK?CVD^5LK,_;4E(#_Q9$1X5.&NQQ[O.C
M;$A3LKN!(!;L 6U5#%![KE5Y](AY9[)#V*\'HQ%VUGWY ^"D)CS0P G[#(^^
MJB6Q+Y'*#664Q7?O((&&=_V(<UK$LR%OC:,":Y?X$(]N()Y"BFB2/P/X]6BM
M6?';%)(<%;6]B2ED\7#&_4'[:B_<JF,@E5TP2@%M91OAO(#4T$(+:1/V]*;3
M^@97,$>C(IB-D!0<OI>984B*+4!'AQ/!^?Q19 !NX5FDAK>>,C7UN?M/ "="
MLWM3VI0,WFG_QR_OBQ:]OBC"=%$(?"$E9?4FBG$-CDO=2-1,16VL#/E#RE+I
M9Z^TS'5;*-R+>U4M<3OAHN1H1_H8;O=</BZWFF7*K^=.9N?DY5 TX<..;TL-
M*$18C"$9'I_3RCEFX\X;PW TP9)'HP0FEPO^-_(!P';Q_*%<\0L9_UKV:*(D
M3 N]&7FFY2+JIF4S<C<OL3_>*D;HQ?*H?2HND)#G=-)U,5T279-T7SG;05)F
MX,B30_<?3QX]RA\]>B1QB\F"2>\$UXV50,GDR0+-6AQ;R\!9@&',H!)2$R:X
M*6[T_3"QQGK?\"[FOI^4J6K;)7)60/[?+>7Q18E^%9H3J*5<$+T03M $ZPVS
M$>I4XY(5X4\J#;EK0<(@QZZD^'(XAVX#11?$X <OV;"6%M%N';EY7ZQ$):!*
M.6+KZ1,AX>HO %2$D.#'NB42Q>&60E\+]R3^$<[6%O\F96EW'@)A3F=$GNQT
MKG4&9&,R- 2L$HL\ANZ;'RL&[<B2]Y=7_ZN85^#_.B]L])&Z/=Q?$],1/8%_
MT!=?;PKQV:-O*H7XN3BM2&*+FLG<JL!E]L:Y^=CS!P</6=H!<8-H'WF#^%YS
ME7!!66OW@R])T5O3&J61B_%U0?E/4#1V&U,((WB+H2_/2ME49FP@<)#>*<U[
M\1&T%VF9;VZ)]OO/)ZP02TLG.ZY0NB0B(?>F6'A-,B0HD0 Y8#4Q5N\;H=^E
M &/0A.289L%2F_,&J/M /9+]NSB-^AE^_&I]59XOL@/J#-TCXE,*_9S'55(V
M:!_[*.3%>G9G^U.L)D:"] T>5*6P7DUI6N%';6!=>XUY9+_M3],M)FM.*>[Z
M"'J/[4,H;<IZYR+G  ROZ7X1K31W"/FEYH$R\";/W986I306LI;ZI>9N@IF=
M<4=3F.:*Y:X XNH,LXO59B4(N!=3OW^"VYZ7E!TB">T\XD?$_#6W18:_@[@.
MB6(7-R3_/8:&8L[UZEM0G.6ZP.:>R%1$@8+HYB+3S4*[-\2. 44N!+_(ZV<M
MS>Y.KZG)-"<$*Z:+/U#Z21<VC%E+8-MDP%Z2V<5J0^%^H<A>Z:-B32F3:,$M
M/W&?D$XG6_O4-'113]17.)N!ZAL]TAV\\6I=H$\=V+EOT!9T"I9MBCD16R.>
M)<!)D&W:W?&88\]JP7)W[OQJX@A4/\/58/1U2.4B<9'+ N"M]+G@HO!R038>
M0U\F'63SMMYX[=NL:)C*@""/&<V0]0FSX/2L-3.D2_1!8=VY0'@D2XIFC;"&
MX&E+=M=-+@-/_"7O8%W\UN_*0;J/@BKD%92L0P/R&24]NAOZ+$WZ9M%X=4.\
MG6%*@J\:K*5I19BU6T5==^%1?!QV"14O'3XFRGHR-YA9&^A<Y)1=Z_MI04EP
M3- X=ZL>FVL@&P=?)#6[^A*,($1R!)+KY+VJ)'EJ 33Q; 0AF'PDU++$S;3I
M;67*I':/=;GB=P9#YK$)@8\@A$5PFNDB#"0@3&XK<*--,MLDPP*[LHG3PSGD
M&< AII :XO0%'RU5R_0<RI9-#F3G66RBZ,(YVN"15-2QKBR@%U#.<H\TK=N6
MH*9LNM<BNIH2&@:4]#38ALR\(1/ZH72GV"QLST& -5:*L-2I"0,>+QEO@I[B
MU^ ZLI-77$/-)!'3;9;>IA:"S3)!K>$.;.:T=].[8Q9.DJ8LN((!!#J0E.)>
M?ORG90?,L_-ZMFPS#U"K+)=D0"0HJ1R1W\A%D@,S,L*X>^M.<V:O-+5]MYSA
M9&.WGEWQ'@U;\NJ_XOS/XV\J_[,EA$P]WJ@H@&8"5QX:6(K+)'OIURD1E?L%
MZ\OCSLB0TC5DO-E%-EOF MT)-MD24>0!?WU%]/B>5RC@GT;'\\+=G+8.;'G4
M+R%H VNR^_W&WIFG^58L*6\)'F-,\-G-L.0H &+,O#G7T6R;<<:,S3RW[FI<
M\\V1[JNA%#<:C-R>&"I%DSH$\]V=/5$BD50.V1QS*N%!20S/4!F]#5 <PN9K
M>2OFH%6LK;4F>'6A)2$7@\U+<'CK:Z0@?D&\V1XJJ^PJ/7BDW1V1%E/\HQ2S
M(&YP%V,F8B9[T X*Q+1[^(0;Y%L7]1>_YZ#H^5 [[3H%:,7*]7!C58U53,(%
MD5O&*XG%_%\\,5;/"K=3(XS)0/=$?^7IW<B7-K).O&%;W;&M?1UWD;&XZCUS
M>5$[I\#X4+C"[V2@L_X<HVB<$]Y\"GMAQ( )<.N*E9MLL^J\,A'*HU-K-[S&
M7P\^G)"6QY</>.K>Q_.%.JKI38E"3GO6KYR# Y;8E^=:S/.,;6T/:G:0!<^9
M;=QMDG.WVRCT* #)8=,1NSOE[W,^ +Q'ZXN(4>C$M6G?BN.KU#FG6'.11W??
MFL%7?.F:BAH0'[0+S@-4QINU$<$V.=@P\1!6VU;A_C62%@S<2:9S]WSN<GT
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M]\D3Q'K79Z@)D)E,W)3TT0:89"6<D<LIT1B(H20F^]E\Z4S[R"C5FMK(; *
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MX4-SN*W[P*?-Y3PE<V>0/:B>4E%CG <9P>!4*DNVE[]/"A&;GGI%0M_!>NU
MI9++%;VUF71QP%BY)=P'N; C^747SN>A*-9=M^=U'\!Z(#07.@CI*19,-R.G
MD#\=9T)EK_R4Z-'3&N4KQABP&,4*$:R&E5Y!</OK=R"&2N;MA  Y;TW9@_1H
M^YZWQAFLU /L9XJMANF'';QHM7%<7W>N+=!6 ABA;,S0+RKH>M^<W4>IS!O&
M_@ 3:^%#8*G,DW=7>D$K]P9 I M0+#HOL<EBO*2=Y$;C^;X 3D';#>L&]&*D
MM7*BG,$ZRVPU!M1' E/PY.&C)]C"'_K1=1M< J>7]J1SAYP[ ?PKGM[ 2Y<
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MUORB1%C'DKQ9TG8 'I&B:HNI^_Y[E$<Z=N[6==74TOGKV7]YK\S\C^1A(=A
MU\)?F<R&>!'+L72+^QO*RP 76IQ!9N+5FB61<0/]!>'GTBSOZ!38GP8@'7P%
MG5C/Z,O-?$8@W"@\0/P2(-AT<1-:U8:= T$;)IZ%)_&0'N@U/Q#B7B3M)Y.0
MP.MZU0JX)0BI=#K*M*AJUKG?^MO$%^N'39T=UQ[VJYD729*D(Q I',%N=(].
M7BDE3!<A'&L.0*QQ.>O9@+UX(C8$F)V(^*$ZT">W, ZT%:QBE]YRYB0(&&<#
MM+QI!B++<DF9?RBQ-=+]BW_9C]IV/#X$$NO)DJTAU1&&U"M/0^QU40)"Y[)'
M3FXSGSSHL>ECWX:58>G@58M$I(,-7@'"343V< -1J9*\F-KNJR?Z@'[OY3[T
M<9'TGN&A7_FY)WS@6 KN\3M*5OP2!SG6)QA!O7=HN*DD;\KN4&*?:<\@/)CR
M<N+9I W8@?:V72XJBUE(!44[![:A!<,_]$L8UXWR/VW,5!V*NYNW6HLI(N[>
MI&=E<&=R[M*C"5;"+X7>WH$[0(+T8Z"U?F1J<](+7UV=(X%C.$][N,:M0V)>
M)Q6,8-<4HX]N-]CS99^RQWAI3]HW\XXT]&"M0Q.N_4*]7#RH)P_F]>ACN6#$
MH0 /J:QH=G:<[^PQ)S8_'V==$IBUH$#DT[4TK6SP)G06(;/59=%<8;K$6O%@
MTA.T-IX0(7TR#K+KYKL[AM<F<NJX=6\*W79M;J('85K(E>0*_I,$(D+]*.:W
MX[878(PH('0A@P#_=A,!L@(8;P'E!B'KHC=SU?<^K,A"&JNA41ZIGG":+D&N
M.%0B3+_0F.-&4'VI<G%P\M@?V;09]2R?EVYY3 9X^OP+3Z&2W1\NZQM@[3:L
MD-'JQHP@@RB$K\6<]>T<)*U$#W+OL8C:@YWGUMB F1^9[O(458Y2<G2>)@Y1
MO#R-3$@:6J>80CSFA&!V1 2S!*.P@P2B7AYEP*I=-W9M)UFS R?);++;C9Q,
MP%,S>!EL4H?("J"E%GY__A=6''@JE)V?FM,RW!E?,P_;\V\J2_:YL)]G*6]/
MO"):1E:0!SXTY[6S=BC[@YUGT>[N$*OV!&K\O6E]48..7W$EXV@*=S86S<<-
M<^T=,TB;"HL.0Q=7FX>FVQ!Z!&TPK*4##BHV^M7H$*NGX]MKX?CFMD9(XEPD
M=+D'IR.WWY@O%]II!8V!T/PWY# ^>?89MMI?7_[MX,/9\>&;H^P?Q\>PV5[^
M[18^ZR<.X?V[T[,'AV_>G1Z?_)0=OOO'T<G!R=EI)H/YHL1<?WGXZ/$07&;9
MX,%WT'*>N26LS&MU@"8+CM+U2--0T>PNQ6AQ>@HO^IZI]<9"T$#,7"M)*J,:
M('0ZVZ1!R*P=<*=QE)-;7J_<9E\Z9$B2H@E^,@Y^@_\4[ND)3\=P\II&LXZK
MR5[0<UPP2H;G"PY:FJ4(, ,=%2;]A6V6;:4HPA(59D?,HX.1V_(6C8 /LU\M
MOXDDIEGDPVBE:B8'L9D^DQ>L"TSK 9>15[)U[CJ*":!L@Z8*P#IQ4Q+B<6)M
M +!@$R%!\SZ&D.XWO@3;IXVUD8X3E)B;!CQ&<!LADSM'\.D,DUDM@%L;QCE%
MCX6WP.>BDHHZ9$@3.H;\ZDLOAP#M5#<%W,^YE^[G)7!_I)Y&'P%DSR@]EB;A
M#-LKL:H:(IW@:FV0F0_F5\LLO+W4 >SM)?::%743@- @R^R=38C%/2U UW1L
MF1A%'DA_ZP+: 3$6EAF3F#/UDO(LL?2PJ8C :G/0- KYA>AR#[/C2?[)B_P6
M"[PIN1X><(E_PCI-3D&T9'5,Z66:'I,N4*#$3*[0 %[UB>MS/\&C.;0JV"K\
M08M"*=5=)&P[$V"/KPAA@^V>-$?XMRZC961$W8!/G?<%,'3;R^". O=?#]ZX
M:'AJ/D$>A?/RCS: PYP&GP6\Z[R1)P/>R"M._:!E>,>9T#?^/;F_'G,6BCOF
M[AVR]S6Q6I#$)\!QJM^SO>?\]559-&V?7>Q0-WA7 YN@?6UW&]T-0@Y31[;;
MA"4D/NK&BEEV6!C>-1?NZO\JN*W_E?I"GR[%4/X^6D[G&B=4X<N4VALQWH)A
M0[QQ*JT"1A.TX9MK*O![VFO+A=V8ONNMQ[XWT)3_ZG\[(_SBG5^-H.-+H[:-
M-7N,)K/\SV^*F_V8Z2=$7BEA,6F3V+Y1>'\8SP5=S#''"?4X:K.&H3U(]Z,,
M/ V7G@A1YUDN>WHZ[A-'RL&BN\5L.@_2 -1#-5E.$8KLSJ-JS.\8B@'"[H@T
MYUJE3:+N*:(QR3M=A2:U(&M4L@AJU[PD"]YK)4U)!NP.6]V4:+!U.VU=].Q,
M\&]"#Q[L!1*D@,ZCH5?OMA^^=N6KPQX^7L9F&KIJ6X/3\/6F\?[R3:7QM@6[
M;;JZ^\V(L,^&]/&X6B=HRZG=C: _S'S5PW4F5)AFZ2/8M*4UC+DNM)* DRH:
MTL#$2\"NZ#*/2J^9+NA@1_<+8^TECXTSZ$U[C[-AC@O;$P?VB9X!+=50PP\<
M\$I$;,VYN4O&9@[F,<@:./^=A"P@CL-OP+1\<J'W-H[ATXT4W#JB9.OS51:/
M'"N>1H[7]DU6H< -961C<)3:<3SD9_@.I 1(:HI@48GL'Y-!@@<*8?&&EI8D
M!J5$!PT".9?W9*^AECQ<-P<U B"@HC8"YSN R+C@P[B\B3E;(SY!@B%:7TP"
M$$Q<E"P\T8C*ZV*Z#+P[4KF?)-P_SXY;AR@FTXY 8VC#02!"[PH:%R7A'K6_
M=8NE"4-#KYK+P,JRKV@)'),D E,U+!X3_.<^JWPO4A!)JQ\OSV%PA,*-XKZ$
M1!Q6!X1'-V+4FW>NXZM.;+Y5>G_M,HQ&Y6NA[N^=7C_S\GM$-Z3*&&L:[D4X
M0[24^*Q28QS5\Q5AB]@2S:#6//78F4NHE:J/O$Z4T):-X\HG165M/\ E49Z.
M90EOI1&8K#9I /+I$H%=#VS34M8MY0+7)C@PC-/$]AC(G>HH;1FISR9?;#!O
MN1@;YAA BG0FOK)[8>UKSCB^ C@DXQ<KXL>G(^3<_2<P?H+:2X,8ZC[U2KT%
M4ZR#>1@)DX^:<WIKDZIQEI;T[_RLAYR,H2!=7$6I>(7;OR-%$M826J$R@E[=
MU8,)W&COV7>\Y\?0JD>'HV'<PT%:.5$ O\T1WR(9 ?Q*XN4T3 7&[R);2!"8
M$'.)<PP)QBQP *@2&DJ^8*Z,;%DL#,KH;D+@!'<(FT:3J- XWJX6&D9[6-Y[
M(9*%E8#,(18*LXD<8>Y%^F8K$7Q"4C;GARQ"FC8K\V(.+/1+*2#L4RC?K-S1
MDK),<BW;"WHZ$@]WGZ[LHKV57)]:3CLC7I<OFH'PS"8OGZ;TRU,.N+7Y;, Y
M1?VW$;?,OC.CAOUR8'J][EVR\BS*JG?=W["\@TX!V@@^$K7-XTK_R,H(MD/&
MUS';FF4M+$&^I<3WY^=M:T8]),P)%\8\5ZP)MDV-*DGD3'/8EHO%%-I7P7Y<
MNO>*]-L3]^<<Y@DS>H4&9[DA'L="#QQH2Q"L(_BE6673NH!^$[>;O)845N_C
MK*6&GL$B?5E,M=8ON<H._JK"B!M=@EA\W5GB9LF-#\L9ILVTR1'JX,L%I,),
MZ[?&][PZ<M^,3%RWXV5)X6]0Y(F(]Q@:P'Q^5=O6U!E2&@"GK=5SE;P2RM[D
M'!#%@^3]F,J]''/R+WSNBVE]7D2O N[O6T& =B*%_Z''$N!#7Y?'UXQQ^_Z;
M2HY]3E3[[2UR #/I&%^K;)"OL[IP0U_MM*?8YAC>M)OWC&F'3&V+2(<LO4M(
M V=N'U"UN;><OKY"2,EO Q:]4VE-I2'ZI#C<ZA"]34.*4F1&'73]D>)]L/#U
M),\&=>=N[<<A(UDA@X/"/24U/N6RL%Q,<.9B*(0E +T)"&CH09*N48>24.0=
M<)_2'-2^']R D^A\7@!\X:#H@E<%L!$+TZSII3?I"ON"D'H.&J-^EP_#%[6W
MZG8*];V<3SKU*;_\+W.W[:?<3VH,!@BG$_5EM86X2X$(-_O O=T&VW6/:%M_
MC3(QF+#I03OX#5[W;?#1!AL</A6!3K:?W R#,;_1KD OQG!?Z<O:(/Q1[!]+
MU?2KK^36N-FJKK%$!A.3PRL/,G:^KYHI+Z5PX:U7;64\@ESA'LYXD:W9QI#6
M$V[A[HY6R8-M>EM9314GB:U*K(BE#P)SB9 &MCN:?] G=$:%,$H9CC,C[Z%3
M*3?S&,\;Z!;8";/3U)?FF8'A#Y/@LUZKDDPWP$,ZTR=A;V"S<)EAGP_($82J
MU]#3>:%X"13YQ60]]":+*^Y^7H^9F[7;TP+F7/64K>1U$JG>=V2/]M<&KY_)
MJ(RW,RH=6)4U)^EG&V]F3;RL\"W-R0"QZ^<S(W'>_U961/S*KAGI3'?:@!C[
M$>(J%=(@;;+XQ:&K!EC SQ;*BZ.WN^.]5 1J*OX3?+LP0V6:L#'+!_CS&=*X
MC&7_B3^5]S^J^^'0XY-P9, C>JODB/%'X5?0$98!.*1X@6?N71K![+/8P+4F
M4-48^VS@V-C +^I7E?UHPPCL0^4-K]$;X(.<XXSF:89Z-1@1<OG$:)CU=%[
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M[.P&'G?3;G)GN,V?CDZ./AR\R=Y_>/>/X]/C=R>G=P/??/QH76L))/6X6>2
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M.Q_^SJZ!5R8J0GA)=YYFT1@ 8CDTC@@^VH:S!2/ZFKG_?OBFLG&??( _'SC
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M)P@Q\T:N(,:M0]L[[7_9SDTXA;NY&3?:9OQ@CFVF=,F1B -R;FJO6E@]J(X
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M3^K,,-37;F8+MO>A(!!Y:J%W;'K]@0R"4KE,(A#T_).XB'_#K:_@RAH@F]#
M5-<4 +*GHS%,8D7:-FGV<X9>#=E]:0_UA#3PY+1;A=R"+<>:-SW$7<M*ZS:@
MJI!*$5<=E4?Q7BUF<2]=1$Z1,?@R3? 9ME^YU>&65JTB7CF>0M@;3B2<?2:%
MT^+<(D^40=PV)^J_0)"K#DQ)K6BR+7D@,@[[51R**M6*8"E:NBH^/<TA3YO"
MC6^^)-5%DFL'H[SR@2X-M$"[ZBP994J#I&X>&U54MA<B5\A%?J49U>>/OJF,
MZI;=W3Y/:/7LBN1:8Q>DHL.A'=PG%D@E"R[> ;0+"WNLQE<I? F-/5US*"%-
MN#49R2W"4/?67)6-J@A0>W>S6[?F(IBYJ[%3G=1J7-@HQM(,:IEE) C!?%!&
M^2#>\[SW;IQ5:^OR.N04$>4.PU4\ 7E50UG,ERGN%M8PI+9.01 \CAOYBRP,
M\GV+,TV$E?_BO&7HWN>2S>8P7C C=&!2(LF3I:2=SPL<D;3:CTU^O$<:=%R[
M9W8N)3R!9^1=L.#]*S?BF\+X71<5(IT(!"/O?G195R.QUQ/G]BWD908 EF8)
M_"U[LH-Z[Q7D@'];-E4[KG!*B "2N9*]0CV[FF81*4F!_76,RNO<>%._$$N6
M(ZVUT[MU@X:N+XIXVTR?TGT?\405[_ &3TDD95LX3W ?L$'U])K3VCUI=KPM
M9]O."]CUX"3E2/Y2"O6+Y";8Z>E>33V&'DJA=(DRU):/(:5P@\/ZZJHBS>4W
M)<S&?@C P;7>E$0\=^N%FER?TMSUAZW/K'=YZJVV6)ZTRS]U?<J=!^W?9V'P
MQ+3Z@/U[73?+*RC=L#\.+_*0ZCJ(ZON[>3RC8W<OB#TA]/8[-LT.Y@M3>42T
M1$H580289R3QTJ%G%.)FH7F6 Q2 #8N$^J;?)><-)*P60;C$WL&D')>,6":1
M<KQ:BT+EG(S_M0)0[L4"MKE:UY"'[U4).3_\P2'^/E 9D/2ZUH!'6""E4)]'
MM+L3+F(I*T77C1T4'QA )EID.! @PJ]D4W.,O@+Y(NS4H<? ;,H5XU"Q"MLH
M8&4.::O,Z]#G2BGO_P#LG>Y_FKIM'[#X9V/K7B@(0)*@0H@3L>#DZBZ"ACTY
M-Q E0PUZ%7R8.!J\FC.1<L@*[3\F3![1G@1ISM"US&T)"G U_KL[4*B!.<7T
M.;F)-G:+:,GLV62SG76J(B8+)2%:NI:U;$%<9;G<98(6REC6Q$XZ7<Z!>) 6
M:J_=S[%C;T% <?_'FEC@.R!B.%T\L6&P18!I%$E%9 "O>2O3#J9"=9@P=*'
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MK"%J5CN0$=?GC@.=@7 Q[!$ #A6_=Q.OUU.0FA^VBWKT$8+9RV)V46+C&MH
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M%]5T-F"_?8_/%!92\'DQ[M>\%]L[+UIO6YY_5D&&05[$BW<$;$[?/%7P4V$
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M MIOQYA2AU&_JB\NKX?G/S^5P;*[)I\]CQBB_?9;LX[,DGM0I^XO#"LF"9[
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MCX]<QORWBQ1A]827FM21F)Z@^$"$R4$&E6+A(XN\0XPHT<%UB(?\V6R&7U+
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M?__G?_[G_YY&+3']=H6+RV;?TH,4/%"ASZOH2^)@PKW%R*YZ9K28(]F8D%K
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M"NIX=O0;?/CSU<>3'_\_4$L#!!0    ( %8V2D_S&B1!9Q   &,U   1
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M$A$!FY+'D!FJ>",U5#[>$[G48:\*W4^(2?(0=1>PM+#M!/[B9M$"<PVWJLQ
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M==T%\(5*B[K!?C&]!U4!BN;-8".J AR1YH=X%*C,=VA:_E=8*)'8H;L_;?4
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M9+5<AKP%MQ;[@)O).ARY4K8;U^YVZ>H:F&QV<+O3[_1FJYDT^/474$L#!!0
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M-D%-_<E,Q=(/XNVJD3E1*/.=B97CGB5IL-V6B3N1P9:6+X-<1V_N.0M9Q"!
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M'G+]Q@BWU7*1WUI]4\![(YF9%:;A2!XQ,U]'D-=W=^Y+B2J%CF!V,(7[(IO
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M^\5)<OC8(%4F59'@$>89>G*!4_^Z)Y,S07XC5-VY?L.^Q?S>2<RWC,/#(IV
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M\C=02P$"% ,4    " !6-DI/'HBD45P8  "/DP  #@              @ $
M    9#@Q,3@P-60X:RYH=&U02P$"% ,4    " !6-DI/I#WHQ,@Z 0":.0<
M$               @ &(&   9#@Q,3@P-61E>#(Q+FAT;5!+ 0(4 Q0    (
M %8V2D_S&B1!9Q   &,U   1              "  7Y3 0!D.#$Q.# U9&5X
M.3DQ+FAT;5!+ 0(4 Q0    ( %8V2D^P9S=H7P,  !L,   /
M  "  11D 0!M9"TR,#$Y,3 Q,"YX<V102P$"% ,4    " !6-DI/X#?\J5\&
M  !)1   $P              @ &@9P$ ;60M,C Q.3$P,3!?;&%B+GAM;%!+
M 0(4 Q0    ( %8V2D\XBOM=M 0   $K   3              "  3!N 0!M
H9"TR,#$Y,3 Q,%]P<F4N>&UL4$L%!@     &  8 > $  !5S 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>97</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d811805d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mednax.com//20191010/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d811805d8k.htm">d811805d8k.htm</File>
    <File>d811805dex21.htm</File>
    <File>d811805dex991.htm</File>
    <File>md-20191010.xsd</File>
    <File>md-20191010_lab.xml</File>
    <File>md-20191010_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
